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Abstract 
Rheumatic Heart Disease remains one of the most neglected cardiac conditions in children and 
young adults around the world. The pathogenesis is complex and remains elusive, and the 
clinical characteristics vary around the world. This thesis concentrates on different aspects of the 
disease in Egypt, where it is known to have a high incidence.  
The methodology included epidemiological studies in school children in Aswan and 
investigation of RHD in a population with history of RF, using newly developed 
echocardiographic criteria. Concomitantly, the pattern of immune response in RF and RHD was 
determined in serum and excised valves.  
In this series RF presents in children and young adults, as well as adults, (0.2-44 years, 10.69 ± 
6.24) with polyarthritis being the most common clinical presentation (87.9%) and recurrences of 
RF being very common (98.2%). RHD affected 23 in 1000 school children in Aswan with over 
90% of the cases being subclinical and developed in up to 69.2% of the individuals with history 
of RF, predominantly as mitral regurgitation.  Risk factors for the development and severity of 
RHD were shown to be low disease awareness, non-compliance to penicillin prophylaxis or a 
regimen of longer than 15-days. Resistance to antibiotic regimens, including Penicillin and 
Vancomicin seems to lead to development and recurrences of RF in Egypt. This series showed 
the presence of immune activation and ongoing immunological reaction in an apparently 
quiescent phase of the disease with distortion of normal valvular architecture, histology and 
composition. 
This work has served to define the epidemiology, pattern of disease, immune reponse and 
predisposing factors in a population with no previous data, also contributing to the improvement 
of the echocardiographic diagnostic criteria. Standardization of the criteria will allow comparison 
of prevalence in different areas and improve case detection.   
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1.1 Background 
Summary 
Rheumatic heart disease (RHD) is estimated to affect around 15,6 to 19,6 million people 
worldwide, of whom 2,4 million are children (Carapetis 1999, 2004, 2005
1
). The disease is 
responsible for 25–50% of cardiac conditions in children and young adults in some areas (Woo 
1983, Markowitz 1981). However, the true disease burden is certainly substantially higher and 
the true prevalence of RHD has been underestimated, owing to the almost total lack of 
echocardiographic screening for this disease.  
RHD starts with a pharyngeal infection, caused by group A (GAS), group C (GCS) or G (GGS) 
streptococci leading to Rheumatic Fever (RF), which presents in a variety of ways after a latent 
period of two to three weeks following the initial pharyngitis. Importantly, the geographical 
variety in types of streptococcal strains and their rheumatogenicity has not been clarified till 
date.  
Carditis occurs in up to 80% of patients with RF, and at least 60% of untreated patients develop 
chronic progressive and permanent valvular damage and dysfunction known as RHD (Steer 
2009
2
) affecting predominantly the mitral valve (Carapetis 2008, Ramakrishnan 2009, Reddy 
2004) with appearent difference in the exact type of valve affection in different parts of the 
world. Subclinical RHD shows a prevalence of 90%, for which echocardiography is a successful 
screening tool (Marijon 2007). However, there has been debate concerning the echocardiographic signs 
of early RHD and the diagnostic criteria to be used.  
The pathogenesis of RHD is complex and involves both microbial and host factors that 
predispose and influence the development of the clinical features by triggering the autoimmune 
humoral and cellular response that causes inflammation leading to the establishment of chronic 
RHD. A major role is attributed to inflammatory cytokines in mediating heart lesions (Guilherme 
2009) as streptococcal throat infection triggers an inflammatory reaction that involves several 
proinflammatory cytokines which can be detected in peripheral blood as well as valvular tissue 
of RF and RHD patients (Guilherme 2009). Nevertheless, RHD valves also show signs of 
cellular infiltration in combination with specific structural and biochemical features (Sampaio 
2007). 
Chapter 1 Introduction 
 
21  
 
   
Rheumatic Heart Disease in Egypt 
 
 
RHD causes high morbidity and mortality and remains a major public health problem among 
most of the world‘s population. However, RHD remains being badly neglected, with very few 
important initiatives and little research and many gaps in our knowledge of its pathogenesis and 
mechanisms. In Egypt, a high percentage of schoolchildren have clinical evidence of cardiac 
valvular damage due to RHD and the course is found to be severe and aggressive (Kassem 1982, 
Abdin 1968, El Sherif 1975), nevertheless, the prevalence and determinants which seem to differ 
from other areas are still unknown while data remains lacking.  
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1.2 Rheumatic Fever 
The worldwide incidence is estimated to reach up to 700 cases per 100,000 among children and 
young adults between ages 5 and 20 leading to around 10 to 20 million new cases every year 
(Carapetis 2005
1
, Carapetis 2005
2
, Tibazarwa 2008, Carapetis 2000, Soto Lopez 2001) in certain 
parts of the world of whom 60% to 90% will develop RHD (Ganguly 2004, Carapetis 2005
1
, 
Carapetis 2005
2
). Importantly, the epidemiology of RF varies between countries and regions 
(Bisno 1997, Dinkla 2003), and there is great concern about the high prevalence of streptococcal 
infection and RF (WHO 1986, Steer 2009) which remains endemic in different areas. The  
decline  of  the  incidence  of  RF  in  industrialized countries over the past four decades has been 
attributed to more hygienic and less crowded living conditions, improvement  of  access  to  
medical  care  and  introduction of  antibiotics. However, focal outbreaks of RF have been 
reported, often in combination with the reappearance of certain rheumatogenic serotypes (Veasy 
1987). The acute illness causes considerable morbidity and mortality, however, the major clinical 
and public health effects derive from RHD (Olivier 2000). 
 
 
 
 
Figure 1.1 Age-standardised disability-adjusted life year (DALY) rates from RHD by country 
(per 100,000 inhabitants) 
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1.2.1 Presentation 
The first symptoms appear after a latent period of two to three weeks following the initial 
pharyngitis, presenting in a variety of ways, including arthritis, carditis, chorea, subcutaneous 
nodules, and erythema marginatum. Polyarthritis is the earliest as well as the most common 
manifestation of RF, present in 60% to 80% of patients (Guilherme 2009) starting 
characteristically in the joints of the lower extremities early in the rheumatic attack when 
streptococcal antibodies are at peak elevation (Ilia 1992). 
Carditis, the most serious complication, occurs a few weeks after the infection in 40% to 80% of 
patients with RF and leads to chronic damage to the heart valves, known as Rheumatic Heart 
Disease (RHD), characterized by progressive and permanent valvular lesions (Guilherme 2009, 
Sanyal 1982, Sanyal 1974, Steer 2009
2
, Bland 1951). 
Sydenham chorea occurs in 10 to 30% of patients with RF.  Unlike arthritis or carditis, 
symptoms of chorea present late, usually months after the initial pharyngitis and the process is 
self-limiting and reversible (Jones Criteria 1992). Erythema marginatum, the characteristic rash, 
also known as erythema annulare, occurs in 5 to 13% patients (Massell 1958). Subcutaneous 
nodules are currently an infrequent manifestation of RF with a small frequency of 0 to 8% 
(Massell 1958) varying in different series and countries (Behera 1994). 
History of an antecedent sore throat 1-5 weeks prior to onset of RF is present in 70% of older 
children and young adults. However, only 20% of the younger children can recall an antecedent 
sore throat.   Although individuals of any age group may be affected, most cases are reported in 
persons aged 5 to 15 years (Steer 2009) as streptococcal pharyngitis is mainly found in this age 
group (Bassili 2000, Dajani 1992, Bharani 2010). RF is therefore principally a disease of 
childhood, with a median age of 10 years, being rare in children younger than 3 or above 18 
years (Carapetis 2005
1
). While pre-school children may frequently acquire stretococcal 
infections, overt disease is usually mild or absent although outbreaks in child care settings have 
been reported (Majeed 1986). The low incidence of less than 6 percent of streptococcal throat 
infection in children below 2 years of age may be the result of the low adherence rate of 
streptococci to buccal mucosal epithelia during the first years of life (Guggenbichler 1994). 
Streptococcal pharyngitis remains an uncommon cause of pharyngitis in pre-school children. 
However, approximately 40 percent of streptococcal infections are believed to occur in children 
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2 to 6 years of age (Markowitz 1963) and it is not clear why RF is uncommon in children below 
5 years and rare in children younger than 3 years (Guggenbichler 1994, Rosenthal 1968). 
Furthermore, although less commonly seen in adults compared with children, rheumatic fever in 
adults accounts for 20% of cases.  
Rheumatic fever occurs equally in males and females, however, with a worse prognosis for 
females (Sanyal 1982, Cole 1976, Longo-Mbenza 1998, Mahmudi 2006). Patients with previous 
RF are at risk of recurrence, which is the highest within 5 years and younger age at the time of 
the initial episode. Generally, the recurrent attacks are similar to the initial attack, however, risk 
of carditis and severity of valve damage increase with each attack (Sanyal 1982). 
 
1.2.2 Diagnosis 
The main clinical features of RF are outlined in the Jones Criteria (Stollerman 2001), which are 
constantly updated (Stollerman 1965, Stollerman 2001, Jones Criteria 1992) (Table 1.1). The 
diagnosis is made upon the presence of two major, or one major and two minor manifestations, 
plus evidence of previous GAS infection. Chorea and indolent carditis do not require evidence of 
previous GAS infection and recurrent episode requires only one major or several minor 
manifestations, plus evidence of previous GAS infection. The minor criteria lack diagnostic 
specificity than the major criteria and arthralgia without objective findings is common in RF. 
The pain usually involves large joints, maybe mild or incapacitating, and may be present for days 
to weeks, often varying in severity (Agarwal 1986, Nair 1990). 
Although, every revision increases the specificity but decreases the sensitivity of the criteria, in 
response to the steadily declining incidence of RF in developed countries (WHO 2004). 
Furthermore, the diagnosis of a recurrent RF attack can be less obvious than that of a first 
episode (Jones Criteria (1992 update)), therefore the Jones Criteria is applied more readily to 
initial attacks (Stollerman 2001). 
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Table 1.1 Guidelines for the diagnosis of rheumatic fever (Jones Criteria, 1992 update) 
Major manifestations 
-Carditis 
-Polyarthritis 
-Chorea 
-Erythema marginatum  
-Subcutaneous nodules 
 
Minor manifestations 
Clinical findings: 
-arthralgia  
-Fever  
 
Laboratory findings: 
-Raised Erythrocyte sedimentation rate or C-reactive protein concentrations 
-prolonged PR interval on electrocardiogram 
 
Supporting evidence of antecedent GAS infection: 
-Positive throat culture or rapid antigen test for GAS   
-Rased or rising streptococcal antibody titer 
*Criteria: Two major, or one major and two minor manifestations must be present, plus evidence of 
previous GAS infection. Chorea and indolent carditis do not require evidence of previous GAS infection. 
Recurrent episode requires only one major or several minor manifestations, plus evidence of previous 
GAS infection. 
 
Alternatively, the 2002-03 WHO criteria (Table 1.2) (WHO 2004) specify less stringent 
requirements for the diagnosis of recurrent RF in patients with established RHD and are thought 
to be more sensitive than the Jones criteria (Olivier 2000, WHO 2004). 
 
Table 1.2 WHO Criteria (2002-03) (WHO 2004) 
First episode 
-as per Jones criteria (Guidelines for the diagnosis of rheumatic fever. Jones 
Criteria, 1992 update) 
 
Recurrent episode  
-In a patient without established RHD: as per first episode 
-In a patient with established RHD: requires two minor manifestations, plus 
evidence of antecedent GAS infection. Evidence of antecedent GAS 
infection as per Jones Criteria, but with addition of recent scarlet fever. 
*Chorea and indolent carditis do not require evidence of antecedent GAS infection 
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1.2.3 Diagnostic tools 
There are different additive diagnostic tools for the detection of streptococcal infection and the 
diagnosis of RF.  
 
Streptococcal isolation 
Streptococci can be isolated by culture of throat swab, but they are only found in 15-20% of 
patients. This may be due to both the latency period between infection and the onset of RF 
symptoms and the prior use of antibiotic. Nevertheless, non-invasive carriage of group A 
streptococcus contributes to the low sensitivity of throat culture in diagnosing a preceding 
infection and rapid antigen detection tests from throat swabs have the same limitations as 
cultures with specificity of 95% but lower sensitivity.  
 
Laboratory tests 
Laboratory tests cannot independently determine the diagnosis of RF, although some provide 
supporting evidence of illness or are used to follow the progress of treatment. Different infection 
parameters are used to confirm the suspicion of RF differentiating between general infection 
parameters and streptococcal specific parameters.  
The initial routine laboratory assessment should consist of a complete blood cell count (CBC), 
including a white blood cell and differential count, and the determination of acute phase 
indicators such as ESR and CRP, the major inflammatory parameters. These acute phase 
reactants are plasma proteins that increase during acute phase of inflammation. They are 
produced by the liver under regulation of circulating cytokines such as interleukin-6 (IL-6), 
interleukin-1β (IL-1β), and tumor necrosis factor-α (TNF-α), released by monocytes and 
macrophages. Importantly, both ESR and CRP are affected by anti-inflammatory medications 
(Lane 2002, Wagner-Weiner 2002). 
Evidence of preceding streptococcal infection is set with the presence of increased 
antistreptolysin O (ASO), the antibody produced against an antigen produced by streptococci or 
other streptococcal antibodies as anti-DNAse B or antihyaluronidase, positive rapid direct group 
A strep carbohydrate antigen test or recent scarlet fever (Stollerman 2001). 
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Complete blood count (CBC) 
A complete blood cell count (CBC) includes a white blood cell and differential count. 
Leukocytosis with neutrophilia and mild to moderate anaemia are found in RF. Haemologlobin 
levels below 90g/l are usually associated with severe carditis. Lymhocytosis and severe anaemia 
suggest a differential diagnosis that includes leukemia and sickle cell anaemia.  
 
Erythrocyte sedimentation rate (ESR) 
Acute phase reactants are always elevated at the onset of acute RF. ESR is one of the major 
monitoring tests for acute phase inflammation because it correlates with increased levels of acute 
phase reactants, in particular, fibrinogen, which is one of the acute phase reactants produced by 
the liver in response to IL-6, IL-1, and TNF. About 60 to 70% of ESR depends on fibrinogen 
because of its neutralizing effect on erythrocyte syalic acid, which inhibits red blood cell 
aggregation (Kowalczyk 2006, Sox 1986, Paulus 2004).  
The erythrocyte sedimentation rate (ESR) is elevated in the first weeks of the disease, and higher 
levels are found among patients with cardiac involvement.  
 
C-reactive protein (CRP) 
CRP is an acute-phase protein which recognizes pathogens and mediates the complement system 
and phagocytic cells. It activates neutrophils, monocytes, and platelets, upregulates adhesion 
molecules, and appears to play a role in the clearance of apoptotic and necrotic host cells. These 
latter properties of CRP have been suspected to contribute to inflammation and autoimmune 
diseases. CRP is a member of the pentraxin family of proteins, made in the liver under the 
control of cytokines such as IL-6, IL-1, and TNF-α (Volanakis 2001, Du Clos 2004, Szalai 
2004). 
CRP usually appears in the sera of patients in the acute stages of a number of inflammatory 
conditions such as most bacterial as for example acute RF with or without carditis. CRP is 
considered to be a sensitive indicator of inflammation. Changes in the serum level of CRP with 
time from the same patient can be used as an index of recovery. The use of the CRP test to 
measure the effectiveness of therapy is of great clinical significance in cases such as acute 
Chapter 1 Introduction 
 
28  
 
   
Rheumatic Heart Disease in Egypt 
 
 
rheumatic fever. C-reactive protein (CRP) is elevated at the onset of the acute phase and tends to 
disappear at the end of the second or third week (Yeh 2004). 
 
Anti-streptolisin O (ASO) 
The ASO titer (ASOT) demonstrates the body's reaction to an infection caused by streptococci 
which produces the enzyme streptolysin O, which can lyse red blood cells. Because streptolysin 
O is antigenic containing a protein foreign to the body, the body reacts by producing 
antistreptolysin O (ASO), which is a neutralizing antibody. Serial ASO testing is often 
performed and recommended at 15-day intervals to determine the difference between an acute or 
convalescent blood sample. The normal values are 160 Todd units/ml for adults and 170-330 
Todd units/ml for children from 5 to 12 years. The sensitivity of ASO titer (adults with >240 
Todd U and children with >320 Todd U) is 80%. Streptococcal antibodies are the most useful 
infection parameters because they reach a peak titer at about the time of onset of RF, they 
indicate true infection rather than transient carriage and any significant recent streptococcal 
infection may be detected by making several tests of different antibodies. Approximately 20% of 
patients with RF may not have this antibody. In these cases, determination of anti-hyaluronidase, 
ant-deaoxyribonuclease B (Anti-Dnase B) and/or anti-streptokinase antibodies may be essential 
for the diagnosis of recent infection. Negative infection parameters should be followed by a 
throat culture (Bisno 1997, Hahn 2005, Roodpeyma 2005). 
 
Chest Radiograph and Electrocardiogram (ECG) 
The chest radiograph and ECG may be abnormal in only 30% of patients with carditis. The chest 
radiograph usually shows cardiomegally only in patients with myocarditis or moderate to severe 
pericardial effusion. 
Electrocardiograms may reflect the effect of the inflammatory process on the conduction system 
and repolarization abnormalities characterized by prolonged PR and QT intervals can be 
observed. The most characteristic feature in acute RF is conduction disturbances most commonly 
in the form of 1st degree heart block (a prolonged PR interval) which occurs in 24- 40%.  Repeat 
tracings are recommended to demonstrate a variation in atrioventricular conduction which is 
more valuable. The PR interval usually returns to normal after the disease becomes inactive and 
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it can occur with or without carditis. In acute rheumatic pericarditis, ST elevation or inversion is 
present. Low-voltage QRS complexes and abnormalities of the ST interval may be seen with 
pericarditis (WHO 2004). 
 
Echocardiography 
Echocardiography improves the diagnosis and is successfully used for the detection of carditis 
without overt evidence of valvular or other cardiac involvement (Marijon 2007, Carapetis 2008). 
Therefore, ultrasound should be considered as the primary diagnostic modality for RHD survey 
in children and should be used to diagnose subclinical acute rheumatic carditis and silent 
indolent rheumatic carditis (Olivier 2000, WHO 2004, Carapetis 2005
2
). The echo criteria is an 
important issue for consensus definition, and there is an increased interest in new and 
comprehensive criteria to enforce the diagnostic criteria for RHD.  
 
1.3 Rheumatic Heart Disease 
It is believed that there are 15,6 to 19,6 million people affected with RHD worldwide, of which 
2,4 million children aged between 5 to 14 years (Carapetis 2005
1
, Carapetis 2004). Importantly, 
estimates suggest that over 6 million of the 10 to 20 million individuals who acquire RF every 
year go on to develop RHD with most deaths occurring in childhood and early adulthood 
(Carapetis 1999, Carapetis 2005
1
). RF and RHD are therefore one of the major and leading 
causes of cardiovascular disease as they are responsible for 25 to 50% of cardiac conditions in 
children and young adults in endemic areas (Dale 1985, Woo 1983, Markowitz 1981). However, 
the true disease burden is likely to be substantially higher as these estimates are based on 
conservative assumptions, and the overall quality of epidemiological data from developing 
countries is poor particularly with respect to epidemiologic studies and the lack of screening 
(Carapetis 2004).   
 
School children 
Echocardiography has resulted in prevalence rates of 62 in 1,000 in Kenya (Anabwani 1996), 48 
in 1,000 in Nicaragua (Paar 2010) and 30.4 in 1,000 in Mozambique (Marijon 2007) providing 
an average point prevalence of 40 in 1,000 in school-aged children (Paar 2010). Importantly, this 
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prevalence increases significantly with age, peaking up to 42.6 per 1,000 in children aged 10–12 
years (Carapetis 2008). These results confirm that the prevalence of RHD in school-aged 
children is far greater than earlier estimates and extend the observations to show a high 
prevalence of subclinical disease in young adults who may be at great risk for developing 
chronic progressive RHD. Importantly, on the basis of the few studies that have estimated age-
specific prevalence in a broad range of ages (Carapetis 2000, Agarwal 1995, Aung 1992, Brown 
2003), it has been previously calculated that the number of RHD cases in children aged 5-14 
years should be increased fivefold to sevenfold in order to reflect the true number of prevalent 
cases in the general population (Carapetis 2005
1
) as the number of cases of RHD in school-aged 
children represents less than 20% of the cases in the whole population (Steer 2009). 
In Egypt, a high percentage of schoolchildren have clinical evidence of cardiac valvular damage 
due to RHD and the course is found to be severe and aggressive (Kassem 1982, Abdin 1968, El 
Sherif 1975), nevertheless, the true prevalence and determinants are still unknown and while data 
from several other places is available, current accurate data from Egypt is lacking. However, a 
prevalence of 5.1 per 1000 schoolchildren has been previously estimated in the early 1990‘s 
(Alwan 1993, WHO 1992).  
 
1.3.1 Clinical presentation 
RHD is usually the result of cumulative cardiac valve damage from recurrent or persistent 
episodes of RF, which are sometimes asymptomatic but leading to significant rheumatic valve 
disease in later life after just one carditis episode, as confirmed by echocardiography. Subclinical 
carditis or valvular affection, without clinical murmurs but documented functional changes is 
relatively common in RF (Tubridy-Clark 2007, Figueroa 2001) and approximately 90% of cases 
of RHD are clinically silent, occurring in asymptomatic individuals without audible murmurs 
(Marijon 2007). Therefore, many people with RHD do not have a known history of RF and are 
unaware of their disease until it is detected incidentally during a medical examination, or until 
their disease worsens and they develop symptoms of cardiac failure (Carapetis 2005
1
). 
Cardiac involvement is often established by finding of a new murmur of mitral or aortic 
insufficiency. Mitral regurgitation, heard best at the apex, is generally of moderate-to-high 
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intensity throughout systole. Aortic insufficiency is a basal diastolic murmur that is usually high-
pitched and blowing and decreases in intensity toward the end of diastole.  
RHD predominantly affects the mitral valve and, less commonly, the aortic valve. Mitral valve 
incompetence is the most common valvular lesion with a prevalence ranging up to 94% 
(Carapetis 2008, Ramakrishnan 2009), particularly in the early stages of the disease. Importantly, 
patients with mitral incompetence can remain relatively asymptomatic for up to 10 years, as a 
result of compensatory left atrial and left ventricular dilatation before the onset of left ventricular 
systolic dysfunction. Mitral stenosis is believed to develop later as a result of persistent or 
recurrent valvulitis, although rapid progression to mitral stenosis has been described in some 
areas. Tricuspid regurgitation can occur as a result of volume overload, usually caused by mitral 
stenosis (Jaffe 1988, Vasan 1996, Carapetis 2000). 
 
Similar prevalence of subclinical carditis and permanent RHD features suggests that acute valve 
lesions induced by subclinical rheumatic carditis persist to about the same extent as the lesions in 
clinically evident acute RHD (Marijon 2007). Importantly, progression of the rheumatic valvular 
lesions to chronic subclinical valvular disease is around 82% (Meira 2005) and the prevalence of 
persistence or deterioration of subclinical carditis is around 60% after five years of follow up in 
spite of continuous penicillin prophylaxis and no evidence of recurrent disease (Figeroa 2001). 
However, the long-term outcome of patients with subclinical carditis and RHD has not been 
established, and therefore, the persistence and development of permanent valvular lesions is not 
known.   
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Figure 1.2 Thickened, fibrosed and fused leaflets of the aortic valve, leading to regurgitation 
 
Figure 1.3 Calcific aortic valve 
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1.3.2 Risk factors 
Variables that seem to correlate with severity of valve disease include the number of previous 
attacks of rheumatic fever, the length of time between the onset of disease and start of therapy, 
and gender. RHD has been reported to be more severe in females than in males as isolated mitral 
stenosis is more common in girls than in boys with a ratio of 1:2 (Cole 1976, Longo-Mbenza 
1998) and carditis, valvulitis, and cardiomegaly are significantly more common in female 
patients (Mahmudi 2006). 
Repeated episodes of RF are believed to lead to further inflammatory damage and subsequent 
scarring of cardiac valves (Veasy 1997, Majeed 1992). Mitral and aortic regurgitation are the 
most common events caused by repeated valvulitis (Guilherme 2009) while recurrence of RF 
leads to worsening of rheumatic valve lesions. 
Meanwhile, reversibility has been reported and insufficiency from acute rheumatic valve disease 
has been shown to resolve in 60-80% of patients who adhere to antibiotic prophylaxis (Chin 
2010). However, other, additional influencing factors have not yet been reported.  
 
1.3.3 Prevention 
The administration of penicillin has been the most extensively strategy used to prevent and treat 
RF (Markowitz 1993, Bisno 1997, Macris 1998, Gibofsky 1993, Bisno 2004, Bisno 2002), but 
the currently available methods for prevention of streptococcal infections and its sequelae are 
still insufficient and inadequate (Bisno 2005, Bisno 1997, Carapetis 2005
2
, Jones Criteria 1992).  
  
Primary prevention 
Primary prevention of RF with prompt diagnosis and focus on antibiotic treatment of acute 
streptococcal pharyngitis (Tandon 2004, Bisno 2002) is beneficial in individual cases but has not 
been effective in controlling the disease, although the organism remains uniformly susceptible to 
penicillin (Bisno 2005, Bisno 1997, Betriu 1993). Therefore, penicillin is considered mandatory 
for the eradication of streptococcal infection of the upper respiratory tract (Bisno 2002) though it 
does not alter the cardiac outcome (Carapetis 2005
2
, Meira 1993, Lennon 2000, Bisno 2002). 
However, patients receiving penicillin show a slight faster clinical improvement, and a modest 
Chapter 1 Introduction 
 
34  
 
   
Rheumatic Heart Disease in Egypt 
 
 
reduction in symptom duration with antibiotic therapy, with more rapid decrease in fever and 
symptoms.  
A 10-day oral penicillin V regimen is required to prevent RF (Bisno 1997). This regimen can be 
replaced by an injection of benzathine penicillin G in regions where RF is still endemic. This 
preventive antibiotic treatment does not achieve more than 90 to 95% eradication of organisms 
from the throat, but is a reliable guideline for primary prevention of RF and the intrafamilial 
spread of virulent strains (Stollerman 2001, El Kholy 1980).  
 
Secondary prevention 
Repeated episodes of RF lead to further inflammatory damage and subsequent scarring of 
cardiac valves, therefore, the aim of secondary penicillin prophylaxis is to prevent development 
and worsening of RHD by reducing the incidence of recurrent RF (Veasy 1997, Majeed 1992, 
Massell 1988). Therefore, secondary prevention relies on accurate
 
case detection for the 
appropriate use of prophylactic antibiotics
 
and regular medical surveillance as it may be highly 
effective in preventing disease progression, even in children with subclinical disease. Penicillin 
prophylaxis is therefore a critical cost-effective intervention for preventing morbidity and 
mortality related to RF and the most practical strategy for prevention of recurrences of RF and 
the resultant progression to RHD (Michaud 1993, Carapetis 2005
2
, Stewart 2007, Steer 2009). 
Secondary prevention of RF consists of continuous long-term administration of intramuscular 
benzathine penicillin G (Manyemba 2002, Dajani 1995, Lennon 2002, Bisno 2005, Carapetis 
2005
2
, McDonald 2005, Manyemba 2003). The ideal dose, route, frequency, and duration of 
administration for penicillin as secondary prophylaxis have not been established specially for 
children and considerable variation is evident in practice and in guidelines around the world 
(WHO 2001, Gerber 2009, NHF Australia 2006, Saxena 2008). However, a systematic review of 
randomized controlled trials revealed that intramuscular injection of benzathine penicillin G is 
superior to daily oral penicillin (Manyemba 2002, Kassem 1992, Kassem 1996) and that a 
prophylaxis regimen of 2 or 3 weeks, rather than 4 weeks, reduces the number of recurrences of 
RF (Lue 1986, Lue 1994). 
Most physicians believe that prophylaxis should continue at least until the patient is a young 
adult, 18 to 20 years, which usually is 10 years from an acute attack with no recurrence  (Dajani 
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1995). The potential efficacy of prescription duration of prophylaxis five years or age 18 if no 
carditis during previous episodes, or ten years or age 25 in patients with only mild mitral 
regurgitation or healed carditis has been evaluated and shown to lead to a lower recurrence of RF 
attacks. Importantly, individuals with documented evidence of RHD should be on continuous 
prophylaxis indefinitely because RF can recur as late as the fifth or sixth decade of life. 
However, secondary prophylaxis with penicillin is expensive and has not been very effective in 
controlling RF, as the compliance to this regimen is low resulting in many recurrences of the 
attacks (Nordet 1992, Carapetis 1996). Nevertheless penicillin prophylaxis is the only proven 
cost-effective intervention (Carapetis 2005
2
, McDonald 2005, Manyemba 2003), and should be 
promoted. This approach requires patient compliance for the treatment and a well-developed 
public health infrastructure to assure fidelity and maintenance of registries (McDonald 2005, 
Bisno 2005). Nevertheless, regardless of whether or not prophylaxis is continued, there should 
always be a low threshold to test and treat acute episodes of streptococcal pharyngitis.  
 
1.3.4 Screening 
The fact that subclinical carditis is relatively common in RF (Tubridy-Clark  2007) ranging up to 
90% (Folger 1992, Abernethy 1994) and that detection at such an early stage is believed to limit 
the progression to and improve the prognosis of chronic valvular disease with adherence to 
secondary penicillin prophylaxis lending support to the fact that screening is essential. Therefore 
early detection of subclinical RHD is vital, as it presents an opportunity for case detection at a 
time prophylactic penicillin can prevent progression to important valve disease in young adult 
life. The fact that only screening can indicate the true disease burden and detect those in danger 
of developing or progressing into valvular disease highlights the importance of developing 
effective screening programmes to identify patients at risk or those who have asymptomatic 
disease in the community. Apart from its importance for applying secondary prevention, 
screening programs in different parts of the world where the disease is common, are essential for 
understanding the pathogenesis of the disease, developing new specific diagnostic methods and 
importantly helping the development of effective vaccines (Bisno 2005). 
In populations with high prevalence, RHD satisfies all the Council of Europe‘s criteria for 
selecting diseases suitable for screening. The Council of Europe (1994) and the WHO 
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recommended school-based screening as a way to estimate disease burden for RHD and as a way 
to identify patients in an area with a high prevalence of RHD (Bisno 2001, WHO 2004, Council 
of Europe 1994). However, specific recommendations regarding screening methods were not 
mentioned. A study carried out by highly trained clinicians in New Zealand found that clinical 
diagnosis of heart valve lesions is often inaccurate (Jaffe 1988). 
1.4 Echocardiography 
Echocardiography is a highly accurate method for diagnosing and characterizing valve lesions 
(Jaffe 1988, Bisno 2001), giving excellent details of the structural and functional abnormalities 
in RF and RHD and increasing the case detection rate by 10-fold compared to clinical 
examination, identifying children at risk of developing RHD for whom secondary prevention 
with penicillin prophylaxis may be effective (Marijon 2001, Marijon 2007) and resulting in 
major potential public health benefits. 
 
1.4.1 Echocardiographic criteria   
Echocardiography is found to be the only approach with sufficient sensitivity and specificity for 
the detection of subclinical carditis and RHD in the absence of auscultatory findings and overt 
evidence of valvular or other cardiac involvement (Marijon 2007, Carapetis 2008), during both 
the acute and the quiescent phases of the disease (Veasy 1993, Veasy 1994, Wilson 1995) and is 
therefore the perfect screening tool. However, there are no universally agreed criteria for the 
echocardiographic diagnosis of RHD and there has been debate concerning the 
echocardiographic signs of early RHD and the criteria to be used as an echo definition of RHD 
based on the length, velocity, and persistence
 
of the regurgitant jet may depend
 
on the gain 
settings on the ultrasound equipment (Minich 1997, Wilson 1995, WHO 2004). 
Based on the fact that progress and prognosis of RHD depends on case detection and adherence 
to penicillin prophylaxis shows the need for standard echocardiographic criteria to diagnose 
RHD. The evaluation of inclusion of echocardiographic assessment in the Jones criteria has led 
to the conduction several studies to define the role and value of echocardiography and screening 
in the diagnosis and assessment of subclinical RHD.  
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Criteria 1 (WHO 2004) 
The currently utilized World Health Organization (WHO) criteria for the diagnosis of subclinical 
RHD refers to a set of consensus recommendations by a WHO expert panel, widely used by 
practitioners for the diagnosis of subclinical RHD, and are based only on Doppler characteristics 
of the valvular regurgitation, defined by the association of a regurgitant jet >1 cm in length, seen 
in at least 2 planes, a mosaic color jet with a peak velocity >2.5 m/s, persisting throughout 
systole or diastole (WHO 2004) (Table 1.3). This set of criteria emphasizes the presence of 
pathological valve regurgitation but does not include valve structural features of RHD 
presumably missing up to three quarters of cases of subclinically affected and therefore 
potentially treatable children with RHD.  
 
Table 1.3 WHO criteria 
    Doppler criteria 
        A regurgitant jet >1 cm in length 
        A regurgitant jet in at least 2 planes 
        A mosaic colour jet with a peak velocity >2.5 m/s 
        The jet persists throughout systole or diastole 
 
Criteria 2 (Carapetis 2008) 
An stringent criteria that combined internationally accepted definitions of pathological valvular 
regurgitation (Bisno 2008) with evidence of structural changes to valve appearance that are 
typical of RHD has been developed defining regurgitation as pathological when meeting all four 
criteria defined by the WHO (Table 1.3) otherwise classifying it as physiological (Carapetis 
2008, Carapetis 2008
2
, Bisno 2008, Folger 1992, Wilson 1995) has also been used.  
This criteria resulted from a study that developed an abbreviated protocol that took 5–10 min per 
child and focused on rheumatic pathology of the mitral and aortic valves with diagnostic criteria 
consistent with those cited in a number of reports (Bisno 2008, Wilson 1995, Carapetis 2008
2
). 
Because the WHO criteria do not provide guidelines for categorizing severity, the division 
between categories was subjectively based on the direction of the regurgitant jet and its width, 
length and size compared with the left atrium. Structural abnormalities of the mitral valve such 
as valvular thickening and/or an elbow deformity of the anterior mitral valve leaflet 
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characteristic of rheumatic carditis were required for the diagnosis of definite RHD. If the mitral 
valve appeared normal, a diagnosis of definite RHD was made only if regurgitation was of mild 
or greater severity. Very mild pathological mitral regurgitation with normal valve morphology 
and the available views were only suggestive of RHD leading to a diagnosis of borderline RHD. 
However, any degree of pathological aortic regurgitation, mitral or aortic stenoses were 
considered to indicate definite RHD as they represent a condition rare in healthy children (Folger 
1992). Mitral stenosis was diagnosed if flow acceleration across the mitral valve and a mean 
pressure gradient greater than 4 mmHg were seen on echocardiography. Similarly, flow 
acceleration across the aortic valve with a peak velocity greater than 2 m/s was necessary for 
diagnosis of aortic stenosis. The severity of stenosis was also subjectively classified as very mild, 
mild, moderate or severe.  
These criteria included stenotic lesions but ignored the leaflet mobility and the subvalvular 
apparatus. Furthermore, a combination of functional and structural characteristics was not always 
necessary for the diagnosis of RHD, which might lead to a lower sensitivity of the criteria for the 
diagnosis by neglecting structural features. 
 
Criteria 3 (Marijon 2007) 
A systematic echocardiographic school based screening achieved a case detection rate 10-fold 
that achieved by clinical examination only. The criteria used considered RHD by the presence of 
any definite evidence
 
of mitral- or aortic-valve regurgitation seen in two planes
 
by Doppler 
echocardiography, accompanied by at least two of
 
the following three structural abnormalities of 
the regurgitant
 
valve: (1) leaflet morphology (typical marked thickening of the margins), (2) 
leaflet mobility (abnormal motion due to the posterior leaflet tip restriction), and (3) subvalvular 
apparatus morphology (prominent thickening, most often just below the valve, and shortening of 
chordal structures). Only left-sided valves were examined
 
for features of RHD. Mild tricuspid 
regurgitation
 
and pulmonary regurgitation were frequently noted but were not
 
regarded as 
indicating RHD as these conditions are frequent and seldom rheumatic in origin. This criteria 
included valvular stenotic lesions in the evaluation but failed to specify the parameters used for 
the definition of relevant valvular disease and regurgitation on echocardiography (Marijon 2007).  
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Table 1.4 Criteria 3 
 Any degree of valvular regurgitation seen in at least 2 planes 
Associated with at least 2 structural signs: 
        Leaflet restriction 
        Subvalvular thickening 
        Valvular thickening 
 
Recently, this criteria has been compared to the WHO criteria in the setting of systematic 
echocardiographic screening of randomly selected school children aged 6 to 17 years to assess 
the echocardiographic RHD prevalence, and evaluate both criteria showing a significant lower 
detection rate by the WHO criteria. This confirms that case detection may differ importantly 
according to the diagnostic criteria utilized and that emphasis of the pathological valvular 
function and exclusion of valvular structural features of RHD leads to underdiagnosis of up to 
three quarters of cases of subclinically affected individuals. 
This data indicates that inclusion of structural valve features in addition to regurgitation has the 
potential to increase case detection rates by up to 3-fold, with major potential public health 
benefits. Nevertheless, the WHO criteria is more likely related to acute RHD, whereas structural 
changes as defined in the combined criteria is more likely to suggest chronic RHD lesions. The 
WHO criteria may be easier to use at screenings with a portable ultrasound system, however this 
set of criteria seems to suffer from a substantially lower sensitivity than the combined one 
(Marijon 2009). 
  
1.5 Pathogenesis 
RF is a delayed, non-suppurative consequence of a streptococcal pharyngeal infection with B-
hemolytic streptococci of Lancefield group A (Group A Streptococcus, GAS), C (GCS) and G 
(GGS) resulting in an autoimmune response (Olivier 2000, Cunningham 2000, Guilherme 2009, 
Dinkla 2007). However, the pathogenesis of RF/RHD is complex and involves both microbial 
factors and host factors that predispose and influence the development of autoimmune reactions 
and sequelae following streptococcal infection (Guilherme 1995). Although the pathogenesis of 
RF and RHD remains somewhat elusive, RF is clearly the result of an exaggerated immune 
response related to molecular mimicry between streptococcal and human proteins triggering 
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factors leading to autoimmune humoral and cellular responses directed toward human tissues in 
the response to streptococci. However, the host genetic markers for the predisposition to develop 
RHD have not yet been identified (Carreno-Manjarrez 2000) although an increased frequency of 
specific HLA class II haplotypes has been observed among RHD patients (Guilherme 2009, 
Cunningham 2000, Bisno 2003). 
 
1.5.1 Molecular mimicry 
Sharing of antigenic determinants between epitopes on the pathogen, the streptococci and 
specific human tissues is implicated in RF and RHD (Bisno 2005, Zabriskie 2004) by triggering 
the autoimmune response that causes RF (Cunningham 2000, Guilherme 2001, Cunningham 
2003). This molecular mimicry between streptococcal antigens and human host tissue is thought 
to be the basis of cross-reactivity (Guilherme 2006). 
Streptococcal M proteins share epitopes with human heart tissue including cardiac myosin 
(Carapetis 2005
2
), troppomyosin, vimentin, laminin and sarcolemmal membrane proteins 
mediating B and/or T cell cross-reactions (Cunningham 2000). Therefore, antibodies against the 
M protein can cross-react with heart tissue and induce heart valve damage due to inflammatory 
reactions. This molecular mimicry between streptococcal and human proteins has been proposed 
as the triggering factor leading to autoimmunity in RF and RHD. 
The structural and immunological similarities between streptococcal M protein and human 
myosin, both α-helical and coiled-coil molecules seems essential for the development of 
rheumatic carditis (Carapetis 2005
2
). However, valvular disease, rather than acute myocarditis, is 
responsible for most of the cardiac morbidity and mortality of RF (Williams 2002, Kamblock 
2003, Gentles 2001, Essop 1993).  
 
1.5.2 Cellular and humoral immune response 
Humoral and cellular immune responses are involved in the development of RF autoimmune 
reactions (Guilherme 2005
2
) and both B- and T-cells play important role in the development of 
RF (Guilherme 2007). The role of the humoral immune response in the development of RHD 
lesions is to trigger endothelial inflammation, leading to subsequent T- cell infiltration 
(Guilherme 2005
2
). 
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Streptococcal and host antigen cross-reactive antibodies facilitate heart tissue infiltration by T- 
lymphocytes. Activation of CD4
+
 T-cells which are believed to be the major effectors of heart 
tissue lesions is triggered by the presentation of streptococcal antigens, mainly, via HLA class II 
molecules leading to a degenerate pattern of antigen recognition between streptococcal antigens 
and autoantigens (Guilherme 2005
2
, Guilherme 2007). T-cells are therefore able to recognize 
Streptococcal M5 protein peptides and produce various inflammatory cytokines such as TNF-α, 
IFN-γ, IL-10, IL-4 which could be responsible for progressive fibrotic valvular lesions (Chopra 
2007). 
The recognition of bacterial and/or human-antigens depends on antigen presentation by antigen-
presenting cells (APCs), such as macrophages, dendritic cells, and B-lymphocytes, in the context 
of MHC class I or II to T-cells via T-cell receptor. Recognition of human-proteins by other cells 
is mediated by the mechanism of ―epitope spreading,‖ in which an initial immune response 
against a determined pathogen generates broad diversity recognition of human-antigens that 
triggers an amplification and diversification of the autoimmune response (Lehmann 1992). 
The activation of CD4
+
 T-cells is triggered by the presentation of streptococcal antigens, mainly, 
via HLA class II molecules. However, pathogen epitopes that present structural or sequential 
similarity to human-epitopes might activate autoreactive T-lymphocytes that have escaped 
immune tolerance by the molecular mimicry mechanism also activating B-cells that will produce 
pathogen and human-antigen-specific antibodies (Guilherme 2009). 
Antigen-activated CD4
+
 T-cells polarize to Th1 or Th2 or Th17 subsets, the three subsets of T- 
helper (Th) cytokines currently described, depending on the cytokine secreted. Once activated, 
T- cells secrete cytokines that activate autoreactive B-cells. Polarization of the immune response 
towards either B- or T- cells results in different manifestations of the disease, such as arthritis, 
Sydenham's chorea, and carditis. Th1 are involved with the cellular immune response and 
produce IL-2, IFNγ, and TNF-α. Th2 cells mediate humoral and allergic immune responses and 
produce IL-4, IL-5, and IL-13. Th17 cells have recently been identified as a new lineage of 
effector Th cells, with an important role in host defense against infections by recruiting 
neutrophils and macrophages to infected tissues (Stanevicha 2003) showing a type of 
proinflammatory response mediated by IL-17 with the differentiator factors being cytokines 
TGF-ß, IL-6, and IL-23 (Guilherme 2009).  
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It is suggested that cell-mediated immunity within the heart is responsible for the resulting 
cardiac damage (Stollerman 2001, Guilherme 2009) as there is presence of heart-reactive 
antibodies in the serum of patients with RHD and deposition of such antibodies in the 
myocardium, which emphasises the importance of humoral immunity.  Therefore, it is believed 
that antigenic mimicry or cross-reactivity between streptococcal antigens and cardiac 
autoantigens may initiate the autoimmune response resulting in cardiovascular damage.  
The description of intralesional T-cell reactivity demonstrates the role of CD4
+
 T-cells as 
effectors of the autoimmune lesions and how these cells expand when driven by streptococcal 
cross-reactive heart tissue suggesting their role as major effectors of autoimmune reactions in the 
heart tissue in RHD patients. Therefore, the pattern of cytokine production in the heart lesions 
favors a Th1-mediated disease. 
 
1.5.2.1 Cytokines 
Cytokines are important secondary signals following an infection as they trigger effective 
immune responses and deleterious responses in autoimmune disease. Streptococcal throat 
infection triggers an inflammatory reaction that involves several proinflammatory cytokines, 
such as IL-1, IL-6, and TNF-α (Hackett 1992, Kotb 1993, Tomai 1990, Ramasawmy. 
unpublished observations). Cytokines  appear  to  play  a  crucial  role  in  triggering 
immunologic  and  inflammatory  reactions  in  RF. Moreover, IL-6 and TNF-α are well-known 
inducers of acute phase reactants and show significant correlation with the CRP and ESR. (Yegin 
1997) The presence of these cytokines shown in peripheral blood of acute RF and active RHD 
patients (Yegin 1997, Miller 1989, Morris 1993, Narin 1995, Samsonov 1995) as well as 
valvular tissue suggests a major role for inflammatory cytokines in mediating heart lesions in 
RHD, however, their definite role as major damage mediators have not been cleared yet 
(Guilherme 2009). 
The cytokine pattern produced by Th cells in response to defined antigens is crucial to drive the 
humoral or cellular immune responses. In addition, the concept of pathological or physiological 
autoimmune reactions depends on the cytokine produced in response to the autoantigens that are 
being recognized by T-cells. The different manifestations of RF involve particular autoantigens 
as targets of pathological autoimmunity (Stollerman 1988). Arthritis, chorea and mild RHD are 
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in part due to a pathological autoimmune reaction probably mediated by Th2-type cytokines, 
leading to an exacerbated humoral response, as reported in several studies (Cunningham 2000). 
On the other hand, carditis, valvulitis and severe RHD are mediated mainly by T-lymphocytes 
(Guilherme 2001, Guilherme 1995, Guilherme 2007, Raizada 1983, Kemeny 1989). 
Increased plasma levels of IL-1, IL-6, and TNF-α in patients with heart failure (Matsumori 1994, 
Mann 2001, Lane 1992, Smith 1992) and significant changes in serum values of IL-6 and TNF-α 
in the acute phase of RF have been reported (Miller 1989). Furthermore, the TNFa levels have 
also been shown to correlate with the IL-6 levels (Yegin 1997). It has therefore been suggested 
that estimation of IL-1α in carditis and IL-6 in arthritis may be helpful as minor criteria for 
diagnosis and follow-up of rheumatic activity, and advised therapy for rheumatic carditis with 
anticytokines such as anti-IL-1α and anti-TNF-α immediately after diagnosis to prevent or 
reduce valvular damage (Hafez 2001). 
 
Interleukin-1 (IL-1) 
IL-1β is predominantly expressed by monocytes while IL-1α is mainly expressed by 
keratinocytes. However, IL-1 is also produced by activated macrophages from different sources 
and by peripheral neutrophil granulocytes, T- and B-cells.  The main biological activity of IL-1 
is the stimulation of T-helper cells, which are induced to secrete IL-2 and to express IL-2 
receptors. IL-1 acts directly on B-cells, promoting their proliferation and the synthesis of 
immunoglobulins and functions as one of the priming factors that makes B-cells responsive to 
IL-5 and by enhancing the expression of adhesion molecules IL-1 promotes the adhesion of 
neutrophils, monocytes, T-cells, and B-cells. In combination with other cytokines IL-1 is an 
important mediator of inflammatory reactions as it markedly enhances the metabolism of 
arachidonic acid (in particular of prostacyclin and PGE2) in inflammatory cells such as 
fibroblasts, synovial cells, chondrocytes, endothelial cells, hepatocytes, and osteoclasts. 
Furthermore, IL-1 is also a strong chemoattractant for leukocytes and activates oxidative 
metabolism in neutrophils. Apart from its clinical significance as a stimulator of T-cells, IL-1 has 
been shown to also promote wound healing, which is thought to involve effects on angiogenesis, 
the promotion of proliferation of fibroblasts, and the chemotactic activity on neutrophils.  
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IL-1 is reported to increase during active rheumatic carditis and significantly elevated amounts 
of IL-1α as well as IL-1b (Yegin 1997) have been found in ARF and active RHD patients 
(Morris 1993) persisting for up to 48 weeks (Miller 1989). 
 
Interleukin-2 (IL-2) 
IL-2 is produced mainly by T-cells expressing the surface antigen CD4
+
. IL-2 causes and 
stimulates the proliferation of T-cells and is a growth factor for all subpopulations of T-
lymphocytes being an antigen-unspecific proliferation factor for T-cells that induces cell cycle 
progression in resting cells and thus allowing clonal expansion of activated T-lymphocytes.  
IL-2 also promotes the proliferation of activated B-cells in the presence of additional factors, for 
example, IL-4. Due to its effects on T-cells and B-cells IL-2 is a central regulator of immune 
responses and plays a role in anti-inflammatory reactions, hematopoiesis and tumor surveillance. 
IL-2 stimulates the synthesis of IFN-γ in peripheral leukocytes and also induces the secretion of 
IL-1, TNF-α and TNF-β. Increased production of IL-2 during ARF and in patients with active 
RHD correlating with the numbers of CD4
+
 and CD25
+
 cells on the periphery (Yegin 1997) has 
been reported (Morris 1993). 
 
Interleukin-4 (IL-4) 
IL-4 is produced mainly by a subpopulation of activated Th2 cells which are the biologically 
most active helper cells for B-cells and also secrete IL-5 and IL-6. However, a lesser extent of 
IL-4 is also produced by Th1 cells. 
IL-4 promotes the proliferation and differentiation of activated B-cells, the expression of MHC 
class 2 antigens and low affinity IgE receptors in resting B-cells, also enhancing expression of 
MHC class 2 antigens on B-cells and promoting their capacity to respond to other B-cell stimuli 
and present antigens for T-cells. This promotes the clonal expansion of specific B-cells enabling 
the immune system to respond to very low concentrations of antigens. Furthermore, IL-4 
stimulates the proliferation of thymocytes with the marker spectrum CD4
-
 CD8
-
, CD4
+, CD8+. In 
CD4
+ 
cells IL-4 induces the expression of CD8
+
. 
IL-4 may be of clinical importance in the treatment of inflammatory diseases and autoimmune 
diseases since it inhibits the production of inflammatory cytokines such as IL-1, IL-6 and TNF-α 
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by monocytes and of TNF by T-cells. The lack of IL-4, a regulatory cytokine, in the valvular 
tissue is involved in the progression and permanence of RHD lesions. In addition, the lack of IL-
4 is believed to perpetuate and/or exacerbate the production of the inflammatory cytokines TNF-
α and IFN-γ (Guilherme 20053). 
 
 
 
Interleukin-6 (IL-6) 
IL-6 is produced by many different cell types, mainly monocytes, fibroblasts, endothelial cells, 
macrophages, T-cells and B-lymphocytes. Physiological stimuli for the synthesis of IL-6 
includes IL-1, bacterial endotoxins, TNF while IL-6 can also stimulate or inhibits its own 
synthesis, depending upon the cell type. IL-6 is a pleiotropic cytokine influencing antigen-
specific immune responses and inflammatory reactions and is one of the major physiological 
mediators of acute phase reaction and also a B-cell differentiation factor and an activation factor 
for T-cells. In the presence of IL-2, IL-6 induces the differentiation of mature and immature T-
cells into cytotoxic T-cells. IL-6 also induces the proliferation of thymocytes and probably plays 
a role in the development of thymic T-cells and is capable of inducing the final maturation of B-
cells into immunoglobulin-secreting plasma cells if the cells have been pre-activated by IL-4 and 
stimulates the secretion of antibodies in B-cells. 
 
Interleukin-8 (IL-8) 
IL-8 is produced by stimulated monocytes, macrophages, fibroblasts and endothelial cells. In 
many cell types the synthesis of IL-8 is strongly stimulated by IL-1 and TNF-α while interferon 
IFN-γ can function as a costimulator. IL-8 differs from all other cytokines in its ability to 
specifically activate neutrophil granulocytes and causes a transient increase in cytosolic calcium 
levels in neutrophils and the release of enzymes from granules it also affects B-cells directly 
through a specific mechanism that is different from IFN-γ and IFN-α. IL-8 may be a marker of 
different inflammatory processes and is an important inflammatory cytokine in activation of 
chemotaxis and the accumulation of leucocytes into the inflammation site (Endo 1991, Seitz 
1991, Whicher 1990). 
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Significant elevations of IL-8 have been observed in the plasma of RHD patients with cardiac 
failure which suggests that IL-8 might have a role in the pathogenesis of RF (Yegin 1997). 
 
Interleukin-10 (IL-10) 
IL-10 is produced by activated CD8
+
 peripheral blood T-cells, by T-helper CD4
+
 T-cell clones 
(resembling Th0, Th1, and Th2) after both antigen-specific and polyclonal activation, by B-cell 
lymphomas and monocytes following cell activation by bacterial lipopolysaccharides and mast 
cells. The synthesis of IL-10 by monocytes is inhibited by IL-4 and IL-10.  
IL-10 inhibits the synthesis of a number of cytokines such as IFN-γ, IL-2 and TNF-β in Th1 T-
helper subpopulations of T-cells but not of Th2 T-helper cells which can be antagonized by IL-4. 
The inhibitory effect on IFN-γ production is indirect and appears to be the result of a suppression 
of IL-12 synthesis by accessory cells. IL-10 is produced by, and downregulates the function of, 
Th1 and Th2 cells. In macrophages stimulated by bacterial lipopolysaccharides IL-10 inhibits the 
synthesis of IL-1, IL-6 and TNF-α. It also leads to an inhibition of antigen presentation. In 
human monocytes IFN-γ and IL-10 antagonize each other's production and function. IL-10 has 
also been shown to be a physiologic antagonist of IL-12 and reduce the production of IFN-γ and 
IL-2. IL-10 appears to be responsible for most or all of the ability of the conditioned medium of 
Th2 T-helper cells to inhibit cytokine synthesis by Th1 cells and acts as a costimulator of the 
proliferation of mast cells (in the presence of IL-3 and/or IL-4) and peripheral lymphocytes.  
IL-10 is also a costimulator for the growth of mature and immature thymocytes (together with 
IL-2, IL-4 and IL7) and functions as a cytotoxic T-cell differentiation factor, promoting a higher 
number of IL-2 activated precursors of cytotoxic T-lymphocytes to proliferate and differentiate 
into cytotoxic effector cells. IL-10 sustains viability of B-cells and also stimulates B-cells and 
promotes their differentiation. It enhances the expression of MHC class 2 antigens on B-cells 
whereas it inhibits MHC class 2 expression on monocytes. In B-cells activated via their antigen 
receptors or via CD40, IL-10 induces the secretion of IgG, IgA and IgM. This effect is 
synergised by IL-4 while the synthesis of immunoglobulins induced by IL-10 is antagonized by 
TGF-β. Furthermore, the activation of macrophages can be prevented by IL-10.  
 
Interleukin-12 (IL-12) 
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It is produced mainly by B-cells and to a lesser extent by T-cells and is secreted by peripheral 
lymphocytes after induction. The most powerful inducers of IL-12 are bacteria, bacterial 
products, and parasites. IL-12 stimulates the proliferation of human lymphoblasts following cell 
activation by phytohemagglutinin and activates CD56
+
 NK-cells, being blocked by antibodies 
specific for TNF-α.  
In peripheral lymphocytes of the Th1 T-helper cell type IL-12 induces the synthesis of IFN-γ and 
IL-2, and TNF. TNF-α also appears to be involved in mediating the effects of IL-12 on natural 
killer cells since the effects of IL-12 are inhibited by an antibody directed against TNF-α. IL-12 
and TNF-α are costimulators for IFN-γ production with IL-12 maximizing the IFN-γ response 
and the production of IL-12, TNF, and IFN-γ is inhibited by IL-10. In Th2 T-helper cells IL-12 
reduces the synthesis of IL-4, IL-5, and IL-10.  
IL-12 synergises with suboptimal amounts of IL-2 in promoting the proliferation of mononuclear 
cells in the peripheral blood and in promoting the generation of LAK cells (lymphokine activated 
killer cells). However, picomolar concentrations of IL-12 are as effective as nanomolar 
concentrations of IL-2 in augmenting the cytolytic activity of natural killer cells expanded in 
vivo by IL-2.  
 
TNF-α 
TNF is secreted by macrophages, monocytes, neutrophils, T-cells, NK-cells following their 
stimulation by bacterial lipopolysaccharides. Cells expressing CD4
+
 secrete TNF-α while CD8+ 
cells secrete little or no TNF-α. The synthesis of TNF-α is induced by many different stimuli 
including interferons (IFN), IL-2, Immune complexes and PAF (platelet activating factor) and 
the production is inhibited by IL-6, TGF-β. 
TNF-α enhances phagocytosis and cytotoxicity in neutrophilic granulocytes and also modulates 
the expression of many other proteins, including IL-1 and IL-6. In combination with IL-1, TNF-α 
is responsible for many alterations of the endothelium. TNF-α also inhibits anticoagulatory 
mechanisms and promotes thrombotic processes and therefore plays an important role in 
pathological processes such as venous thromboses, arteriosclerosis, vasculitis, and disseminated 
intravasal coagulation.  
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IL-6 suppresses the synthesis of IL-1 induced by bacterial endotoxins and TNF, and the synthesis 
of TNF induced by endotoxins. TNF mediates part of the cell mediated immunity against 
obligate and facultative bacteria and parasites. However, although TNF-α is required also for 
normal immune responses the overexpression has severe pathological consequences.   
Elevation of TNFa levels may have  important  pathophysiological  and  clinical  implications 
and the  possible  relation  between  cardiac  contractility and circulating level of TNFa has been 
pointed. Furthermore, it has been shown that TNFa and other cytokines inhibit the contractility 
of cultured cardiac myocytes (Gulick 1989, Hasenpud 1989, Weisensee 1993) It has been 
suggested that TNF-α could be responsible for the development and progression of heart failure 
and that the production of TNF-α could be the result of immune response activation because of 
tissue injury, stress, or underperfusion of systemic circulation, but could also be locally produced 
by myocytes. It has also been shown that patients with chronic mitral valve regurgitation present 
high production of TNF-α in the plasma and increased expression in the myocardium, which 
suggests that TNF-α plays a role in the remodeling of left ventricular volume (Kevasan 1997, 
Kapadia 1998, Herrera-Garza 1999, Dibbs 1999). 
RF and RHD patients present increased levels of TNF-α (Narin 1995, Samsonov 1995, Yegin 
1997, Taneja 1989, Olmez 1993, Hernandez-Pacheco 2003, Miller 1989, Morris 1993) and TNF-
α is apparently one of the cytokines with an active and prominent role in the pathogenesis of the 
rheumatic process the initiation of multisystemic inflammatory response in RF and pathogenesis 
of RHD. TNFa may therefore, be the major cytokine in RF leading to IL-6 and IL-8 production 
(Yegin 1997). 
 
1.5.3 Cellular and humoral response in valvular tissue 
Heart biopsies exhibit cellular infiltration with a predominance of CD4
+
 T-cells (Guilherme 
1995) with the highest number of both CD4
+
 and CD8
+
 T-cells in patients that present rheumatic 
activity (Guilherme 2001). It seems that during the acute episode there are expansions of auto 
reactive T-cells in the heart and after the acute episode these auto reactive T-cells decrease in 
numbers but remain important to maintain the heart lesions (Sampaio 2007). Inflammatory 
infiltrates may be sparse and patchy in the chronic lesions, but are usually dense in the acute 
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phase of the disease. In RHD the main finding is dense valvular inflammatory infiltrates 
characterized mainly as CD4
+
 T-cells and macrophages at the site of heart lesions. 
Intralesional CD4
+
 T-cell clones from surgical fragments of severe RHD patients‘ crossreact 
with immunodominant M5 peptides and heart tissue proteins which indicates the existence of T-
cell molecular mimicry between streptococci and heart tissues relevant in the pathogenesis of 
RHD. Apparently, adhesion molecules such as VCAM-1 facilitate the extravasation of CD4
+
 and 
CD8
+
 T-cells into the valves, after being up-regulated on the vascular endothelium of the mitral 
valve of ARF patients (Guilherme 2004, Roberts 2001, Guilherme 2004, Roberts 2001). The 
concomitant presence of fibrin deposits as verrucae on the endocardial surface implies that there 
is rheumatic activity (Sampaio 2007). The differential cytokine polarization in the heart in RHD 
is probably related to immigrant autoreactive T-cells, local chemokines produced by 
inflammatory cells and adhesion molecules (Guilherme 2004). 
Mononuclear cells from heart lesions predominantly secrete inflammatory cytokines IFNγ and 
TNF-α, Th1-type cytokines such as the regulatory cytokine IL-10, in both acute RF and chronic 
RHD patients. This indicates that, even during the chronic phase, these mononuclear cells still 
produce inflammatory cytokines. Usually, there is a sparse production of IL-4 by valve-
infiltrating cells and large numbers of IL-4 positive cells which suggests that low numbers of IL-
4 producing cells in the valvular tissue and the lack of IL-4, a regulatory cytokine, may 
contribute to the induction of progression and maintenance of valvular RHD lesions. In addition, 
the lack of IL-4 probably perpetuates and/or exacerbates the production of inflammatory 
cytokines such as TNF-α and IFN-γ which are believed to be the  mediators  of  valve  lesions  
and  the  presence  of few mononuclear cells (Guilherme 2007). Furthermore, the production of 
IL-1, IL-2 and TNF-α was correlated with the progression of the Aschoff nodules in the valve 
lesions of ARF patients  (Kemeny 1989). 
These observations show the involvement of different mononuclear and cytokine producing cells 
in the myocardium and valves reinforcing the putative role of regulatory and inflammatory 
cytokines in myocardium healing in RHD and in the induction of progressive and permanent 
valve damage (Guilherme 2004, Guilherme 2005
2
, Guilherme 2007, Guilherme 2009). Whether 
the initial valvular insult is due to antibody or cell-mediated immunological damage is uncertain, 
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but the subsequent damage seems to be caused by T-cell and macrophage infiltration 
(Cunningham 2003, Roberts 2001, Guilherme 2004, Guilherme 2009). 
 
1.5.4 Valvular architecture 
The valve cusps are three-layered structures consisting of a ventricularis/atrialis, spongiosa, and   
fibrosa and composed of differing amounts of primarily collagen, elastin, and a 
glycosaminoglycan-rich ground substance, representing about 60, 10 and 20% of the dry weight 
of the valve, respectively (Kunzelman 1993). However, little quantitative information is 
available on the amount, location, orientation, and overall structure of these constituents in the 
three layers (Scott 1995). 
RHD valves have shown altered architecture and histology, including fibrosis, calcification and 
neovascularization (Sampaio 2007) as well as changes in the collagen, elastin and 
glycosaminoglycans (GAGs) distribution and localization, which seem to lead to distortion of 
valve function and mechanics (Guilherme 2009
1
, Sampaio 2007). 
Valvulitis and endocarditis have been observed in excised RHD valves. The disease 
predominantly affects the valvular endocardium culminating in crippling valve deformities and 
the valves show various degrees of calcification, which is a sign of chronic valvular involvement. 
Interestingly, recent histopathological and clinical studies indicate that calcification is not merely 
an inactive, "dystrophic" process but involves a active and highly regulated inflammatory 
process associated with expression of osteoblast markers and neoangiogenesis (Messika-Zeitoun 
2004). Furthermore, increased plasma osteopontin levels correlated with severity of mitral valve 
calcification (Chopra 2007). Importantly, deposition of calcium phosphate on the delicate 
valvular structures can lead to cumulative damage and result in valvular dysfunction and stenosis 
(Atar 2003). Features like fibrosis and neovascularization are observed in most of the valves, 
indicating that the valve has gone through previous episodes of rheumatic activity and usually, 
the degree of fibrosis is also proportional to the number of acute episodes (Sampaio 2007). 
Importantly, molecular mimicry between streptococcal and human antigens causes inflammation 
that leads to neo-vascularization, which enables further recruitment of T-cells, leading to 
granulomatous inflammation and the establishment of chronic RHD while repeated episodes of 
RF lead to further inflammatory damage and subsequent scarring of cardiac valves (Veasy 1997). 
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Elastin structures are found to contribute significantly to the mechanical function of the valve 
cusps (Vesely 1998) and damage to the elastin network of the cusps alters the valvular 
mechanics, subjects the tissue to abnormal loading conditions and accelerates mechanical 
degeneration. This is due the fact that damage to elastin in aortic valves leads to a passive 
elongation of the tissue, a reduction in extensibility, and an increase in stiffness.  
Fragmentation of elastin and reconformation of collagen fibers may also have additional effects 
on this mechanism (Viidik 1982). It is also speculated that the permanent elongation of the valve 
cusps and their decreased extensibility results partly from the slippage of collagen fibrils and 
partly from the mechanical interaction between elastin and collagen. It is therefore believed that 
the initial response to mechanical loading is mainly due to elastin, while the final stiffness is 
defined by collagen.  
Elastin structures impose tensile forces on collagen fibers during valve unloading and the 
dominant restorative force when the ventricularis is stretched in the radial direction is the tension 
produced by elastin as the collagen takes over the load and limits further extension as it relatively 
inextensible. Furthermore, the fibrosa passively relies on the ventricularis to pull it back, through 
the collagen mechanisms into its folded shape. Furthermore, valvular elastin also likely acts as a 
‗housekeeper‘ that restores the collagen fibre geometry back to its original conformation between 
successive loading cycles, and is therefore critical to proper valve function (Vesely 1998). 
The function of elastin is highly dependent on its configuration and relative content in the given 
material, however elastin content alone does not dictate mechanics, important is its organization 
relative to collagen.  
As the mechanics of the whole ventricularis is not identical in the radial and circumferential 
directions, it is suggested that the amount of collagen or the types of connections between the 
elastin and collagen structures are responsible for this anisotropy and not only the mechanics of 
the elastin itself.  Importantly, increase in mature elastic fibers has been found with age 
(McDonald 2002, Bashey 1967), particularly between the second and fifth decades of human life 
(Sell 1965) and in pathological valves (Imayama 1989). Therefore, distortion of valve function 
and mechanics seems to be an interaction between elastin and collagen conditions and changes.  
The collagen component is predominantly type I and III (74% and 24%, respectively) and 
collagen fibre bundles appear to be surrounded by elastin fibrils (Kunzelman 1993) which are 
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much thinner than collagen fibrils and arranged in a branching pattern (Stevens and Lowe 1997). 
Collagen I is found predominantly in the ventricularis while collagen III can normally be found 
in the fibrosa.  
Glycosaminoglycans (GAGs) form a highly hydrated gel-like ground substance in which other 
matrix molecules are located (Kunzelman 1993) and are therefore critical to the function of 
numerous soft connective tissues, including heart valves, providing material properties such as 
viscoelasticity, resistance to compression and tension (Kinsella 2004, Rothenburger 2002). 
GAGs also play crucial roles in tissue differentiation, growth factor regulation and various 
pathologies (Rothenburger 2002) including many heart valve diseases. Furthermore, recent 
evidence also suggests that GAG‘s may act as a key component in the development of calcific 
AV disease (Grande-Allen 2007) and the loss of the GAG-rich spongiosa layer, which normally 
provides shear between the outer valve layers and thus enables complex valve leaflet movement 
(Vesely 2004), is known to be instrumental in the failure of porcine bioprosthetic aortic valves. 
Valvular GAGs are complex in their composition and distribution and change throughout 
development and aging, when the heart valves experience significant changes in mechanical 
loading and tissue differentiation. However, the composition of GAGs is different between layers 
and varies regionally based on the type of mechanical loading experienced by these tissues, 
(Grande-Allen 2004) showing abundance in the spongiosa of the aortic valve. Importantly, 
regions experiencing tension containe fewer GAG overall, compared to regions experiencing 
compression. Meanwhile, human valves also demonstrate age-associated decrease in total GAGs, 
unique  to  specific  histological  layers  as  well  as associated  with  differences  in  mechanical  
loading  (Stephens 2008). 
 
1.5.5 Structural and biochemical imaging techniques 
Raman spectroscopy 
It  has  been  demonstrated  that  optical  spectroscopy  techniques,  such  as  reflectance,  
fluorescence,  infrared  absorption, and  Raman  scattering  can  provide  information  about  
tissue composition at the molecular level (Lucas 1996, Buschman 2000, Hanlon 2000). MRI may 
allow the discrimination of large lipid pools, calcifications, and fibrous caps in atheromatous 
plaques but cannot quantify the chemical composition (Toussaint 1996). Therefore, of these 
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techniques, Raman spectroscopy shows great promise to provide valuable biochemical 
information for nondestructive diagnosis of cardiovascular disorders (Buschman 2000, Hanlon 
2000). Raman spectroscopy of tissue yields more information about chemical composition 
because the Raman spectra of biological compounds are unique (Brennan 1994, 1995, 1995
2
, 
1997, 1997
2
). 
Raman scattering is an inelastic process that occurs when a sample is illuminated with a 
monochromatic light source, such as a laser beam. In this process, energy from the incident 
photons is transferred to the sample‘s molecules, exciting them to high vibrational modes. 
Scattered photons have lower frequency than the incident ones due to the energy that is lost in 
the scattering process. This radiation frequency shift corresponds to the difference in molecular 
vibrational frequencies of the sample (Hanlon 2000). Raman spectra of tissues show narrow and 
well-resolved bands with line width of 10-20 cm
–1
, revealing the presence of many biochemical 
molecules (Lucas 1996). The  relative  contribution  of these  biochemical  molecules  for  the  
tissue  Raman  spectrum  is proportional to their concentration in the tissue, which is the basis for 
the diagnostic data acquired by the Raman spectra (Buschman 2000). Among the many types of 
biomedical investigation made possible by Raman spectroscopy cardiac valves are among the 
most important diagnostic applications (Otero 2004). 
Raman spectroscopy has shown to be a promising technique to characterize the chemical 
compounds found in biological tissues, allowing the identification of compounds in different 
states, and giving information about the molecular geometry from the analysis of the vibrational 
spectra (Elbagerma 2010). The use of Raman spectroscopy as a diagnostic tool for pathological 
alterations is based on the uniqueness of the Raman spectrum of a given molecule (Raman 1928, 
Manoharan 1996, Frank 1995, Lawson 1997). Using sensitive laboratory equipment, Raman 
spectra can be obtained in less than a second and most spectral features are visible in spectra 
collected in only a few seconds via optical fiber catheters (Brennan 1997). 
Considerable advantages result from the fact that Raman spectroscopy is a fast and non-
destructive technique and that spectra can be recorded directly from specimens even in an 
aqueous environment (De Beer 2004) providing quantitative information about the chemical 
composition (Baraga 1992). Furthermore, it has been shown that Raman spectroscopy can be 
used to quantify the relative amounts of protein, cholesterol, adventitial fat, and calcium salts 
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(Brennan 1997
2
). Spectroscopic methods for determination of stability constants have the 
advantages of sensitivity and reliability and are suitable for determination of stability constants 
in solution under different experimental conditions (Elbagerma 2010). 
 
Atomic force microscopy (AFM) enables structural studies revealing nanometer-scale details of 
biological objects and when working in the contact mode in air is a useful tool for imaging 
surfaces of human heart valves at the supramolecular level. AFM images have revealed different 
local architecture of collagen fibrils on the valve surface showing areas with entirely different 
spatial organization of the collagen fibril bundles. This included zones with multidirectional, 
stacked collagen fibrils, as well as areas with regular dense packing of thin collagen fibrils. It 
was also found that different forms of fibril packing had an impact on the collagen D-spacing 
distance. The ventricularis layer, which is abundant in elastin, and fibrosa layer was recognized 
spectroscopically to contain mostly collagen. Moreover, carbohydrates, which are the main 
components of GAGs, and minerals deposits (hydroxyapatites) were also detected. Therefore, it 
has been shown that AFM imaging in the contact mode and FT-IR spectroscopy are suitable 
methods for structural characterization of heart valves at the molecular and supramolecular levels 
(Jastrzebska 2006). 
 
1.6 Streptococcal pathogenesis 
RF was believed to be caused by repeated infections with GAS (Figure 1.4) but recent studies 
suggest streptococci of group C and G are also linked to its pathogenesis (Dinkla 2007). 
Streptococci are able to adhere to and colonize (Neeman 1998) skin, oralnasal mucosa, and 
tonsils (McMillan 2004, Cunningham 2000) and are able to disseminate to other organs (Bisno 
2005). Tissue invasion can lead to local suppurative complications or systemic infections 
(Cunningham 2000). 
Streptococci manipulate innate immune defences at several levels and virulent streptococci 
down-regulate inflammation and restrict activation of the alternative complement system, which 
is critical to the phagocytosis and killing of GAS by the nonimmune host. Surface-associated 
C5a peptidase and M proteins inhibit detection and phagocytosis by polymorphonuclear 
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leukocytes (PMNs), by specific destruction of the early complement chemotaxin, C5a, and then 
by M protein–restricted deposition of C3b opsonin (Wang 2000). 
Streptococcal strains express multiple adhesins, such as lipoteichoic acid, M protein, and 
fibronectin binding proteins (Cunningham 2000, Bisno 2003). These adhesins, of which M 
protein, fibronectin binding protein Sfb1/PrtF, and fibronectin binding protein 54 (FBP54) have 
been shown to promote efficient intracellular invasion of mammalian cells (Wang 2000). 
Meanwhile, immunity to GAS is mediated by antibodies to the M protein, which exists as a 
coiled-coil protein on the surface of the bacteria.
 
 
 
Figure 1.4 Group A streptococci 
 
1.6.1 GAS 
The classification of Group A streptococci (GAS) into specific types based on the type of M 
protein has been vital for the understanding of the epidemiology of streptococcal disease (Sheree 
1994). The M protein was believed to be the major virulence
 
determinant of the GAS organisms 
(Pruksakorn 1994) and also the major
 
protective antigen (Lei 2004) as it enables streptococci to 
resist phagocytosis (Kotb 2002) by binding factor H, thus regulating complement deposition and 
preventing C3b-dependent phagocytosis.  
The M protein is an α-helical coiled-coil protein (Carapetis 20052) and consists of a variable 
nonrepeated amino terminal region, which contains determinants of type-specificity defining the 
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GAS serotype, and a highly conserved carboxy terminal C-repeat region, common in different 
serotypes. Antibodies directed against the type specific M protein epitopes neutralise the 
antiphagocytic property of M protein rendering cells susceptible to phagocytosis (Sheree 1994), 
by opsonizing streptococci in the presence of neutrophils. However, this antibody response is 
directed against the hyper-variable amino terminal region of the strepotococcal M protein, being 
thus type-specific (Robinson 1992, Malmanche 1994) and protecting only against GAS 
organisms of the same M serotype. Therefore, protective immunity to GAS has been associated 
with type specific opsonic antibodies against M protein (Sheree 1994). However, serum 
bactericidal antibodies targeting the streptococci M protein appear
 
following natural infection of 
humans and are associated with
 
protection against subsequent infection with the same serotype 
persisting  for as long as 30 years following infection.   
 
1.6.1.1 Variety of M-types 
There are over 150 known different M protein types (Kehoe 1991, Beall 1995, Sheree 1994, 
Facklam 2002), and only a single type is expressed by each strain.  The type specificity of each 
M
 
protein is largely determined
 
by the epitopes located in the amino-terminal 40 to 50 amino
 
acid 
residues (Beall 1995) being the amino acid sequence of the amino terminus in the M protein 
responsible for the serotype of the organism (Kehoe 1991). Diversity in the emm sequence is 
generated by corrected frameshift
 
mutations, point mutations, and small in-frame mutations. 
Therefore, variations in emm gene sequences occur and result in amino
 
acid substitutions or 
insertion of short sequences within the
 
N-terminal, the hypervariable segments of the M proteins. 
The high variability of the N-terminal region of the M protein between different streptococcal 
strains has lead to the presence of different streptococcal serotypes with a number of serotypes 
being much more common than others within a population,
 
varying between distinct geographic 
locations leading to geographic variations among streptococcal strains (Carapetis 2000). 
Nevertheless, some strains are also believed to be more likely to cause RF than others (Carapetis 
2005
2
) suggesting a particular rheumatogenic potential of certain strains of GAS.  
Rheumatogenicity was considered a feature only of strains belonging to certain M serotypes, 
however results of several studies indicate no definitive association between group A 
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streptococcus emm sequence, class, or pattern group, and site of infection or ability to cause 
disease (Carapetis 2005
2
). Although amino-terminal M protein epitopes
 
from common reference 
strains of GAS have been identified, protective
 
epitopes from GAS strains prevalent within a 
GAS-endemic region
 
remain unknown.  Thus, the issue of potential and specific rheumatogenic 
strains remains unresolved (Stollerman 2001) as virulence and molecular differences between 
strains are not clear (Stollerman 2001).  
 
M protein amino (N)-terminus 
Phagocytic killing of GAS is promoted by antibodies targeting the amino (N)-terminus of the M 
protein, which also forms the basis for GAS serotyping.  The amino terminus of the M protein is 
highly variable between the GAS serotypes and frequently undergoes genetic recombination of 
the amino sequence which gives rise to subtypes, and can lead to loss in opsonizing ability of 
type-specific antibodies. Antibodies to the amino terminus of the M protein are opsonic and 
provide protection against challenge from homologous organisms and are therefore type specific.  
 
M protein carboxyl (C)-terminus  
The M protein carboxyl (C)-terminus contains the so-called ―C-repeats‖. These C-repeats are 
highly conserved epitopes among GAS serotypes, located at the proximal end of the M-protein 
(Pichichero 2004). It has been shown that epitopes within the C-repeat region of M proteins 
evoke antibodies that cross-opsonize many serotypes of streptococci and also opsonic antibodies 
specific to the C-region have been demonstrated in humans.  
 
1.6.2 Group C streptococci (GCS) and group G streptococci (GGS) 
Group C (GCS) and group G (GGS) are considered as important veterinary pathogens but are 
also involved in human infections and in geographical areas with a high incidence of RF there is 
a widespread carriage of these streptococcal groups (Haidan 2000, McDonald 2006, Ahmed 
2003, Baracco, 2006). Their spectrum of diseases is very similar to the one of GAS, comprising 
pharyngitis, skin and soft tissue infections as well as bacteremia and streptococcal toxic shock 
syndrome (Baracco 2006) and some strains have the potential to induce autoimmunity against 
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cardiac myosin, suggesting contribution to the pathogenesis of RF/RHD (Haidan 2000). This 
might partially explain the high incidence of RF while pharyngeal isolation of GAS is rare. 
 
1.6.3 Streptococcal PARF peptide and human collagen IV 
It has been shown that rheumatogenic GAS strains are able to bind and aggregate human 
collagen. One mechanism applied
 
by streptococcal strains capable of causing acute rheumatic
 
fever is formation of an autoantigenic complex with human collagen
 
IV (Dinkla 2003). The 
recent hypothesis is that
 
human collagen IV, a major component of subendothelial basement
 
membranes, acts as such an autoantigen after forming
 
a complex with streptococcal strains, 
which have a potential of
 
causing ARF. In sera of RF patients such a collagen
 
autoimmune 
response was accompanied by specific reactivity against
 
the collagen-binding proteins, linking 
the observed effect to
 
clinical cases.  
Binding to collagen occurs through M protein or M18 hyaluronic acid capsule. This aggregation 
of collagen leads to autoantigenicity, which in turn induces RF. The sera from ARF patients 
shows significantly increased titers of anticollagen antibodies as compared with healthy controls.  
An M-like protein, FOG, which was described as an adhesin (Nitsche, 2006) was identified as 
the group G streptococcal surface protein that is capable of binding different members of the 
collagen family thereby inducing the collagen autoimmune response. The low selectivity of FOG 
within the collagen family suggests that the autoimmune response is not caused by collagen IV 
only and other collagen types that interact with FOG may therefore be involved. Considering the 
high similarity between collagens, it seems likely that the autoimmunity against collagen IV at 
least partially depends on cross-reactivity being part of a broader anti-collagen response.  
Further analysis of streptococcal collagen interaction revealed that an octapeptide, AXYLZZLN, 
designated PARF (peptide associated with rheumatic fever) in M proteins of rheumatogenic 
strains is responsible for binding and aggregation of collagen. Direct binding of collagen
 
to 
streptococcal surface components is, therefore, considered
 
as one of the key mechanisms for 
induction of ARF (Figure 1.11). GGS and GCS, like GAS, have been shown to have a 
rheumatogenic potential and have been reported to express M protein with PARF sequences. Just 
like rheumatogenic GAS strains, they are capable of binding and aggregating collagen and 
generating anticollagen antibodies, through the identified octapeptide motif PARF. Taken 
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together, the data demonstrate that the
 
identified octapeptide motif (PARF) plays a crucial role in 
the pathogenesis of RF through its action on collagen, which makes it a promising candidate for 
diagnosis of rheumatogenic streptococcal strains. Unfortunately, the mechanisms known today 
are still not sufficient to fully explain the pathogenesis of RF. 
Re-evaluations of existing data or new epidemiological
 
studies, which take these findings into 
account, may shed more
 
light on regional characteristics of ARF pathogenesis and help
 
to 
identify and eradicate the causative bacteria and the value of PARF as a diagnostic marker for 
the early detection of rheumatogenic strains (Dinkla 2007). 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.5 Binding and aggregation of collagen IV on the GGS surface. Field emission scanning 
electron micrograph of FOG-expressing strain G45 (A) and of a FOG-negative non-collagen 
binding strain G50 (B), which were incubated with soluble collagen IV. Only the FOG-positive 
strain shows massive aggregation of collagen on its surface. The bars correspond to 1 µm.
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2.1 Aims 
Many aspects of RF and RHD have still not been clarified. Data on epidemiology and 
geographical variety in clinical manifestation remain scarce with lack of systemic programs for 
screening and early detection and no consensus about diagnostic criteria and management while 
a high prevalence of the disease is suspected in different areas. The long-term outcome of 
patients with RHD has not been established, and therefore, the persistence and development of 
permanent valvular lesions is not known. Echocardiography is found to be the only approach 
with sufficient sensitivity and specificity for the detection of RHD, however, there are no 
universally agreed criteria and consensus of the echocardiographic signs of early RHD. 
A major role for inflammatory cytokines has been suggested in mediating heart lesions in RHD  
with cellular infiltration of predominance of CD4
+
 T-cells, showing geographic variety in 
immune response. However, the definite role of inflammatory cells as major damage mediators 
and signs of immune activation have not been cleared yet.  
The key mechanism used by streptococcal strain and which defines rheumatogenicity seems to 
be the formation of a streptococcal autoantigenic complex with human collagen IV with binding 
and aggregation to collagen through PARF, which has been suggested as a diagnostic marker for 
the early detection of rheumatogenic strains and the diagnosis of RHD. 
In addition, there are still gaps in the knowledge of the microbial, autoimmune and biochemical 
processes corresponding to the structural and functional features in RF and RHD. Importantly, 
better understanding of epidemiology, clinical characteristic and pathogenesis pathways of RF 
and RHD may facilitate improvement of the management of the disease, long term outcome and 
prognosis.  
 
Therefore, we aim to: 
-Determine the epidemiological and clinical characteristics of RF and RHD  
-Perform in depth analysis of cellular and structural features in RF and RHD 
-Atempt to define antigenic targets for evaluation and diagnosis of streptococcal infection 
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2.2 Plan of investigation 
RF and RHD are endemic in Egypt where data on prevalence, characteristics, immune response 
and microbiology are lacking. Therefore, Egypt is a perfect setting for research and elucidation 
of the factors and mechanisms surrounding RF and RHD.  This study was developed to unveil 
these factors in the Egyptian community.  
 
DETERMINATION OF THE EPIDEMIOLOGICAL AND CLINICAL 
CHARACTERISTICS OF RF AND RHD  
In order to achieve this aim the following studies were performed: 
 
School based screening for RHD 
A cross-sectional screening was performed in a cohort of randomly selected school children in 
Aswan, in whom auscultation followed by echocardiography was used to identify the presence, 
characteristics and determinants of RHD. Aswan was chosen for this epidemiological study, as 
the area hosts a relatively stable population, with generally low income, living in a less humid or 
polluted environment, which has never been studied before regarding to this particular disease. 
The assessment included a questionnaire containing questions regarding the patient‘s 
demographics, family environment, risk factors, history of RF and penicillin prophylaxis 
developed to detect the epidemiologic factors and determinants of RF and RHD. Physical 
examination included general analysis of the patients‘ health, recognition of Jones criteria and 
careful cardiac auscultation and detailed transthoracic echocardiography evolving a newly 
developed protocol to define the characteristics of RHD and the role of echocardiography as a 
screening tool. This study evolves a set of rigid echocardiographic criteria, designed to enhance 
the specificity of the diagnosis of RHD to increase case detection rates and therefore the 
treatment of individuals at risk, preventing the progression of valvular lesions.  
 
Characterization of RF in a hospital based study in Egypt 
A cohort of patients with history of RF and RHD assessed at the penicillin clinic and 
cardiothoracic surgery department of the National Heart Institute (NHI), which is a major referral 
heart center, serving the population of Cairo and surrounding areas with a big influx of patients 
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from all over Egypt. A penicillin prophylaxis program of the Ministry of Health is based at the 
NHI for patients that have been previously diagnosed with RF and prescribed penicillin 
prophylaxis. This clinic is assessable to all patients in the area and receives patients from all over 
Egypt by self referral. Therefore, the population visiting the NHI is thought to represent the 
prevalence of the RF and RHD in the highly populated Northern part of Egypt.  
The assessment included a questionnaire containing questions regarding the patient‘s 
demographics, family environment, risk factors, history of RF and penicillin prophylaxis 
developed to detect the epidemiologic factors and determinants of RF and RHD. Physical 
examination included general analysis of the patients‘ health, recognition of Jones criteria and 
careful cardiac auscultation. 
This study focused on the epidemiological profile and clinical manifestation of RF in Egypt as 
well as the use and compliance to secondary prevention and define the determinants of RHD. 
 
Clinical characteristics and determinants of RHD in a hospital study in Egypt 
The individuals screened at the NHI were assessed by detailed transthoracic echocardiography 
evolving a newly developed protocol. 
 
Diagnosis of RHD: The characteristics of RHD and the role of echocardiography as a screening 
tool was defined. This study evolves a set of rigid echocardiographic criteria, designed to 
enhance the specificity of the diagnosis of RHD  to increase case detection rates and therefore 
the treatment of individuals at risk, preventing the progression of valvular lesions. 
 
Subclinical RHD in individuals with history of RF in Egypt: Subclinical RHD was determined in 
individuals with history of RF presenting at the penicillin clinic of the NHI by echocardiography. 
 
Echocardiographic characteristics of RHD: Echocardiographic data of individuals diagnosed 
with RHD was analyzed for the determination of the echocardiographic characteristics. 
 
Prognosis of RHD: The patients recruited in the penicillin clinic were reassessed 6 months after 
the first consultation for the evaluation of the lesions, progression and/ or resolution of the 
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cardiac condition to analyze the reversibility of subclinical valvular lesions with adherence to 
secondary prophylaxis regimens and determine the long-term outcome of patients with 
subclinical RHD.  
 
Determinants of RHD: The factors influencing the presence and characteristics of RHD were 
analyzed in the cohort.  
 
ANALYSIS OF CELLULAR AND STRUCTURAL FEATURES IN RF AND RHD 
In order to achieve this aim the following studies were performed: 
 
Immune mediators in RF and RHD 
Blood samples and excised valve tissue material collected at the time of surgery from patients 
requiring valve replacement from the individuals recruited at the NHI collection of samples were 
analyzed for determination of the immune response in RF and RHD.  
 
Haemal immune response in RF and RHD: Analysis of cellular features and the signs of immune 
activation included determination of haemal inflammatory parameters as CBC, ESR, ASOT and CRP 
and cytokine levels in the serum and valvular tissue. Serum and plasma were obtained and stored 
for further analysis of the acute phase proteins, pro- and anti-inflammatory cytokines and signs of 
immune activation to determine the molecular and cellular mechanisms  
 
Valvular immune activation in RHD: The valves collected were analyzed by immunohistochemistry for 
the presence and distribution of pro- and anti-inflammatory markers to determine the cellular 
features of RHD and the role of regulatory cytokines in valvular damage.  
 
Determinants of RF and RHD: The haemal and valvular immune activation and response were analyzed 
to determine the immune mediators in RF and RHD. The influence of inflammatory and immune 
parameters on valvular affection were analyzed to determine the mediators of valvular lesions in 
RHD. 
Structural characteristics of RHD 
Excised valve tissue material collected at the time of surgery from patients requiring valve 
replacement from the individuals recruited at the NHI collection of samples were analyzed by 
Chapter 2 Aims and Plan of Investigation 
 
65  
 
 
Rheumatic Heart Disease in Egypt 
 
 
histology and immunohostochmistry to determine the structural and architectural features of 
valvular damage related to RHD. 
 
DEFINITION OF ANTIGENIC TARGETS FOR EVALUATION AND DIAGNOSIS OF 
STREPTOCOCCAL INFECTION 
A throat swab and venous blood were collected from the individuals recruited at the NHI.  
 
Streptococcal strain responsible for RF in Egypt: The throat swab were streaked across a blood 
agar plate for culturing of the organism and the hemolytic colonies identified were tested for 
antibiotic sensitivity for the analysis of the effectiveness of antibiotic treatment and prophylaxis 
in these cases. Cultures of throat swab material and serum samples were analyzed to identify the 
particular strain of Streptococci responsible for RF/RHD in Egypt and its rheumatogenicity 
through serotyping for the particular type of M protein as well as DNA studies of the genes 
which encode these virulence factors (emm). 
 
Atempt to determine the potential of PARF as a diagnostic marker: Collagen-binding assays 
were performed for the evaluation and analysis of the binding between the octapeptide PARF 
and collagen IV and the potential of PARF as a diagnostic marker for
 
the early detection of 
rheumatogenic strains and the diagnosis of RHD. 
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2.2.1 Design of the investigations 
Our  research  project  included  three  main  branches,  namely  community-based  studies,  
hospital-based research and laboratory work (Diagram 2.1). 
 
 
 
(1) Community Work 1 (National Heart Institute – Cairo, Egypt) 
Epidemiology studies 
Prevalence study  
Follow-up of participants in epidemiology and clinical studies 
Establishment of a follow-up facility for patients with RF and RHD 
 
(1) Community Work 2 (Aswan Heart Centre – Aswan, Egypt) 
Training of local staff 
Design and Installation of Research Facilities  
Contribution to establishment and development of Aswan Heart Centre 
Epidemiology studies 
Prevalence study  
Establishing cohort of school children  
Follow-up of participants in epidemiology and clinical studies  
Establishment of a follow-up facility for patients with RF and RHD  
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(2) Clinical Research 1 (National Heart Institute – Cairo, Egypt) 
Establishment of a Penicillin Prophylaxis Registry 
Data collection  
Clinical follow-up of patients 
Blood and tissue collection and storage 
 
 
(2) Clinical Research 2 (Aswan Heart Centre – Aswan, Egypt) 
Organization and participation in surgical missions 
Establishment of surgical registry 
Pre- and post-operative management 
Establishment of a RF and RHD registry 
Data collection 
Blood and tissue collection and storage 
Clinical follow-up of patients 
 
(3) Laboratory Studies (United Kingdom and Germany) 
Performing the laboratory work 
 
Diagram 2.1. Work undertaken by the investigator in the four main sites of research 
 
 
2.2.2 Ethical considerations 
Individuals were notified about the results of the tests and eventual need of any further treatment 
or follow-up and were informed that they are free to withdraw from the study at any time without 
giving any specific reasons.  
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Figure 2.1 Cardiac surgery at the Aswan Heart Centre 
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2.3 Layout 
The work presented in this thesis has been divided in 11 chapters, starting with an introductory 
chapter, followed by the current chapter describing the aims and plan of investigation. 
 
Chapter 3 details of the design of research and the procedures used to implement the research 
program, including the methods used in the different studies.   
 
The school based screening for RHD is described in chapter 4, which involves large-scale 
echocardiographic screening and determination of prevalence of RHD in Aswan including 
description of the sampling method, issues related to preparation and implementation and the 
results found.  
 
Chapter 5 presents a study in a cohort of patients with history of RF and RHD assessed at the 
penicillin clinic and cardiothoracic surgery department of the National Heart Institute (NHI) to 
unveil the epidemiology of RF in Egypt focusing on the epidemiological profile and clinical 
manifestation of RF as well as the use and compliance to secondary prevention and define the 
determinants of RHD. 
 
Chapter 6 describes the clinical characteristics and determinants of RHD patients with history of 
RF in Egypt assessed by detailed transthoracic echocardiography evolving evaluation of a newly 
developed protocol. The different parts of the chapter present the determination of subclinical 
RHD as well as the echocardiographic characteristics of RHD, the prognosis of valvular lesions 
and determinants of the disease.  
 
Chapter 7 describes the pattern of immune response in RF and RHD with analysis of cellular 
features and the signs of immune activation including haemal inflammatory parameters and 
cytokine levels. The valvular activation in RHD is described in the second part of the chapter, 
analyzing the inflammatory markers and the role of regulatory cytokines in valvular damage 
determining the immune mediators of RHD.  
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The structural features seen in valvular damage related to RHD are presented in chapter 8 as 
analyzed by histology and immunohostochmistry to determine the structural and architectural 
characteristics of the disease.  
 
Determination of the antibiotic sensitivity and resistance rates of the found hemolytic colonies is 
described in chapter 9. 
 
Chapter 10 presents the studies performed for definition of the Streptococcal strain responsible 
for RF in Egypt and its rheumatogenicity through serotyping for the particular type of M protein 
as well as DNA studies of the genes which encode these virulence factors (emm). Part 2 of the 
chapter describes the collagen-binding assays performed for the evaluation and analysis of the 
binding between the octapeptide PARF and collagen IV for the potential of PARF as a diagnostic 
marker for
 
the early detection of rheumatogenic strains and the diagnosis of RHD. 
 
The last chapter summarizes the conclusions of our work and proposes new research lines into 
the mechanisms of RF and RHD. 
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CHAPTER 3 
 
 
METHODS 
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3.1 Epidemiology study  
Egypt 
Egypt is located in North Africa, with the Sinai Peninsula forming a land bridge in Western Asia. 
Covering an area of about 1,010,000 square kilometers (390,000 sq mi) (Figure 3.1). 
 
Figure 3.1 Map of Africa, with Egypt marked in red. 
 
 
Figure 3.2 Detailed map of Egypt 
  
At 1,001,450 square kilometers (386,660 sq mi), Egypt is the world's 38th-largest country. Egypt 
is divided into 29 governorates, which are further divided into regions. Egypt is one of the most 
populous countries in Africa and the Middle East with its 83,082,869 (July 2009 est.) citizens. 
For population characteristics see (Appendix I).  
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The great majority of the population lives near the banks of the Nile River, in an area of about 
40,000 square kilometers (15,000 sq mi), where the only arable agricultural land is found. The 
large areas of the Sahara Desert are sparsely inhabited. The population density is estimated 81.5 
per sq km (Figure 3.3). 
 
Figure 3.3 Population density 
 
3.1.1 Epidemiological set-up  
Study area 
Cairo  
The Egyptian capital has a surface of 214 km2 and 18,3 million inhabitants (2008 estimate) with 
a density exceeding 37,136 inhabitants/km
2
 (Figure 3.4). 
 
Figure 3.4 Site of Cairo (top centre) 
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National Heart and Lung Institute 
The National Heart Institute (NHI), in Imbaba, Cairo, is one of the major heart centres in Cairo 
and surrounding areas and has a big influx of patients from all over Egypt. The NHI, founded in 
1965 as a public institute, is a part of the General Organization of the Teaching Hospitals and 
Institutes "GOTHI" and has a total of 350 beds. A penicillin prophylaxis program of the Ministry 
of Health is based at the NHI and is meant for patients that have been previously diagnosed with 
RF and prescribed penicillin prophylaxis. This clinic is assessable to all patients in the area and 
receives patients from all over Egypt who choose to be treated at the NHI.  
 
Aswan 
In order to perform the screening of school children in Aswan an epidemiological study was 
performed.  
 
Figure 3.5 Site of Aswan 
 
Aswan Governorate is the south most governorate in Upper Egypt (Figure 3.5). The distance 
between Cairo and Aswan is 879 km (549 miles). The population of the governorate is around 
1,484,433 and its area is 34,608 km². Primary school attendance is over 95%. The schools are 
distributed among 7 areas. The distribution of the schools and school children in each area is 
shown in Appendix II. There are in total 51 402 school children distributed among 95 schools 
(Table 3.1). 
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Table 3.1 Amount of school children per age group 
Age group number 
5 years 
6-12 years 
13-15 years 
Total 
  1 249 
14 457 
35 696 
51 402 
 
Hospital-based study 
Individuals were recruited at the National Heart Institute (NHI), in Imbaba, Cairo, one of the 
major heart centers in Cairo and surrounding areas with a big influx of patients from all over 
Egypt, where a penicillin prophylaxis program of the Ministry of Health is based for patients that 
have been previously diagnosed with RF and prescribed penicillin prophylaxis. This clinic is 
assessable to all patients in the area and receives patients from all over Egypt who choose to be 
treated at the NHI.  
Individuals visiting the outpatient clinic or admitted at the Cardio-thoracic department of the 
NHI were assessed for the investigation of the epidemiological and clinical characteristics, 
molecular and cellular mechanisms and microbiology of RF and RHD.  
 
The study population consisted of: 
 Group I: -Individuals with a positive history of RF visiting the centre for penicillin  
                prophylaxis with or without cardiac involvement 
-Individuals visiting the NHI outpatient clinic for suspicion of RF or RHD  
 Group II: Patients admitted for RHD and scheduled for valve replacement.  
 
The individuals recruited in the penicillin clinic were reassessed 6 months after the first 
consultation for evaluation of the development, progression and/ or resolution of the cardiac 
manifestation to analyze the reversibility of valvular lesions with adherence to secondary 
prophylaxis regimens and determine the long-term outcome of patients with subclinical RHD. 
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We think that it is legitimate to compare both patient groups, as they form part of the same 
patient population that visits the NHI and group II represents group I in a later stage of the 
disease. Therefore, this allowed us to compare different stages and presentations of the disease: 
individuals on penicillin prophylaxis with and without RF and/or cardiac involvement, 
individuals with evidence of RHD with and without history of RF and/or penicillin prophylaxis. 
 
School-based screening 
A cross-sectional screening of schoolchildren from 5 to 15 years of age was performed in 
Aswan, Egypt.  
     
 
  
Figure 3.6 School children awaiting assessment in Aswan during the screening 
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Sample size calculation  
Previous studies in Mozambique and Cambodia reveal a prevalence of RHD as detected by 
echocardiography of 3.0% (95% CI 2.3-3.8) and 2.2% (95% CI 1.7-2.6) respectively in 
schoolchildren aged 6-17 years. Assuming that the clinical prevalence of RHD in school children 
in Egypt is comparable to the previous studies we hypothesize a prevalence of RHD in school 
children in Aswan around 2.5 to 3.0%.  This means that 25 to 30 RHD cases would be detected 
per 1,000 screened children.  
In epidemiological studies and studies that investigate factors associated with RHD, it is required 
to have a substantial number of RHD cases, approximately 50 cases, in order to be able to do 
multivariable analyses. Therefore it was decided to screen 3,000 children which is expected to 
detect 75 children showing characteristics of RHD following the earlier provided prevalence 
forecast. 
 
Sample selection 
The Governorate of Aswan provided us with the map of Aswan, distributed in 7 geographical 
areas and created a list of all schools in the area. By this mean we were able to obtain the number 
of schools and school children for each age group in the different areas. 
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Figure 3.7 Map of Aswan City divided in 7 geographical areas 
 
 
Sample size 
The number of children needed to screen from each area was calculated as following: 
 (1) 
            
             
                      
Childrenarea = total school children in the area 
Childrentotal = total of school children in Aswan 
Represenationarea = representation of the area in the total cohort 
(2) 
                                             
Representationarea = representation of the area in the total cohort 
Screentotal = total number to screen (in this case= 3000) 
Screenarea = number needed to screen in the area 
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The schools are distributed in 3 age groups: 5 years, 6 to 12 years and 13 to 15 years. The 
number of children screened in each age group was dependent on their representation in the age 
groups in the area so that the screened population was representative for the area as well as the 
age group. The number of children needed to screen from each age group was calculated as 
following: 
 (3) 
                
            
                          
Childrenagegroup = total of children in a certain age group 
Childrenarea = total school children in the area 
Represenationagegroup = representation of the age group in the area 
 
(4) 
                                                    
Represenationagegroup = representation of the age group in the area 
Screenarea = number needed to screen in the area 
Screenagegroup = number needed to screen in the age group 
 
The distribution of the children by area, age group, representation and the number needed to 
screen per area and age group can be found in appendix III.  
 
Sampling 
Selection of the sample was done by randomization in three stages stratified by area, school and 
age group and weighed by distribution of school children across the 7 areas and 3 age groups.  
The schools were stratified by area and age group and randomly selected using computer-
generated random-number sampling.  
On the day of screening, the children were invited to participate in the study and attributed 
numbers for random-number sampling, according to the number needed to screen, weighed by 
the representation of the age group in the area. There was no exclusion criteria and all children 
had the same probability chances of being chosen. The list of schools visited, selected by age 
group as well as the number of children screened can be found in Appendix IV.  
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The number of children screened in each school and area exceeds slightly the number needed to 
screen due to logistical matters. Area 7 did not have schools in the category of 5 year olds and 
the number needed to screen in area 1 for this category was 1 which was not feasible due to 
logistics.  
 
 
3.2 Clinical study 
Examination protocol 
The screened individuals underwent a standardized examination protocol consisting of detailed 
medical history recorded by the investigator, physical examination including general analysis of 
the patients‘ health, recognition of Jones criteria and careful cardiac auscultation with the patient 
in the supine and left lateral decubitus positions. From individuals assessed at the NHI blood 
samples and throat swabs were obtained. A unique identification number was attributed to all 
participants. The patient flow chart for clinical investigation in RF and RHD patients at the NHI 
penicillin clinic are shown in diagram 2.2 and diagram 2.3. The flowchart for clinical 
investigation in a cohort of school children in Aswan is shown in diagram 2.4. 
Disease manifestations and auscultatory findings were evaluated according to internationally 
approved criteria, including the published data from World Health Organization (WHO 1988, 
Figueroa 1992). Detailed transthoracic echocardiography was performed with the use of a hand-
carried, battery operated echocardiographic system (Vivid i, General Electric) with M-mode, 
two-dimensional, and Doppler (pulsed, continuous, and color) imaging. The following were 
obtained: apical two-, four-, and five-chamber views, parasternal long-axis and short-axis views 
at the level of the papillary muscles and the aortic valve and subcostal views. 
This study developed an abbreviated protocol that took 5–10 min per child and focused on 
rheumatic pathology of the mitral and aortic valves. Particular attention was paid to valve 
morphology on cross-sectional, two dimensional imaging and the degree and extent of mitral and 
aortic regurgitation, assessed by color flow Doppler imaging. The apical imaging included 
anterior angulation to evaluate the left ventricular outflow tract and the aortic valve. 
Transvalvular flow was assessed by measuring the peak velocity with continuous wave Doppler 
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imaging. Hard copies with detailed location and type of lesions (Appendix V, page 3) and 
electronic records of relevant data were kept for offline re-evaluation.  
The echocardiographic study was performed by the candidate. Two blinded experienced 
cardiologists reviewed the records. The diagnosis of RHD was accepted when there was 
agreement of at least two cardiologists, including the researcher. All children suspected of 
cardiac involvement or lesions were reassessed by echocardiography at the Aswan Heart Centre.  
 
 
 
Visit to Penicillin clinic at the NHI 
(Referred by health unit, referred by the community or self-referral) 
↓ 
Registration (after informed consent) 
↓ 
Clinical history and examination 
Echocardiography 
↓ 
Throat swab 
Storage of B-hemolytic strains in THB tubes for bacteriology studies (Germany) 
↓ 
Blood collection 
Full Blood count 
ESR, CRP, ASOT 
Storage of plasma, serum and blood cells at -80˚C for studies on pathogenesis (UK) 
↓ 
Follow-up: medical appointment after at least 6 months 
 
Diagram 2.2 Flowchart for clinical investigation in RF and RHD patients at the NHI penicillin 
clinic 
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Admission to cardiothoracic surgery department at the NHI 
(Referred by health unit, referred by the community or self-referral) 
↓ 
Registration (after informed consent) 
↓ 
Clinical history and examination 
Echocardiography 
↓ 
Throat swab 
Storage of B-hemolytic strains in THB tubes for bacteriology studies (Germany) 
↓ 
Blood collection 
Full Blood count 
ESR, CRP, ASOT 
Storage of plasma, serum and blood cells at -80˚C for studies on pathogenesis (UK) 
↓ 
Surgery 
Collection of valvular tissue during procedure and storage of samples 
 
Diagram 2.3 Flowchart for clinical investigation in RHD patients scheduled for surgery at the 
NHI 
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Figure 3.8 Echocardiographic screening of school children 
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Randomization of the schools by area, age and school 
↓ 
Visit to schools in Aswan 
Randomization of the children in the school 
↓ 
Registration  
↓ 
Clinical history and examination 
Echocardiography 
↓ 
Revision of retrieved echocardiographic data 
↓ 
When required: Follow-up and reassessment appointment at the AHC 
 
Diagram 2.4 Flowchart for clinical investigation in a cohort of school children in Aswan  
 
 
Sample collection  
A throat swab was taken and blood was collected by venipuncture into 1 siliconised EDTA, 1 
non-additive and 1 citrate ESR tube. The throat swab was streaked immediately across a blood 
agar plate for culturing of the organism. The hemolytic colonies identified were tested for 
antibiotic sensitivity, stored into THB agar tubes.  
A complete CBC, ESR analysis, qualitative determination and semi-quantitative determination of 
the ASOT and CRP was done. Serum and plasma was obtained and stored. 
From the patients scheduled for valve replacement excised valve tissue material was collected at 
the time of surgery. The collected valves were immersed in formalin upon dissection followed by 
embedding of parts of the tissue sample in paraffin. 
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Demographic data 
Demographic data from every subject selected were collected in the form of a standardized 
questionnaire (Appendix V). The questionnaire contains questions regarding the patient‘s 
demographics, family environment, risk factors, history of RF, its severity, treatment and 
prophylaxis.  
Issues regarding the onset age of RF, symptoms, severity, presence of recurrences of RF, 
medication and penicillin prophylaxis were questioned on the history of RF and the presence of 
symptoms to confirm the presence of RF and clinical presentation. Penicillin prophylaxis 
schedule was divided into 3 categories, following the most used and prescribed schedules for 
penicillin prophylaxis, every 15 days, 3 weeks or monthly. Compliance rate for the penicillin 
prophylaxis was evaluated by asking the patient about the schedule, how often he ignored or 
postponed the injection date and if he was strict to the schedule. Compliance was then also be 
evaluated in relation to the schedule. A schedule of less than 9 injections a year was considered 
poor. A schedule of 9 to 12 injections a year was considered fair, while an excellent compliance 
rate was more than 12 injections a year. Many individuals were receiving prophylaxis for the 
first time therefore questions on schedule and compliance was not applicable. 
The disease awareness as classified in 3 categories evaluated on the patients‘ knowledge of the 
RF history, symptoms and penicillin prophylaxis. The disease awareness was also be evaluated 
by the amount and type of questions answered on the knowledge of RF and RF history. The 
disease awareness was evaluated as poor when the patient had no knowledge of the reason for 
penicillin prophylaxis. When the patient was aware of RF or the valvular damage, and knew that 
penicillin is a way of prophylactic prevention but did not know the link between RF and the 
valvular damage the awareness was evaluated as fair. The patient‘s awareness was evaluated as 
good when he was also aware of the correlation between RF and cardiac disease (RHD). The 
same scale was used for the parents‘ awareness. Dental care was evaluated during collection of 
throat swabs by the general condition of the mouth and teeth.  
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Echocardiographic criteria 
Based on recent studies on the design and development of diagnostic criteria for RHD (WHO 
2004, Marijon 2007, Carapetis 2008, Marijon 2009) and our own clinical experience a new 
comprehensive set of criteria to determine the presence and extent of cardiac involvement was 
developed (Criteria 4, Aswan Heart Centre (AHC) criteria). 
Our suggested criteria for the diagnosis of RHD consists of the presence of any Doppler-detected 
valvular affection of the right-sided valves in association with at least one structural rheumatic 
valvular feature. Regurgitation should be defined as pathological when meeting all four criteria 
defined by the WHO (Table 1.3). However, including trivial affection. Mitral stenosis should 
diagnosed in case of flow acceleration across the mitral valve and a mean pressure gradient 
greater than 4 mmHg. Similarly, flow acceleration across the aortic valve with a peak velocity 
greater than 2 m/s is necessary for diagnosis of aortic stenosis.  
The structural criteria should be based on the study of (1) quantitative leaflet morphology 
(typical marked thickening of the margins, greater than 4mm), (2) leaflet shortening with 
abnormal motion due to the posterior leaflet tip restriction), and (3) subvalvular apparatus 
morphology (prominent thickening, most often just below the valve, and shortening of chordal 
structures) (Table 3.2). 
  
Table 3.2 AHC criteria: Echocardiographic criteria for the diagnosis of RHD (Criteria 4)  
Functional criteria 
Mitral or Aortic Regurgitation  (at least mild) 
1. Mitral or Aortic Stenosis 
Structural criteria  
Thickening of valve cusps  
Doming of valve cusps  
1. Fused subvalvular apparatus  
2. Leaflet shortening and restriction 
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After completion of the hospital based study and evaluation of the data we have decided to adjust 
the echocardiographic criteria for the diagnosis of RHD in the school based screening (Criteria 
5). We believe that in a young population subclinical RHD can present as single and isolated 
lesions rather than combinations of lesions which are expected to appear in a more chronic 
phase.  
In this criteria any degree of regurgitation together with valvular thickening of leaflet restriction 
lead to the diagnosis of RHD, as well as the finding of isolated fusion of the subvalvular 
apparatus and/or commisure or aortic regurgitation, as these features are uncommon in healthy 
children. Isolated valvular thickening, leaflet restriction or at least mild mitral regurgitation 
indicate possible RHD (Table 3.3). We believe that this criteria is more sensitive for screening 
purposes in young children, avoiding over- and underdiagnosis of RHD.  
 
Table 3.3 Modified AHC criteria: Echocardiographic criteria for the diagnosis of RHD (Criteria 
5)  
Definite RHD 
Valvular thickening & any degree of regurgitation 
Leaflet restriction & any degree of regurgitation 
Fusion of subvalvular apparatus or/and 
commisures 
Aortic regurgitation caused by cusp retraction 
Possible RHD 
Isolated valvular thickening 
Isolated leaflet restriction 
Isolated ≥ mild mitral regurgitation  
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3.3 Laboratory study 
3.3.1 Haemal assays 
Sample collection: The blood was collected following international venipuncture protocols. 
Detailed steps of venipuncture: 
 The median cubital and cephalic veins of the arm were palpated and traced with the index 
finger 
 The patient as positioned so he or she was comfortable and safe in case of fainting and falling 
 The venipuncture site was prepared with an alcohol swab in a circular fashion.  
 The tourniquet was applied 3-4 inches above the selected puncture site. 
 The venipuncture was performed with the patient‘s arm in a downward position.  
 The tourniquet was removed as soon as blood appeared in the tube 
 Succeeding tube was placed in the holder puncturing stopper to initiate flow 
 While each successive tube was filling the previous tube was inverted gently 5 times 
 When all tubes of blood had been collected, the last tube was removed from the vacutainer 
holder, and a cotton ball or gauze was placed over the site and the needle was withdrawn in a 
smooth and cautious manner 
 After withdrawing the needle fully, pressure was applied to the cotton ball over the puncture 
site and hold pressure. The patient was asked to apply pressure for 3 to 5 minutes until the 
bleeding stops. 
 
Blood was collected into: 
-1 siliconised glass tubes containing EDTA  
-1 non-additive tube 
-1 citrate ESR tube 
 
Preparation of samples 
EDTA tube: The tube containing blood on EDTA was run through the Sysmex KX-21N for CBC 
count and the centrifuged to obtain plasma. 
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Non-additive tube: The blood collected in the non-additive tube was centrifuged to obtain serum. 
This serum was used for the CRP and ASOT analysis. 1 ml of whole blood was aliquoted in an 
Eppendorf tube for storage.  
 
ESR citrate tube: 1 ml of blood was collected in an ESR tube to determine the rate with the 
Wintrobe method.  
 
Preparation of serum 
 blood samples collected in non-additive blood collection tubes were centrifuged at 4000 rpm 
for 4 min 
 the supernatant (serum) was aliquoted into 2 Eppendorf tubes (approximately 1ml of serum 
each) 
 the eppendorf tubes were stored in a freezer at -40°C 
 the samples were later transported to the Helmholtz Centre in an icebox  
 
Preparation of plasma 
 blood samples collected in EDTA collection tubes were centrifuged at 4000 rpm for 4 min 
 the plasma was aliquoted into 2 Eppendorf tubes (approximately 1ml of plasma each) 
 the Eppendorf tubes were stored in a freezer at -40°C 
 
3.3.2 Valvular tissue assays 
Sample collection: Excised valves of patients with a history of RF/RHD were collected during 
routine valve replacement procedures. The valvular tissue was stored in formalin directly after 
collection. Parts of the tissue was later embedded in paraffin.  
 
Paraffin embedding protocol 
 The tissue was fixed in 70% Ethanol  
 The tissue was then placed in the tissue processor.  
 The specimens were embedded in paraffin. 
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 The tissue block was attached to a hardwood block by melting the back of the tissue 
block with a warm spatula and firmly pressing the two together. 
 8 μm thick sections were cut with a standard microtome 
 The sections and paraffin blocks were stored at room temperature. 
 
2.3.3 Bacteriology assays 
Sample collection: The specimen for throat culture were obtained by the following protocol: 
 The patient was asked to tilt the head back and open the mouth wide. 
 With the tongue depressed and the patient saying "ah," the back of the throat and the 
tonsils were wiped with a sterile swab. 
 The swab is removed gently without touching the teeth, gums, or tongue.  
 The swab was streaked immediately across a blood agar plate 
 
Culturing 
 The swab was streaked immediately after collection across a blood agar plate 
 The blood agar plate was allowed to incubate at (35°–37°C) for 24–48 hours to allow the 
growth of bacteria 
 After incubation the colonies on the agar plates were analyzed 
 Hemolytic colonies were identified  
 
Sensitivity testing: Susceptibility testing is used to determine which antimicrobial inhibits the 
growth of the bacteria causing the infection. If the bacteria are susceptible to a particular 
antibiotic, an area of clearing surrounds the wafer where bacteria are not capable of 
growing (called a zone of inhibition). The size of the zone and the rate of antibiotic 
diffusion are used to estimate the bacteria‘s sensitivity to that particular antibiotic. The 
results from this test helped determine which antibiotic was the most effective in treating 
the infection. 
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 Antibiotics tested:  
 Levofloxacin 5 mcg (BioAnalyse) 
 Erythromycin 15 mcg (BioAnalyse) 
 Vancomycin 30 mcg (BioAnalyse) 
 Ciprofloxacin 5 mcg (BioAnalyse) 
 Gentamycin 10 mcg (BioAnalyse) 
 Doxycicline 30 mcg (BioAnalyse) 
 Penicillin 10U (BioAnalyse) 
 Bacitracin 10U (BioAnalyse) 
 Taxo- differentiation discs (Benex Limited) 
 
Detailed steps: 
 Samples of the identified colonies were re-streaked on antibiotic agar plates  
 Antibiotic discs were placed on the agar plate 
 After incubation the colonies on the agar plates were analyzed for the growth pattern 
 The antibiotic sensitivity was analyzed  
 
Storage 
 Samples of the identified colonies were collected with a sterile loop 
 Sterile loop were stabbed in THB agar tubes 
 The tubes was allowed to incubate at (35°–37°C) for 24–48 hours  
 The agar tubes were stored at 4°C for a maximum of 3 weeks 
 The tubes were transported to the Helmholtz Centre at room temperature 
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3.4 Statistical Analysis 
Statistical analysis was performed using Statistical Package for Social Sciences, version 16 
(SPSS 16). Firstly all variables were tested for normality using Kolmogrov-Smirnov test. If the 
test was significant, non-normality was accepted otherwise double-check using graphs, skewness 
and kurtosis were required to confirm normality (Chan 2003). 
Most  of  the  quantitative  variables  in  this  research  were  not  normally  distributed and 
accordingly are presented as median (range). Quantitative data are presented as mean ± SD when 
normality assumptions were satisfied. Qualitative data as frequencies are presented as number 
(percentage).   
Categorical variables were compared using Chi-square analysis ( 2) (Chan 20032). A P-value of 
<0.05 was considered statistically significant (Chan 2003). Because  most  of  quantitative  data  
were  not  normally  distributed,  variables  were compared between two related samples using 
the Spearman test and two unrelated samples using the Mann Whitney U test. When normal 
distribution was confirmed, data were compared using paired and unpaired T-test, respectively 
(Chan 2003). 
 
3.5 Ethical considerations  
Hospital-based study  
Ethical approval was granted by the Imperial College London (appendix VI) and the National 
Heart Institute. Patient information sheet and informed consent were designed (Appendix VII). 
All volunteers were given written and oral detailed information, interviewed through the RF and 
RHD characteristic questionnaire and asked to sign an informed consent form which was 
translated into Arabic.  
All subjects were asked to undertake physical and echocardiographic examination and collection 
of blood and throat swab samples. The physical examination included general analysis of the 
patients‘ health, recognition of Jones criteria, cardiac auscultation and echocardiography. From 
the patients scheduled for valve replacement excised valve tissue material was collected at the 
time of surgery. Individuals were notified about the results of the tests and eventual need of any 
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further treatment or follow-up and were free to withdraw from the study at any time without 
giving any specific reasons. 
 
Cohort school children  
The research project was approved by the appropriate authorities at the Governorate of Aswan 
and the Egyptian Ministry of Health and Education, as representatives of the population and 
education system (Appendix VIII). 
The local authorities and school personnel were given written and oral detailed information. The 
physical examination included general analysis of the patients‘ health, recognition of Jones 
criteria, cardiac auscultation and echocardiography. The local health authorities and caretakers 
were notified about the results of the tests and eventual need of any further treatment or follow-
up. Individuals were free to withdraw from the study at any time without giving any specific 
reasons. Children with cardiac affection were offered free treatment, follow-up and surgery if 
indicated at the Aswan Heart Centre in Aswan.   
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CHAPTER 4 
 
 
SCHOOL BASED SCREENING FOR  
RHEUMATIC HEART DISEASE 
 
Chapter 4 School based screening for RHD 
 
 
4.1 Background  
In Egypt, a high percentage of schoolchildren have been reported to have clinical evidence of 
cardiac valvular damage due to RHD, with a severe and aggressive couse of the disease (Kassem 
1982, Abdin 1968, El Sherif 1975). Although these studies have been helpful in forming an idea 
on RHD in the Egyptian youth, they have not been systematic and did not use 
echocarediographic evaluation and diagnosis of the valvular lesions. Echocardiography is found 
to be the only approach with sufficient sensitivity and specificity for the detection of subclinical 
carditis and RHD (Marijon 2007, Carapetis 2008) and has resulted in high prevalence rates of 
RHD in different areas confirming that the prevalence of RHD in school-aged children is far 
greater than earlier estimates.  
Due to the lack of data on prevalence, characteristics and determinants we designed a cross-
sectional screening using systemic sampling in a cohort of randomly selected school children in 
Aswan, in whom auscultation followed by echocardiography was used to identify the presence, 
characteristics and determinants of RHD. 
The aim of this study was to evaluate the valvular affection and diagnosis of RHD and determine 
the epidemiological and clinical characteristics as well as risk factors and determinants of RHD 
in an area where data on regard the disease is completely lacking.  
 
4.2 Participants and methods 
Screening  
A cross-sectional screening of schoolchildren from 5 to 15 years of age was performed in Aswan 
as described in chapter 3, pg. 76. 
 
Sample size calculation  
A total of 3,062 children were screened for the characteristics of RHD following the earlier 
provided prevalence forecast. 
 
Sample selection 
The number of schools and school children for each age group in the different areas was 
obtained. 
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Sample size 
The number of children needed to screen from each area was calculated as following: 
 (1) 
            
             
                      
Childrenarea = total school children in the area 
Childrentotal = total of school children in Aswan 
Represenationarea = representation of the area in the total cohort 
(2) 
                                             
Representationarea = representation of the area in the total cohort 
Screentotal = total number to screen (in this case= 3000) 
Screenarea = number needed to screen in the area 
 
The schools are distributed in 3 age groups: 5 years, 6 to 12 years and 13 to 15 years. The 
number of children screened in each age group was dependent on their representation in the age 
groups in the area so that the screened population was representative for the area as well as the 
age group. The number of children needed to screen from each age group was calculated as 
following: 
 (3) 
                
            
                          
Childrenagegroup = total of children in a certain age group 
Childrenarea = total school children in the area 
Represenationagegroup = representation of the age group in the area 
 
(4) 
                                                    
Represenationagegroup = representation of the age group in the area 
Screenarea = number needed to screen in the area 
Screenagegroup = number needed to screen in the age group 
 
The distribution of the children by area, age group, representation and the number needed to 
screen per area and age group can be found in appendix III.  
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Sampling 
Selection of the sample was done by randomization in three stages stratified by area, school and 
age group and weighed by distribution of school children across the 7 areas and 3 age groups.  
The schools were stratified by area and age group and randomly selected using computer-
generated random-number sampling.  
On the day of screening, the children were invited to participate in the study and attributed 
numbers for random-number sampling, according to the number needed to screen, weighed by 
the representation of the age group in the area. There was no exclusion criteria and all children 
had the same probability chances of being chosen. The list of schools visited, selected by age 
group as well as the number of children screened can be found in Appendix IV.  
The number of children screened in each school and area exceeds slightly the number needed to 
screen due to logistical matters. Area 7 did not have schools in the category of 5 year olds and 
the number needed to screen in area 1 for this category was 1 which was not feasible due to 
logistics.  
 
Examination protocol 
The screened individuals underwent a standardized examination protocol consisting of detailed 
medical history recorded by the investigator, physical examination including general analysis of 
the patients‘ health, recognition of Jones criteria and careful cardiac auscultation with the patient 
in the supine and left lateral decubitus positions.  
Disease manifestations and auscultatory findings were evaluated according to internationally 
approved criteria, including the published data from World Health Organization (WHO 1988, 
Figueroa 1992). Detailed transthoracic echocardiography was performed with the use of a hand-
carried, battery operated echocardiographic system (Vivid i, General Electric) with M-mode, 
two-dimensional, and Doppler (pulsed, continuous, and color) imaging. The following were 
obtained: apical two-, four-, and five-chamber views, parasternal long-axis and short-axis views 
at the level of the papillary muscles and the aortic valve and subcostal views. 
Particular attention was paid to valve morphology on cross-sectional, two dimensional imaging 
and the degree and extent of mitral and aortic regurgitation, assessed by color flow Doppler 
imaging. The apical imaging included anterior angulation to evaluate the left ventricular outflow 
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tract and the aortic valve. Transvalvular flow was assessed by measuring the peak velocity with 
continuous wave Doppler imaging. Hard copies with detailed location and type of lesions 
(Appendix V, page 3) and electronic records of relevant data were kept for offline re-evaluation.  
The echocardiographic study was performed by the candidate and two blinded experienced 
cardiologists reviewed the records. The diagnosis of RHD was accepted when there was 
agreement of at least two cardiologists, including the researcher. All children suspected of 
cardiac involvement or lesions were reassessed by echocardiography at the Aswan Heart Centre.  
 
Demographic data 
Demographic data from every subject selected were collected in the form of a standardized 
questionnaire (Appendix V). The questionnaire contains questions regarding the patient‘s 
demographics, family environment, risk factors, history of RF, its severity, treatment and 
prophylaxis.  
 
Echocardiographic criteria 
Only left-sided valves were evaluated for features of RHD as affection of the right sided valves 
is fairly common and not related to the condition (Lembo 1988, Kostucki 1986, Lembo 1988, 
Yoshida 1988). RHD was diagnosed by the different echocardiographic diagnostic criteria as 
following:  
 
Criteria 1 (WHO 2004): (1) a regurgitant jet >1 cm in length, (3) seen in at least 2 planes, (3) a 
mosaic color jet with a peak velocity >2.5 m/s, (4) persisting throughout systole or diastole  
 
Criteria 2 (Carapetis 2008): (1) valvular regurgitation (meeting all four criteria defined by the 
WHO) with evidence of structural changes to valve appearance: (a) valvular thickening (b) 
elbow deformity of the anterior mitral valve leaflet (2) any degree of pathological aortic 
regurgitation (3) mitral stenosis (flow acceleration and a mean pressure gradient > 4 mmHg) (4) 
aortic stenoses (flow acceleration with peak velocity > 2 m/s)  
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Criteria 3 (Marijon 2007): any degree of valvular regurgitation seen in at least 2 planes 
accompanied by at least two of
 
the following three structural abnormalities of the regurgitant
 
valve: (1) leaflet morphology (typical marked thickening of the margins), (2) leaflet mobility 
(abnormal motion due to the posterior leaflet tip restriction), and (3) subvalvular apparatus 
morphology (prominent thickening, most often just below the valve, and shortening of chordal 
structures)  
 
Criteria 4 (AHC criteria): The suggested criteria for the diagnosis of RHD consists of the 
presence of any Doppler-detected valvular affection of the right-sided valves in association with 
at least one structural rheumatic valvular feature (as extensively described in chapter 3, pg. 90). 
Regurgitation should be defined as pathological when meeting all four criteria defined by the 
WHO (Table 1.3), however, including trivial affection. Mitral stenosis should diagnosed in case 
of flow acceleration across the mitral valve and a mean pressure gradient greater than 4 mmHg. 
Similarly, flow acceleration across the aortic valve with a peak velocity greater than 2 m/s is 
necessary for diagnosis of aortic stenosis.  
The structural criteria should be based on the study of (1) quantitative leaflet morphology 
(typical marked thickening of the margins, greater than 4mm), (2) leaflet shortening with 
abnormal motion due to the posterior leaflet tip restriction), and (3) subvalvular apparatus 
morphology (prominent thickening, most often just below the valve, and shortening of chordal 
structures) (Table 3.2). 
 
Criteria 5 (Modified AHC criteria): During the clinical work and evaluation of the data, criteria 
4 was adjusted and modified (Criteria 5). In this criteria any degree of regurgitation together with 
valvular thickening or leaflet restriction lead to the diagnosis of RHD, as well as the finding of 
isolated fusion of the subvalvular apparatus and/or commisure or aortic regurgitation, as these 
features are uncommon in healthy children. Isolated valvular thickening, leaflet restriction or at 
least mild mitral regurgitation indicate possible RHD (Table 3.3).  
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4.3 Results 
4.3.1 Demographics 
A total of 3062 pupils between the ages 5 and 15 were screened in Aswan, representing 6% of 
the schools population in the area.   
 
Age: The mean and median age was 10 years ± 2.6 years. The distribution of the age groups was 
representative for each group in the population of schoolchildren (Figure 6.1).  
 
Figure 4.1 Distribution of age groups 
 
Gender: There was a slight male predominance (58.7%, n=1796) in the group screened. 
 
Social factors: The number of siblings ranged from 0 to 11 (3.14 ± 1.54) in the total of 1515 
(49.47%) children that answered the question.  
The majority of the children (90.2%, n=1776) reported that the father had an active job, while 
literacy of the father was reported in 74.7% (n=1085). A part of the children (20.4%, n=372) 
reported that the mother had an active job, with 63.6% (n=885) reporting literacy.  
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Medical history: The medical history remained unknown as the caretakers were not present 
during the screening and the lecturers and education staff did not have any information on the 
medical history.  
4.3.2 Clinical findings 
No major general health issues were detected and none of the children showed characteristics of 
the Jones Criteria for the diagnosis of RF.  
Cardiac auscultation revealed murmurs in 0.4% (n=12) children, of which 0.23% (n=7) were free 
of cardiac affection as analyzed by echocardiography. Moderate aortic regurgitation was the 
cause of a cardiac murmur in 0.1% (n=3) of the children, while the remaining children (0.07%, 
n=2) had moderate or severe mitral regurgitation. 
 
4.3.3 Echocardiographic findings  
Structural features 
In our series 3.3% (n=101) of the children screened had structural abnormality of the heart 
valves, namely thickening of the valve leaflets or cusps (≥4 mm). Isolated fusion or thickening of 
the subvalvular apparatus was seen in 0.03% (n=1) of the children. A combination of thickening 
of the valve leaflets or cusps and fusion or thickening of the subvalvular apparatus was seen in 
0.1% (n=3) of the children. Prolapse of the mitral valve was seen in 0.16% (n=5) of the children.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2 Measurement of the aorta and left atrium in a parasternal long-axis 
Chapter 4 School based screening for RHD 
 
102  
 
 
Rheumatic Heart Disease in Egypt 
 
 
Functional affection 
Functional affection of the right sided heart valves was found in 16.3% (n=501) of the children 
assessed (Figure 4.2). Trivial mitral valve regurgitation was found in 14.3% (n=440) of the 
children while mild mitral regurgitation was seen in 1.9% (n=57) of the children. Moderate and 
severe mitral regurgitation was seen in 1 child (0.03%), respectively. Isolated mitral valve 
affection was seen in 16.2% (n=498) of the children.  
Mild aortic regurgitation was seen in 0.1% (n=3) of the children. Isolated affection of the aortic 
valves was seen in 2 (0.07%) and a combination of mild mitral and aortic regurgitation was 
found in 1 (0.03%) child. Trivial and mild tricuspid regurgitation was seen in 0.4% (n=12) and 
0.1% (n=4), respectively. No stenotic lesions were found in our study.  
 
Figure 4.3 Valvular affection 
 
Figure 4.4 Distribution of regurgitant valvular affection 
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Features of RHD 
Structural features: Thickening of the valve leaflets or cusps was seen in 94.3% (n=66) of the 
children diagnosed with RHD. Isolated fusion or thickening of the subvalvular apparatus was 
seen in 1.4% (n=1) of the RHD cases. A combination of thickening of the valve leaflets or cusps 
and fusion or thickening of the subvalvular apparatus was seen in 4.3% (n=3) of the children. 
 
Figure 4.5 Thickening of the mitral leaflets in a parasternal long-axis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.6 Thickening of the tip of the mitral leaflet in parasternal long-axis 
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Functional features: Isolated mitral regurgitation was seen in 96% (n=67), isolated aortic 
regurgitation in 2.9% (n=2) and both in 1.4% (n=1) of the RHD cases. No cases of mitral or 
aortic stenosis were seen.  Trivial or mild mitral regurgitation accounted for 44.2% (n=31) and 
51.4% (n=36) of the RHD cases, respectively. The regurgitation was mild in all cases of aortic 
affection (4.2%, n=3).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.7 Mitral regurgitation in apical four-chamber view 
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Figure 4.8 Mitral regurgitation in parasternal long-axis 
 
Congenital Heart Disease 
We identified 3 children with congenital heart disease (prevalence 1 per 1000) in the form of 
PDA (Patent Ductus Arteriosus), PAVC (Partial Atrioventricular Canal) and TGA (Transposition 
of the Great Arteries).  
 
4.3.4 Evaluation of newly developed echocardiographic diagnostic criteria  
Prevalence of subclinical RHD following the different diagnostic criteria 
Following criteria 1 (WHO 2004), which is based on the finding of at least mild mitral and/or 
aortic regurgitation 2% (n=61) would be diagnosed with RHD.  
Following criteria 2 (Carapetis 2008) a total of 1.76% (n=54) would be diagnosed with RHD of 
which 0.1% (n=3) would have been diagnosed by the presence of pathological aortic 
regurgitation and 0.5% (n=16) by the presence of mild mitral regurgitation. A combination of 
mild mitral regurgitation and structural characteristics was seen in 1.1% (n=35) of the children. 
A small number (0.4%, n=12) of the individuals would be diagnosed with borderline RHD in by 
the presence of trivial mitral regurgitation. Following criteria 3 (Marijon 2007) which combines 
valvular regurgitation with at least 2 structural signs a total of 0.09% (n=3) individuals would be 
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diagnosed with RHD as a combination of at least 2 of the structural findings was found in only 
0.1% (n=4) of the individuals. Following our earlier suggested criteria (criteria 4, AHC criteria) 
which combines 1 functional and 1 structural feature (as described in chapter 3, pg. 89), 2.1% 
(n=66) of the children would be diagnosed with RHD. 
 
Figure 4.9 Valvular affection and diagnosis of RHD by criteria 4 (AHC criteria) 
 
By the newly suggested criteria (Criteria 5, modified AHC criteria) (as described in chapter 3, 
pg. 90) 2.3% (n=70) of the children would be diagnosed with RHD, corresponding to a 
prevalence of 23 cases per 1000 children. Isolated thickness of the leaflets or cusps was seen in 
0.6% (n=19) and isolated at least mild mitral regurgitation was found in 0.7% (n=22) of the 
children, leading to a total of 1.3% (n=41) of possible RHD cases.  
 
Figure 4.10 Diagnosis of RHD following the different criteria  
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4.3.5 Clinical versus echocardiographic diagnosis of subclinical RHD 
Clinical assessment by cardiac auscultation revealed cardiac affection in 7.1% (n=5) of the 
children diagnosed with RHD by echocardiography, showing a 14-fold increase of the case 
detection rate by echocardiography.  
 
4.3.6 Determinants of RHD 
There was no significant relation between the age, the gender, or the amount of siblings and the 
presence of structural or functional cardiac affection or the diagnosis of RHD. However, there 
was a slight peak of RHD diagnosis in the group aged 11-12 years (Figure 4.6). Furthermore, 
there was also a slight statistically not significant male predominance in the diagnosis of RHD 
(Figure 4.7).  
 
Figure 4.11 RHD affection by age 
 
Figure 4.12 RHD affection by gender 
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4.4 Discussion 
Our study shows a prevalence of 23 cases of RHD in 1,000 screened school children in Aswan, 
Egypt, which is comparable to earlier reports of systemic echocardiographic screenings from 
Cambodia (21.5 per 1,000) and Mozambique (30.4 per 1,000) (Marijon 2007) and exceeds the 
previously estimated prevalence based on clinical examination of 5.1 per 1000 schoolchildren in 
Egypt (Alwan 1993, WHO 1992). However, previous echocardiographic screenings have 
resulted in prevalence rates for RHD up to 62 in 1,000 (Anabwani 1996, Paar 2010, Marijon 
2007), providing an average point prevalence of 40 in 1,000 in school-aged children (Paar 2010). 
Importantly, the difference in the reported prevalences may rely on geographical differences as 
well as the used criteria.  
 
The age of the cohort studied was in the range with the previous school based screenings 
(Marijon 2007, Carapetis 2008, Paar 2010) enhancing the comparison of the results. Our series 
did not confirm the age differences for the cardiac affection, although RHD is believed to be 
more common in the 11-16 years age group than in younger children (Thakur 1996, Longo-
Mbenza 1998) peaking in those aged 10-12 year (Carapetis 2008). However, there was a slight 
peak in the diagnosis of RHD in the group aged 11-12 years.  
It has been reported that the prevalence of RHD increases significantly with age (Marijon 2007, 
Carapetis 2008, Marijon 2009), peaking in adults aged 20–40 years, with the number of cases of 
RHD in school-aged children representing less than 20% of the cases in the whole population 
(Carapetis 2005
1
, Steer 2009). Therefore, in order to reflect the true number of prevalent cases in 
the general population the prevalence of RHD in children is increased five- to seven-fold 
(Carapetis 2005
1
). In our case this would lead to a horrifying prevalence of 115 to 161 RHD 
cases per 1000 Egyptians.  
Our series does not confirm the earlier suggested gender predisposition for RHD with female 
predominance in the rheumatic affection (Marijon 2007, Marijon 2009), in fact, we have seen a 
statistically not significant male predominance in the diagnosis of RHD. 
 
Structural features were found in 3.3% of the children screened and in 94.3% of the RHD cases, 
particularly in the form of thickening of the valve leaflets or cusps, which has been reported to be 
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the commonest feature of RHD, found in up to 83.8% of the cases (Vijayalakshmi 2008). Fusion 
or thickening of the subvalvular apparatus was less common and only seen in 1.5% of the 
children diagnosed with RHD and a combination of structural features was the second most 
common structural characteristic of RHD.  
Functional affection of the left sided heart valves was found in 16.3% of the children assessed 
with predominance of trivial mitral valve regurgitation, which is in concordance with earlier 
reports (Thakur 1996, Longo-Mbenza 1998). The distribution of the valvular affection in the 
RHD cases found in our series was similar to the study performed in Mozambique (Marijon 
2007) which reports mitral valve affection in up to 95.5%, aortic affection in 1.5% and affection 
of both valves in 3% of the cases. However, we found a slightly higher affection of the aortic 
valve (2.9%) and lower combined affection of the aortic and mitral valves (1.4%) (Marijon 
2007). Nevertheless, studies in Cambodia and Tonga report lower representation of mitral valve 
affection, ranging from 77.2% to 85% and more affection of the aortic valve (12,7% and 9%, 
respectively) and combinations of mitral and aortic pathology (10.1% and 6%, respectively) 
(Marijon 2007, Carapetis 2008).  
Importantly, although the prevalence of aortic regurgitation was lower, the severity of the 
affection was higher than earlier reported (Carapetis 2008). However, moderate or severe 
valvular affection was seen in only a small number of children, suggesting that in this age group 
the majority of the lesions are mild. No stenotic lesions were found in this age group as expected 
(Marijon 2007, Carapetis 2008). This series suggests a slight geographical variety of clinical 
presentation of RHD with a higher affection of the mitral valve and less combined lesions or 
affection of the aortic valve.  
 
None of the screened children had physical signs of RF as defined by the Jones criteria and only 
a small number of children had a cardiac murmur. Our series confirms that cardiac auscultation 
detects an insufficient number of RHD cases, and particularly in those who have trivial or mild 
affection of the valves, showing an increase in case detection rate by echocardiography up to 14-
fold compared to clinical examination, identifying children at risk of developing RHD for whom 
secondary prevention with penicillin prophylaxis may be effective (Marijon 2007). Comparable 
results have been reported earlier, as murmurs are known to be missed and subclinical and even 
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moderate cardiac affection may not be clinically audible, underdiagnosing milder lesions 
(Marijon 2007, Carapetis 2008), leading therefore to a higher sensitivity and accurate diagnosis 
of valvular involvement by echocardiography (Ramakrishnan 2009).  
Screening based only on auscultation misses therefore many cases of RHD, however, the 
increased detection rate of valvular affection by echocardiography has generated debate 
(Carapetis 2007, Carapetis 2008
3
, Marijon 2008). Detection of mild lesions is important because 
children with mild disease benefit most from secondary prophylaxis, however, echocardographic 
evaluation by Doppler and two-dimensional imaging is believed to be subtle and subjective. This 
would suggest a potential of over-interpreting normal physiological features, leading to incorrect 
diagnoses and overestimation of disease burden (Steer 2009). However, in areas with high 
prevalence of RF, the consequences of underdiagnosis are significantly greater than 
overdiagnosis (Ramakrishnan 2009) as secondary prevention of RHD can dramatically reduce 
morbidity and mortality, however, relying upon effective screening and identification of the 
children at risk. 
 
There has been debate concerning the echocardiographic signs of early RHD to define the 
criteria to be used for the diagnosis of subclinical RHD and for the fact that echo definition of 
RHD based only on the length, velocity, and persistence of the regurgitant jet may depend on the 
gain settings on the ultrasound equipment (Minich 1997, Wilson 1995, WHO 2004).  
The detection rate of the newly developed echocardiographic criteria (Criteria 4 (AHC criteria) 
and 5 (modified AHC criteria) is similar, however, the adjusted criteria seems to be more 
sensitive and specific for the screening and diagnosis of RHD in a younger population as it 
detects milder lesions and indicates them as rheumatic. Importantly, these criteria also had a 
similar detection rate as criteria 1 (WHO criteria), however, this was based on different 
echocardiographic criteria which only considers mild mitral or aortic regurgitation to indicate 
RHD, excluding all milder lesions and not evaluating the valvular structure. Furthermore, this 
criteria may also cause overdiagnosis due to the presence of physiological regurgitation. Criteria 
2 (Carapetis 2008) showed a lower detection rate as it excludes trivial regurgitation and misses 
therefore all trivial and milder functional affection of the valves compared to our criteria. Criteria 
3 (Marijon 2007) showed the lowest detection rate due the fact that it requires 2 structural 
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features for the diagnosis of RHD. We believe that this criteria underdiagnoses RHD especially 
in a young population, which still has mild and subclinical vlvular affection and who might have 
not developed combinations of structural rheumatic features as these are more prone to be 
present in chronic and long standing phases of the disease. 
Furthermore, we believe that restriction of leaflet mobility should be only diagnosed in 
combination with shortening of the leaflet, forming together a structural feature of the condition. 
Criteria 3 (Marijon 2007) considers isolated abnormal motion of the leaflet a sign of rheumatic 
affection, leading to a higher diagnostic rate of this finding in their series, while in our study this 
feature was less commonly diagnosed by the requirement of leaflet shortening in combination 
with the mobility restriction. This might explain the discrepancy between the detection rates 
reported by the criteria suggested in this series and criteria 3 (Marijon 2007).   
 
Inclusion of structural characteristics in the diagnostic criteria is believed to prevent 
overdiagnosis of the condition by overcoming the boundary between physiological valve 
regurgitation and authentic but minimal rheumatic lesions. Furthermore, the similar structural 
and functional rate of affection seen in RHD suggests that a combined criteria is more sensitive 
and accurate, avoiding misdiagnosis of the condition and seems to be better suited for screening 
of subclinical RHD. Based on the presented results we would recommend the newly developed 
criteria to be taken in consideration for the diagnosis of subclinical RHD, especially in a young 
population, as it seems to recognize early signs of the condition. We also believe that the most 
common structural feature found in early RHD is thickening of the valvular leaflets and cusps. 
Therefore we think that it is logic to regard isolated thickening as a sign of possible RHD as this 
feature might develop before the related valvular regurgitation. Furthermore, isolated aortic 
regurgitation is considered to indicate RHD as represents a condition rare in healthy children 
(Folger 1992). Importantly, standardization of the diagnostic criteria will allow comparison of 
prevalence in different areas and improve case detection.   
 
It is now recognized that RHD can develop in individuals who did not develop manifest 
streptococcal infection or RF which can sometimes be asymptomatic. Moreover, the fact that 
over 93% of the found RHD cases in our series were subclinical, occurring in asymptomatic 
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children without audible murmurs shows the need for echocardiographic screening to optimize 
case identification and targeted prevention measures. Especially as many of the children 
diagnosed with subclinical cardiac affection will progress to clinically manifested disease in 
young adulthood (Carapetis 2005
2
). Importantly, detection at an early stage is believed to limit 
the progression to and improve the prognosis of chronic valvular disease with adherence to 
secondary penicillin prophylaxis lending support to the fact that screening is essential, and 
therefore, RHD satisfies all standard criteria for a screening program (Council of Europe 1994). 
The use of register-based disease-control programs is recommended in populations with a high 
prevalence of RHD (WHO 2004) to ensure coordinated, ongoing care with a particular focus on 
adherence to secondary prophylaxis regimens trough long-term, regular delivery of penicillin to 
patients with RHD or a history of RF to prevent recurrences and the worsening of valve lesions. 
However, the clinical importance of subclinical rheumatic valves lesions is still unknown 
(Carapetis 2008), which shows the need for follow-up of patients with subclinical lesions to 
determine whether their disease evolves in a similar way to clinically apparent RHD, and 
whether secondary prophylaxis improves disease outcome.  
This study aimed to optimize case identification and targeted (secondary) prevention measures 
by identifying children at risk of developing rheumatic valve disease for whom secondary 
prevention with penicillin prophylaxis may be effective (Marijon 2001, Marijon 2007). We used 
stringent criteria that combines internationally accepted  definitions  of  pathological  valvular 
functional affection (Bisno 2001)  with  evidence  of  structural changes to valve appearance that 
are typical for RHD, expectedly raising case detection rates with major potential public health 
benefits. This study has led to the establishment of a registry for all the RHD cases found during 
the screening for regular follow-up and monitoring of the compliance to the penicillin 
prophylaxis. We hope hereby to enhance the disease awareness and increase the compliance to 
the penicillin regimen. This will also allow us to monitor the development or progression of the 
valvular affection and lesions for early recognition and treatment of RHD leading to better 
knowledge on long-term prognosis of subclinical rheumatic lesions. We will offer and provide 
free treatment, follow-up and surgery if indicated at the Aswan Heart Centre in Aswan.  
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Due to practical and ethical considerations no blood samples were taken, which forms a 
limitation of the study, as it would allow us to analyze the activity of the process. However, 
earlier similar studies have also not included this aspect in the screening (Anabwani 1996, 
Marijon 2007, Carapetis 2008, Paar 2010). Improtanlty, the significance of the findings and 
analysis of progression with determination of long-term prognosis should be addressed by 
follow-up of this cohort, which is uppermost fundamental.  
 
4.5 Conclusion 
This series shows that the prevalence of rheumatic valvular abnormalities in school-age children 
in Egypt is far greater than earlier estimates and extend the observations to show a high 
prevalence of subclinical disease in children in Aswan, Egypt, who may be at great risk for 
developing chronic progressive RHD. We have also confirmed that comprehensive 
echocardiographic screening identifies up to 14 times as many children with RHD as were 
identified by the traditional strategy of clinical cardiac auscultation.  
The presented results reinforce the opinion that screening of asymptomatic school-age children is 
a useful strategy to identify new cases of RHD and subclinical rheumatic valvular affection in 
whom secondary prevention with penicillin prophylaxis may be effective in preventing 
development and worsening of RHD and might encourage a strategy of echocardiography-based 
screening programs. This study has contributed in the insights of the prevalence and 
characteristics of RHD in Aswan, Egypt and confirmed the importance of a combined criteria 
based on structural and functional valvular features. The screening protocol designed in this 
study can easily be used in other regions with high RHD prevalence, improving case finding, 
delivery of effective primary and secondary prevention, and adequate planning of health services 
as RHD remains a major cause of morbidity and mortality in different areas.  
  
 
 
 
 
 
CHAPTER 5 
 
 
CHARACTERIZATION OF RHEUMATIC FEVER 
IN A HOSPITAL BASED STUDY IN EGYPT 
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5.1 Background 
The high worldwide incidence of RF with geographical variety in the epidemiology (Bisno 1997, 
Dinkla 2003) raises great concern as the disease remains endemic in different areas leading to 
considerable morbidity and mortality through RHD (Olivier, 2000). RF presents with a variety of 
symptoms outlined in the Jones Criteria (Stollerman 2001, Guilherme 2009
1
), which has shown 
decreased diagnostic sensitivity mainly due to the considerable variations in the prevalence of 
the symptoms and clinical manifestation of RF in different areas.  
The aim of this study was to determine the epidemiological and clinical characteristics of RF in 
an area where data on regard the disease is completely lacking. The elucidation of determinants 
influencing the development of RF and RHD is of importance for early recognition of 
individuals at risk of developing RF and subsequently RHD and for the future development of 
preventive methods. Furthermore, we believe that the clinical presentation of RF is different in 
Egypt, with a different pattern of prevalence and incidence of the variety of symptoms. 
Therefore, it is of importance to evaluate and validate the Jones Criteria for a new classification 
of the diagnostic criteria RF for early recognition, diagnosis, follow-up and clinical management 
of RF. 
 
5.2 Patients and methods 
Individuals visiting the outpatient clinic or admitted at the Cardio-thoracic department of the 
NHI, in Imbaba, Cairo were assessed for the investigation of the epidemiological and clinical 
characteristics of RF as described in chapter 3, pg. 75. 
 
The study population consisted of: 
 Group I: -Individuals with a positive history of RF visiting the centre for penicillin  
                prophylaxis with or without cardiac involvement 
-Individuals visiting the NHI outpatient clinic for suspicion of RF or RHD  
 Group II: Patients admitted for RHD and scheduled for valve replacement.  
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5.2.1 Data collection 
Demographic data from every subject selected were collected in the form of a standardized 
questionnaire (Appendix V). The questionnaire contains questions regarding the patient‘s 
demographics, family environment, risk factors, history of RF, its severity, treatment and 
prophylaxis.  
Issues regarding the onset age of RF, symptoms, severity, presence of recurrences of RF, 
medication and penicillin prophylaxis were questioned on the history of RF and the presence of 
symptoms to confirm the presence of RF and clinical presentation. Penicillin prophylaxis 
schedule was divided into 3 categories, following the most used and prescribed schedules for 
penicillin prophylaxis, every 15 days, 3 weeks or monthly. Compliance rate for the penicillin 
prophylaxis was evaluated by asking the patient about the schedule, how often he ignored or 
postponed the injection date and if he was strict to the schedule. Compliance was then also be 
evaluated in relation to the schedule. A schedule of less than 9 injections a year was considered 
poor. A schedule of 9 to 12 injections a year was considered fair, while an excellent compliance 
rate was more than 12 injections a year. Many individuals were receiving prophylaxis for the 
first time therefore questions on schedule and compliance was not applicable. 
The disease awareness as classified in 3 categories evaluated on the patients‘ knowledge of the 
RF history, symptoms and penicillin prophylaxis. The disease awareness was also be evaluated 
by the amount and type of questions answered on the knowledge of RF and RF history. The 
disease awareness was evaluated as poor when the patient had no knowledge of the reason for 
penicillin prophylaxis. When the patient was aware of RF or the valvular damage, and knew that 
penicillin is a way of prophylactic prevention but did not know the link between RF and the 
valvular damage the awareness was evaluated as fair. The patient‘s awareness was evaluated as 
good when he was also aware of the correlation between RF and cardiac disease (RHD). The 
same scale was used for the parents‘ awareness. Dental care was evaluated during collection of 
throat swabs by the general condition of the mouth and teeth.  
 
5.2.2 Statistical analysis 
The statistical analysis was performed as described in chapter 3, pg 100.   
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5.3 Results 
5.3.1 Epidemiological profile in RF 
A total of 639 individuals were recruited at the NHI of which 498 seen at the penicillin clinic and 
141 seen at the cardiothoracic surgery department. The patient demographics is shown in Table 
5.1. 
 
Age: The mean age was 23.78 years and the median was 21 years (Figure 5.1). One third (36%, 
n=230) was in the age group 3 to 17 years. Another third (37.40%, n= 239) were young adults 
between 20 and 35 years of age (Figure 5.1). One child (0.2%) was 3 years old and another child 
(0.2%) was 4 years old at the time of presentation at the penicillin clinic. A small number (1.1%, 
n=7) of the individuals screened were 5 years old. 
 
Figure 5.1 Age at the time of screening 
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Figure 5.2 Distribution of age groups 
 
Gender: There was a slight female predominance (52.6%, n=336) with a male to female ratio of 
1:1,1.  
 
Social factors: The number of siblings ranged up to 14, but most individuals came from families 
with a mean of 4 siblings and had good dental care.  
 
Medical history: The majority had no cardiac risk factors and only a small fraction (2.5%, n=16) 
reported other risk factors like diabetes, atrial fibrillation or hypertension.  
 
Family history: The majority of the individuals had a negative family history for cardiac diseases 
and RF. A small fraction of patients (5.4%, n=59) did not know if there was RF in the family.   
 
Disease awareness: Most individuals (43.4%, n=265) had poor disease awareness. A small 
fraction of the individuals (5.28%, n=34) were too young to answer the questions on the disease 
awareness. A total of 182 parents were questioned about their child‘s health condition and the 
majority had a fair awareness of the disease.  
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Table 5.1 Patient demographics 
                   % (nr) Mean ± SD range 
Age   23.78 ± 12.50 3-63 
Sex     
    Male  47.4% (n=303)   
    Female 52.6% (n=336)   
Nr of siblings  4.0 ± 2.21 0-14 
Dental care    
   Poor 4.3% (n=27)   
   Fair 47.8% (n=300)   
   Good  47.8% (n=300)   
Family history for cardiac 
diseases 
   
   Positive 7.2% (n=42)   
   Negative 92.8% (n=543)   
Family history for RF    
   Positive 19.8% (n=116)   
   Negative 80.2% (n=469)   
Other risk factors    
   Yes 2.5% (n=16)   
   No  97.5% (n=620)   
Disease awareness    
   Poor 43.4% (n=265)   
   Fair 33.8% (n=206)   
  Excellent 22.8% (n=139)   
Parents disease awareness    
   Poor 26.8% (n=49)   
   Fair 41.5% (n=76)   
  Excellent 31.7% (n=58)   
        
Previous interventions: A small amount of the individuals had a history of previous interventions 
(5.9%, n=38), including balloon valvuloplasty, mitral valve repair and valve replacement (Table 
5.2). The intervention date from 3 months to 20 year (6.38 ± 5.43). 
 
Table 5.2 Previous interventions  
 Nr (%) 
Type of intervention  
   Balloon  38.2% (n=13) 
   Valve repair 29.4% (n=10) 
   Valve replacement 32.4% (n=11) 
           Mv 54.54% (n=6) 
           Av 27.27% (n=3) 
          Double 18.9% (n=2) 
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 5.3.2 Clinical manifestation of RF in Egypt 
History of RF: The majority of the individuals had a positive history of RF. A fraction of the 
individuals (5.7%, n=37) did not recall the clinical manifestations (Table 5.3).  
 
Age of RF: The age of onset of RF ranged from 2 months to 44 years (10.69 ± 6.24). A 
noticeable amount of patients (17.92%, n=95) was 5 years or younger at the time of the first RF 
attack, with 5.85% (n=31) patients being 3 years or younger at the time of the attack. The 
majority (73.96%, n=392) of individuals was between the 5 and 15 years of age with a peak at 
the age of 10 (14.9%, n=79). A fraction of the patients (7.92%, n=42) were between 20 and 35 
years of age and 0.38% (n=2) were 38 and 44 years old. The median age at the time of the first 
RF attack was 10 years (Figure 5.3). 
 
Figure 5.3 Age at the time of the first RF attack 
 
Sixty individuals (11.3%) reported the attacks being in the last 2 months. However, most of the 
attacks were in the last 12 months (48.6%, n=257) and 24 months (68.5%, n=363), respectively. 
A fraction of the patients reported the RF attacks 5 (14.2%, n=75), 10 (6.22%, n=33) and over 20 
years (2.45%, n=13) ago (Figure 5.4). 
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Figure 5.4 Date of first RF attack 
  
Clinical manifestation: Arthritis was the most prominent symptom reported followed by a 
history of fever and pharyngitis and only a small fraction reported carditis and chorea. None of 
the individuals reported nodules.  
 
Table 5.3 RF history 
 Nr (%) 
History of RF  
   Yes 87.8% (n=560) 
   No 12.2% (n=78) 
Symptoms  
Major manifestations  
   Polyarthritis  87.9% (n=495) 
   Carditis 3.7% (n=21) 
   Chorea 0.4% (n=2) 
   Nodules  0% (n=0) 
Erythema marginatum 0% (n=0) 
Minor manifestations  
   Fever and pharyngitis 65.5% (n=369) 
Tonsillectomy  
   Yes 21.0% (n=122) 
Diagnosis  
   RF symptoms 72.6% (n=464) 
   Cardiac symptoms/ affection 27.4% (n=175) 
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Recurrences: Most individuals reported recurrences of the RF attacks with the majority of the 
attacks reported in the last 3 to 4 weeks (98.2%, n=321), while 25.7% (n=84) reported recurrence 
in the last week (Table 5.4).  Five (23.8%) of the individuals that reported carditis also reported 
recurrences of the carditis attacks.  
        
Table 5.4 Recurrences 
 Nr (%) Mean +/- SD range 
RF recurrences     
   Yes 59.6% (n=333)   
   No 40.4% (n=226)   
Date recurrences  8.49 ± 0.76 1 week-6 months 
Carditis recurrences    
   Yes 0.9 % (n=5)   
   No 99.1% (n=16)   
Date of recurrences   11.0 ± 9.59 2- 24 months 
       
 
5.3.3 Diagnostic criteria 
The difference in incidence between our series and the expected prevalence of the various 
manifestations of RF is shown in Figure 5.5 (CAVE: in the figure the minimum expected 
prevalence is shown). 
 
Figure 5.5 Distribution of symptoms 
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When using the Jones Criteria purely on the presence of two major, or one major and two minor 
manifestations, 51.64% (n=330) of the individuals screened would be diagnosed with RF. The 
prevalence of the combinations of symptoms leading to the diagnosis of RF is shown in Figure 
5.6. 
 
Figure 5.6 Diagnosis of RF based on the Jones Criteria 
 
5.3.4 Secondary prevention 
Penicillin prophylaxis: The majority of individuals were on penicillin prophylaxis, and only a 
small number of individuals had ceased the prophylaxis. The most common prophylaxis 
schedule was reported to be every 15-day, followed by the monthly prophylaxis routine (Table 
5.5). 
The start date of the prophylaxis ranged up to 432 months (36 years), with a mean of 21.82 
months and standard deviation of 48.36 months (Figure 4.6). The period since prophylaxis 
cessation ranged from 1 month up to 84 months (7 years), with a mean of 1.21 months and a 
standard deviation of 6.10 months. Most individuals reported a fair or excellent compliance to 
the penicillin prophylaxis while a fraction of the individuals (9.78%, n=63) were receiving the 
penicillin prophylaxis for the first time.  
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Table 5.5 Penicillin prophylaxis 
 Nr (%) Mean +/- SD range 
Penicillin prophylaxis    
   Yes 84.5% (n=522)   
   No  15.5% (n=96)   
   Stopped 3.3% (n=21)   
Prophylaxis schedule    
   15-day 64.6% (n=318)   
   21-day/ 3 weeks 12.6% (n=62)   
   1-month 22.8% (n=112)   
Start date prophylaxis  21.82 ± 48.36 0 – 432 months 
Period of cessation  1.21 ± 6.10 1 – 84 months 
Compliance     
   Poor 16.0% (n=78)   
   Fair  33.4% (n=163)   
   Excellent 50.6% (n=247)   
 
 
Figure 5.7 Date of start of penicillin prophylaxis 
 
5.3.5 Determinants of RF 
Age: The older patients at the time of the screening tended to have a negative history of RF 
(p=0.00) and more often a cardiac diagnosis instead of a RF symptom based diagnosis (p=0.00).  
Recurrences seemed to be less common among the older patients as the younger the patients the 
more recurrences reported (p=0.001). 
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The older individuals failed more often to be on prophylaxis (p=0.00) and had a higher tendency 
for the 21-day and monthly penicillin schedule (p=0.001). Furthermore, older individuals showed 
a lower compliance to the prophylaxis regimen (p=0.002) and had more often a history of 
previous interventions (p=0.00). 
 
Gender: Of the individuals with a positive history of RF 45.7% (n=256) were male and 54.3% 
(n=304) were female (p=0.016) showing that females had more often a positive history of RF 
(90.7%, n=304) than males (84.5%, n=256) (Figure 5.8). Females tended to be older at the time 
of the first RF attack (p=0.011) but there was no gender difference in how long ago the first RF 
attack had been. Most individuals (56%, n=277) that reported arthritis were female, while 44.0% 
(n=218) were male (p=0.051). 
 
Figure 5. 8 RF history among males and females 
 
Figure 5.9 Distribution of symptoms by gender 
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Females reported more recurrences (66.3%) than males (53.4%) and 58.9% of the recurrences 
were found in females (p=0.002). There was a positive correlation between the gender and the 
type of diagnosis (p=0.019) with females being more often diagnosed trough the RF 
characteristics than males (76.5%, n=257 and 68.3%, n=207, respectively) and males being more 
often diagnosed by cardiac affection (31.7%, n=96) than females (23.5%, n=79) (Table 5.9). 
Females tended to have started later with the penicillin prophylaxis (p= 0.002) but seemed to 
have stopped the prophylaxis use later than males (p=0.027). However, no correlation was found 
between a positive history for previous interventions and the patients gender (p=0.614). 
 
Figure 5.10 Type of diagnosis by gender 
 
Familial predisposition: No correlation was found between a positive family history and history 
and the age during the first RF attack. However, positive family histories for RF lead to more 
diagnosis made by RF symptoms than by cardiac affection (81.9% and 18.1% respectively).  
 
Tonsillectomy: The majority (95.1%, n=116) of the individuals who underwent tonsillectomy 
had a positive history of RF, while 4.9% (n=6) did not (p=0.03). The older the patient during the 
first RF attack the less often he underwent tonsillectomy (p=0.00). 
 
RF history: Of the individuals with a negative history of RF the majority was diagnosed trough 
cardiac symptoms (82.1%, n=64) while only 17.9% (n=14) were diagnosed by the RF symptoms 
(p=0.00) (Figure 5.11). 
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Figure 5.11 Type of diagnosis by history 
 
The majority of the individuals on penicillin (91.0%, n=474) had history of RF while 87.4% 
(n=474) of the individuals with history of RF were on penicillin and 12.6% (n=68) were not 
(p=0.000). However, 9.0% (n=47) of the individuals on penicillin prophylaxis did not recall a 
history of RF (Table 5.12). 
 
Figure 5.12 The use of penicillin prophylaxis and history of RF 
 
Age of RF: The older the patient during the first RF attack, the less often fever and pharyngitis 
was reported as one of the initial symptoms (p=0.00). No correlation was found between the age 
during the first RF attack and the presence of arthritis symptoms. However, the older the patient 
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during the first RF attack the more often carditis was found (p=0.00). Furthermore, the longer 
ago the first RF attack had been, the less recurrences were reported (p=0.001).  
No correlation was found between the age of the first RF attack and the presence of a history of 
RF, age of the first RF attack, type of diagnosis and the use of penicillin prophylaxis. However, 
the longer ago the first RF attack had been, the lower the reported compliance to the penicillin 
prophylaxis (p=0.002 respectively). The start date of the penicillin prophylaxis correlated to the 
date of the first RF attack (p=0.00) meaning that most of the patients started the penicillin 
prophylaxis shortly after the first RF attack. No correlation was found between the age of the 
first RF attack and the presence of a history of previous interventions (p=0.447). However, the 
longer the interval since the first RF attack the more often a history of previous interventions was 
found (p=0.00).  
 
Diagnosis: The majority (77.4%, n=404) of the individuals on penicillin were diagnosed by RF 
symptoms while 22.6% (n=118) were diagnosed by valvular affection (p=0.000). Importantly, 
patients who were firstly diagnosed by the cardiac affection and symptoms had more often a 
history of previous interventions (p=0.003). 
 
Figure 5.13 Type of diagnosis and the use of prophylaxis 
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Recurrences: Diagnosis on basis of valvular affection was more often made in patients who did 
not report recurrences of RF (59.8%, n=67) than in those who had RF recurrences (40.2%, 
n=45), showing that the amount of individuals first diagnosed with RF trough cardiac findings is 
higher in the population that does not have recurrences of the attack (p=0.00). Therefore, 
diagnosis through RF symptoms were more common in individuals with RF recurrences (64.4%, 
n=288) than in patients without recurrences (35.6%, n=159) (Figure 5.14). Most of the 
individuals (62.1%, n=293) of the individuals on penicillin prophylaxis reported recurrences of 
RF while 37.9% (n=179) of the individuals on prophylaxis did not report recurrences.  
 
Figure 5.14 Type of diagnosis depending on recurrences 
 
Disease awareness: The higher the disease awareness the more often history of RF was reported 
(p=0.00). Furthermore, symptoms of fever and pharyngitis seemed to raise the patient disease 
awareness (p=0.018) and patients with a positive family history for RF had a higher disease 
awareness than patients who did not (p=0.007). There was also a significant correlation between 
the patients dental care and the disease awareness (p=0.00) as the better the dental care, the 
higher the awareness.  
No correlation was found between the patient‘s age and the disease awareness and the age during 
the first RF attack did not influence the disease awareness. However, the longer ago the RF 
attack had been, the higher the disease awareness (p=0.001). Importantly, a correlation was 
found between the disease awareness and the type of diagnosis (p=0.000) as a lower disease 
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awareness resulted in a higher number of individuals diagnosed by cardiac symptoms (41.7%, 
23.3% and 12.2% respectively) while higher disease awareness resulted in a higher amount of 
diagnoses made trough the RF symptoms (58.3%, 76.7% and 87.8% respectively). However, no 
correlation was found between the disease awareness and history for previous interventions 
(p=0.606).  
A correlation was also found between the disease awareness and the pattern of secondary 
prevention (p=0.000) as the higher the disease awareness, the higher the adherence to the 
prophylaxis (76.3%, 91.0% and 93.1% respectively) and the better the compliance to the 
prophylaxis (36.1%, 49.4% and 60.5% respectively). 
 
Penicillin prophylaxis: Patients that had recently stopped the penicillin prophylaxis had less 
recurrences than those that had ceased the prophylaxis longer ago (p=0.031). No correlation was 
found between the schedule of the penicillin prophylaxis and the presence of recurrences.  
 
5.4 Discussion 
The age of the population screened in our series ranged from 3 to 63 years, with a median of 21 
years, including therefore the three major age groups of children, adolescents and adults. 
Although no gender predilection is believed to exist and both sexes are believed to be equally 
predisposed to developing RF (Stollerman 1975), female as well as male predominance has been 
reported in the incidence of RF showing male/female ratios of 1:1.3 (Woo 1983) and 2.1:1 
(Vinker 2010, Miyake 2007, Dajani 1993, Mahmudi 2006). Nevertheless, the found female 
predominance in our series is slightly lower than the male to female ratio reported earlier 
(1:1.25) (Bharani 2010). 
The female predominance could have been explained by the treatment seeking profile or attitude 
but most females also tended to have more often a positive history for RF and arthritis symptoms 
than males. Therefore, females tended to be diagnosed trough the RF symptoms while males 
were more often diagnosed later by cardiac affection. Interestingly, females tended to be older at 
the time of the first RF attack. 
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The majority of the individuals was in good general health and did not have any other cardiac 
risk factors. The dental hygiene was evaluated to analyze the general hygiene and physical 
condition as the dental care and oral hygiene is believed to be a general indicator of personal 
hygiene and health care practices, including access to and use of health care services (DeStefano 
1993). In concordance, our series shows that the better the dental care, the higher the disease 
awareness and vice versa. 
Most individuals were from average sized families, with a mean of 4 siblings and from an 
equivalent social and financial status. Heritability for RF among Egyptians has been reported 
trough a positive family history in around one-third of the cases, suggesting a possible genetic 
contribution (Settin 2006). However, other reports show a positive family history ranging up to 
14% (Mahmudi 2006, Dajani 1992), which is more in concordance with our own results.    
 
Our data confirms that the burden imposed by RF is present throughout the life course, with a 
peak in the age group 5 to 15 with a median of 10 years and cases presenting up to the age of 44. 
Although all age groups may be affected, an elevated number of cases is known to occur among 
school-age children between the ages of 5 and 15 (Smith 1989, Falck 1992, Steer 2009, Thakur 
1996) with a median age of 10 years and only 20% of the cases occuring in adults. Surprisingly, 
RF was also reported under the age of 3, and 18% of our patients were younger than 5 years at 
the time of the first RF attack (Chin 2010).  
The majority of the RF attacks were reported in the last 12 and 24 months, showing that the 
population on prophylaxis had a recent diagnosis of RF and were shortly on penicillin 
prophylaxis, with a mean of 21 months. Only a small fraction of the individuals reported RF a 
longer time ago, suggesting therefore that the longer ago RF was diagnosed the more probable it 
was that patients had withdrawn from the prophylaxis.  
 
The most prominent symptom of RF found in our series was arthritis which is not surprising as it 
is believed that up to 88% of the affected children display this symptom (Khriesat 2003), which 
tends to occur early in the disease course and is frequently the presenting complaint (Feinstein 
1962). Importantly, in adolescents and adults, arthritis is often the sole major manifestation on 
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which the diagnosis is based since carditis and chorea are less common in first attacks occurring 
in these age groups. In our study population only 3.7% of the individuals reported episodes of 
carditis while 30 to 80% of the individuals affected are believed to develop carditis which causes 
heart damage with pericardial, myocardial and endocardial  involvement followed by progressive 
and permanent valvular lesions leading to RHD (Mahmudi 2006, Dajani 1992, Carapetis 2007). 
Sydenham chorea and erythema marginatum (Vijayalakshmi 2005) were scarcely represented 
and subcutaneous nodules which are currently an infrequent manifestation of RF were totally 
absent in our series (Massell 1958, Khriesat 2003, Rosenthal 1968, Tani 2003, Chockalingam 
2004, Canter 2004). Erythema marginatum is believed to have become irrelevant as a major 
criterion as it has shown a very low incidence in different studies and has therefore, been 
suggested to be replaced by abnormal echocardiographic findings in the Jones Criteria. This 
sounds encouraging as we believe that early and precise diagnosis of carditis in acute rheumatic 
fever, though difficult, is very important in preventing the development of RHD and the 
following morbidity and mortality.  
 
Importantly, the age at the time of the first RF attack seems to influence the clinical presentation, 
as older patients reported less fever and pharyingitis as the initial symptoms. Nevertheless, 
studies from other endemic areas show a different distribution of the RF symptoms, with carditis 
being the most common clinical manifestation seen in up to 81% of the cases (Khriesat 2003, 
Mahmudi 2006), followed by arthritis (69%) (Mahmudi 2006) and a more abundant incidence of 
chorea, seen in up to 42% and nodules in 15% of the individuals (Commerford 2006). 
In our series only 51.64% of the individuals screened would have been diagnosed with RF 
following the current Jones Criteria while 87.8% had a positive history of RF. Most of them 
would be diagnosed by the presence of polyarthritis, fever and history of pharyngitis while the 
majority of the individuals were diagnosed by the presence of fever in combination with one 
major criterion. Therefore, it seems that in Egypt, the most sensitive criteria is the presence of 
polyarthritis in combination with history of fever and pharyngitis and that strict adherence to the 
Jones criteria may result in underdiagnosis and lack of treatment of patients with RF and at risk 
of developing RHD.  
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We have used pharyngitis rather than arthralgia as a diagnostic criterion as we were assessing the 
history of RF retrospectively and symptoms of arthralgia would have been missed as they are 
easier to forget than the pharyngitis. Furthermore, history of an antecedent sore throat 1-5 weeks 
prior to onset of RF is present in up to 78% of older children and young adults (Mahmudi 2006, 
Guilherme 2009
1
). 
 
Our series shows a history of an antecedent sore throat in 65.5% and polyarthritis in 87.9% of the 
individuals screened suggesting a high incidence of individuals that do not recall the initial 
pharyngitis. The morbidity caused by polyarthritis seems to draw attention and allows detection 
of most of the initial episodes of RF as well as recurrences in the community setting. It is also 
believed that when carditis is the only clinical manifestation, patients typically seek health care 
much later in the course of the disease (Narula 1999). It has also been noted that patients with 
severe arthritis or carditis are the ones who most often seek medical attention (Loeffler 1995) 
and that patients with mild rheumatic carditis alone are less likely to be symptomatic or to seek 
medical attention.   
 
We also ignored the requirement of evidence of previous streptococcal infection as this was a 
retrospective study and most of the individuals screened did not have a medical record or reports 
on the medical history or laboratory findings. 
Females and younger patients reported more often recurrences, while patients that reported a 
longer interval since the first RF attack tended to have less recurrence. Importantly, diagnosis on 
basis of valvular affection was more often made in patients who did not report recurrences of RF 
than in those who had RF recurrences. Therefore, recurrences seem to lead to awareness and 
recognition of the disease before affection of the heart. Nevertheless, a positive family history of 
RF seems to raise awareness as it leads to more diagnosis made based on the RF symptoms. 
Importantly, one quarter of the population screened had been diagnosed with RF trough cardiac 
symptoms and affection of the heart which seemed to lead to an increased presence of history of 
previous interventions. One prominent risk factor therefore was a low disease awareness, which 
resulted in more diagnosis based on cardiac symptoms rather than RF symptoms. Furthermore, 
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individuals that reported the first RF attack a longer time ago had more often a history of 
previous cardiac interventions, showing progression of the disease.  
 
Although the compliance to the penicillin prophylaxis is known to be insufficient varying from 
40 to 86% in previous reports (Kumar 1997, Saran 1985, Ravisha 2003) our study population 
reported regular penicillin prophylaxis regimens and a good compliance. However, we lack the 
methods of monitoring the penicillin prophylaxis regimen used and the compliance as there are 
no registries or data on the patients on prophylaxis or follow-up. Adherence to penicillin 
prophylaxis was found to be dependent on the history of RF and the disease awareness, as 
individuals with history of RF and better disease awareness are more often on regular regimens. 
The results presented on a compliance rate to the prophylactic regimen in two-thirds of the 
patients (Bassili 2000) is comparable to earlier studies in Alexandria, Egypt, bearing in mind that 
we assessed a population visiting the hospital for their prophylaxis and we lack data on the total 
of patients frequenting the clinic and the amount of patients that withdraws from or neglects their 
prophylactic regimen. Nevertheless, it is estimated that more than seven-tenths of patients with 
established RHD do not receive secondary prophylaxis (Strasser 1981). However, older age at 
the time of screening, lower disease awareness and a longer time since the RF attack were found 
to be risk factors for a lower compliance to the prophylaxis. Furthermore, older patients also 
tended to be more often on 21-day penicillin regimen than younger individuals. 
Regular prophylaxis with 3 or 4 weekly benzathine penicillin injections is perhaps more realistic 
but for high-prevalence regions 3- or even 2-weekly penicillin is recommended (WHO 2004, 
Kassem 1992, Kassem 1996). It has been stated that penicillin has clearly failed to eradicate this 
disease process (Kaplan 2005) but in fact, this may be caused by the lack of precise diagnosis 
and use and adherence to penicillin prophylaxis, rather than the failure of penicillin 
(Vijayalakshmi 2005). 
We found that more than half of the individuals reported recent recurrences of the RF attack, 
while on penicillin prophylaxis with the advised schedule of injections every 15-days (Kassem 
1992, Kassem 1996). In Alexandria recurrences were seen in one-third of the patients with non-
compliance to the prophylaxis being the significant risk factor. However, in our series, 
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compliance did not seem to affect the presence of recurrences, although cessation of the 
penicillin prophylaxis was found to be a risk factor for recurrences (Kassem 1992). Treatment of 
streptococcal pharyngitis with penicillin has been shown to markedly reduce the incidence of 
initial attacks of RF and to dramatically reduce recurrences of RF (Stollerman 1955, 
Wannamaker 1951), however, the main questions regarding secondary prevention remain on 
which regimen to use, how long to give it, and whether all patients required the same vigor and 
duration of prophylaxis (Narula 1999). 
 
We have succeeded in building a registry of the patients visiting the NHI penicillin clinic for 
regular follow-up and monitoring of the compliance to the penicillin prophylaxis. We hope 
hereby to enhance the disease awareness and increase the compliance to the penicillin regimen. 
This will also allow us to monitor the development or progression of the valvular affection and 
lesions for early recognition and treatment of RHD. However, one of the study limitations is the 
fact that this study cohort only reflects those who seek secondary prophylaxis at the NHI, which 
undoubtedly under-represent the number of individuals affected, receiving prophylaxis elsewhere 
and specially those neglecting prophylaxis.  
 
5.5 Conclusions 
This series confirms that there are considerable variations in the prevalence of the symptoms and 
clinical manifestation of RF in different areas and age groups which shows the need for a 
validation of the criteria in different regions where the disease is common and still endemic. The 
diagnosis of RF based on symptomatology remains difficult as there is no gold standard 
diagnostic feature and the clinical manifestations tend to vary. This shows the need for revision 
of the Jones Criteria, which might be misdiagnosing disease in many countries, and better 
diagnostic methods, based on more specific laboratory tests and objective findings. 
Nevertheless, in Egypt the initial episode of RF is often unnoticed in a substantial proportion of 
children, and arthritis tends to be reported less often than expected. Consequently, secondary 
prophylaxis is often not initiated. Furthermore, there is only limited enforcement of secondary 
prophylaxis and the penicillin injections are frequently missed. Therefore, recurrences are very 
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common, and may contribute to the rapid progression to advanced valvular RHD. The majority 
of the individuals screened had a poor awareness of the disease and although most of them had a 
positive history of RF they did not know the risks, complications, possibility of sequelae and 
treatment and prophylaxis requirement and need. It is believed that the disease awareness affects 
the treatment seeking profile and attitude and the use and compliance to the penicillin 
prophylaxis and that the success of secondary prophylaxis is critically dependent on patient 
education. In our series, adherence to penicillin prophylaxis was found to be dependent on the 
history of RF and the disease awareness, as individuals with history of RF and better disease 
awareness are more often on regular regimens, showing that lower disease awareness is a risk 
factor for non-compliance to the penicillin prophylaxis. 
Overall, the volume and pattern of cases challenge the common assumption that RF presents 
predominantly in children, however our study shows onset of RF in young adults and adults in 
Egypt RF, being also characterized by considerable variations in the prevalence of the symptoms 
and a high tendency to recur even in patients following regular prophylactic programs.  
In conclusion, our study confirms that RF is a notifiable condition, and highlights the persistent 
burden of newly diagnosed cases within the Egyptian population showing that RF remains one of 
the major public health problems in Egypt. However, no measure has been taken till date to 
ensure that cases are enrolled in registers and are offered secondary prophylaxis with regular 
penicillin injections. It remains to the patient and patient‘s responsibles to comply to the 
penicillin regimen while secondary prophylaxis is a cost-effective and proven intervention for 
the prevention of progression of RHD. This is worrying as the majority of individuals has a poor 
awareness and knowledge of the disease and are not aware of the importance and need for 
secondary prophylaxis, leading therefore to insufficient compliance to the penicillin regimen. 
The presented results show the urgent need for the registration of RF and RHD cases in high 
burden countries, as a measure to ensure control of the disease through the implementation of 
registry based secondary prophylaxis programs to improve the compliance to the penicillin 
prophylaxis. 
This data has important clinical and public health implications for Sub-Saharan Africa, the wider 
African continent, and other parts of the world where RF and RHD are endemic. In conclusion, 
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this study provides important insights into the still large and complex burden of RF within the 
Egyptian community, supporting the statements that RF and RHD are of sufficient importance to 
warrant urgent attention of the national and international public health and research community. 
Nevertheless, the found results are irrefutable proof of the need for more laboratory, 
epidemiological, and clinical research.  
  
 
 
 
 
 
CHAPTER 6 
 
 
CLINICAL CHARACTERISTICS AND 
DETERMINANTS OF RHD IN HOSPITAL 
BASED STUDY IN EGYPT 
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6.1 Background 
The prevalence and distribution of the different manifestations of RHD show geographical 
variation with some affections being more reported in some areas. In Egypt, a high percentage of 
schoolchildren have clinical evidence of cardiac valvular damage due to RHD, nevertheless, the 
prevalence of subclinical RHD in a population with history of RF is still unknown. Since there is 
a high incidence of RF and RHD in the Egyptian population, there is likely a high prevalence of 
subclinical and undiagnosed RHD with a different pattern of manifestation including higher 
prevalence of mitral stenosis, which might be a sign of a fast progression from mitral 
regurgitation to stenosis showing a severe course of the disease. A high rate of progression of 
subclinical valvular lesions has been shown in different series (Meira 2005) while also 
reversibility of the valvular lesions has been reported in patients who adhere to antibiotic 
prophylaxis (Chin 2010, Marijon 2007). However, the determining and influencing factors as 
well as the long-term outcome of subclinical RHD are still unknown.  
The aim of this study was to analyze the manifestation and pattern of RHD in a population with 
history of RF in an area where data on regard RF and RHD is completely lacking and determine 
the early echocardiographic signs and features of subclinical valvular damage. This will lead to 
the development of a screening protocol and comprehensive criteria for the detection of 
subclinical RHD and early management of patients at risk of developing permanent, progressive 
and chronic valvular lesions. We also aimed to evaluate the progress and reversibility of 
subclinical valvular lesions in a population with history of RF to determine the long-term 
outcome of RHD as well as the determinant factors in Egypt.  
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6.2 Diagnosis of RHD 
6.2.1 Introduction 
Cardiac involvement in RF and RHD is often established by finding of a new murmur of mitral 
or aortic insufficiency. Nevertheless, doppler echocardiography improves the detection of 
carditis without overt evidence of valvular or other cardiac involvement (Marijon 2007, 
Carapetis 2008), detecting clinically silent RHD 10 times more than clinical examination.  
Echocardiography is therefore the golden standard tool for diagnosing and characterizing valve 
lesions and detection of rheumatic carditis and subclinical RHD (Veasy 1993, Veasy 1994, 
Wilson 1995). However, there are no universally agreed criteria for the echocardiographic 
diagnosis of RHD and definition of cardiac involvement based on functional characteristics may 
depend on the gain settings on the ultrasound equipment, therefore, we hypothesized that the use 
of Doppler criteria for
 
abnormalities associated with structural valve changes
 
will improve the 
specific diagnosis of RHD (Marijon 2007) and is better suited for screening for subclinical RHD.  
This study aims to analyze the characteristics and pattern of rheumatic cardiac affection and 
features in a population with history of RF. We hypothesized that echocardiographic diagnosis of 
subclinical RHD is superior and more specific than clinical diagnosis and detection of a murmur. 
We therefore aimed to evaluate the diagnostic rate, sensitivity and specificity of both methods 
for early diagnosis of subclinical RHD to be used for screening purposes for the diagnosis and 
better management of individuals with subclinical valvular damage which might progress to 
permanent and chronic valvular lesions (RHD). 
The different diagnostic criteria in use were compared and analyzed with the aim to evaluate and 
validate the development of useful and comprehensive echocardiographic criteria for the early 
detection of subclinical RHD and purpose a new classification of characteristics of valvular 
affection and lesions in RHD that could be used in screening purposes as well as clinical 
diagnosis and management of patients.  
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6.2.2 Participants and methods 
The study population consisted of individuals visiting the outpatient clinic or admitted at the 
Cardio-thoracic department of the NHI, Imbaba, Cairo as described in chapter 3, pg 75: 
 
 Group I: -Individuals with a positive history of RF visiting the centre for penicillin  
                prophylaxis with or without cardiac involvement 
-Individuals visiting the NHI outpatient clinic for suspicion of RF or RHD  
 Group II: Patients admitted for RHD and scheduled for valve replacement.  
 
Examination protocol 
The screened individuals underwent a standardized examination protocol consisting of detailed 
medical history recorded by the investigator, physical examination including general analysis of 
the patients‘ health, recognition of Jones criteria and careful cardiac auscultation with the patient 
in the supine and left lateral decubitus positions.  
Disease manifestations and auscultatory findings were evaluated according to internationally 
approved criteria, including the published data from World Health Organization (WHO 1988, 
Figueroa 1992). Detailed transthoracic echocardiography was performed with the use of a hand-
carried, battery operated echocardiographic system (Vivid i, General Electric) with M-mode, 
two-dimensional, and Doppler (pulsed, continuous, and color) imaging. The following were 
obtained: apical two-, four-, and five-chamber views, parasternal long-axis and short-axis views 
at the level of the papillary muscles and the aortic valve and subcostal views. 
Particular attention was paid to valve morphology on cross-sectional, two dimensional imaging 
and the degree and extent of mitral and aortic regurgitation, assessed by color flow Doppler 
imaging. The apical imaging included anterior angulation to evaluate the left ventricular outflow 
tract and the aortic valve. Transvalvular flow was assessed by measuring the peak velocity with 
continuous wave Doppler imaging. Hard copies with detailed location and type of lesions 
(Appendix V, page 3) and electronic records of relevant data were kept for offline re-evaluation.  
The echocardiographic study was performed by the candidate and two blinded experienced 
cardiologists reviewed the records. The diagnosis of RHD was accepted when there was 
agreement of at least two cardiologists, including the researcher.  
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Echocardiographic criteria 
Only left-sided valves were evaluated for features of RHD as affection of the right sided valves 
is fairly common and not related to the condition (Lembo 1988, Kostucki 1986, Lembo 1988, 
Yoshida 1988). RHD was diagnosed by the different echocardiographic diagnostic criteria as 
following:  
 
Criteria 1 (WHO 2004): (1) a regurgitant jet >1 cm in length, (3) seen in at least 2 planes, (3) a 
mosaic color jet with a peak velocity >2.5 m/s, (4) persisting throughout systole or diastole  
 
Criteria 2 (Carapetis 2008): (1) valvular regurgitation (meeting all four criteria defined by the 
WHO) with evidence of structural changes to valve appearance: (a) valvular thickening (b) 
elbow deformity of the anterior mitral valve leaflet (2) any degree of pathological aortic 
regurgitation (3) mitral stenosis (flow acceleration and a mean pressure gradient > 4 mmHg) (4) 
aortic stenoses (flow acceleration with peak velocity > 2 m/s)  
 
Criteria 3 (Marijon 2007): any degree of valvular regurgitation seen in at least 2 planes 
accompanied by at least two of
 
the following three structural abnormalities of the regurgitant
 
valve: (1) leaflet morphology (typical marked thickening of the margins), (2) leaflet mobility 
(abnormal motion due to the posterior leaflet tip restriction), and (3) subvalvular apparatus 
morphology (prominent thickening, most often just below the valve, and shortening of chordal 
structures)  
 
Criteria 4 (AHC criteria): The suggested criteria for the diagnosis of RHD consists of the 
presence of any Doppler-detected valvular affection of the right-sided valves in association with 
at least one structural rheumatic valvular feature (as extensively described in chapter 3, pg. 90). 
Regurgitation should be defined as pathological when meeting all four criteria defined by the 
WHO (Table 1.3), however, including trivial affection. Mitral stenosis should diagnosed in case 
of flow acceleration across the mitral valve and a mean pressure gradient greater than 4 mmHg. 
Similarly, flow acceleration across the aortic valve with a peak velocity greater than 2 m/s is 
necessary for diagnosis of aortic stenosis.  
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The structural criteria should be based on the study of (1) quantitative leaflet morphology 
(typical marked thickening of the margins, greater than 4mm), (2) leaflet shortening with 
abnormal motion due to the posterior leaflet tip restriction), and (3) subvalvular apparatus 
morphology (prominent thickening, most often just below the valve, and shortening of chordal 
structures). 
 
Statistical analysis 
The statistical analysis was performed as descrived in chapter 3, pg 95. 
 
6.2.3 Results 
A total of 639 individuals were screened, excluding individuals with a history of valve 
replacement.  
 
6.2.3.1 Echocardiographic screening 
Structural findings 
Our series showed that 85.6% (n=534) of the individuals assessed had structural affection of the 
heart valves. 28.4% (n=177) had 1 abnormality of the heart valves and 24.0% (n=150) had a 
combination of 2 different abnormalities of the valves.  
 
Figure 6.1 Structural affection 
 
Thickening of the heart valves and subvalvular thickening was found in 79.6% (n=497) and 
27.8% (n=173) of the individuals, respectively. Doming was found in 46.6% (n=291) of the 
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individuals. The commissures were affected in 7.9% (n=49) of the cases. Calcification was found 
in 3.5% (n=22) and restriction of the heart valves was found in 30.4% (n=190) of the cases 
(Table 6.1). 
 
Table 6.1 Incidence of structural features 
Type of feature % (n) 
Thickening of valve cusps 79.6% (n=497) 
Doming of valve cusps 46.6% (n=291) 
Fusion of subvalvular apparatus 27.8% (n=173) 
Fusion of commissures 7.9% (n=49) 
Calcification 3.5% (n=22) 
Fixed leaflets 30.4% (n=190) 
 
 
 
 
 
Figure 6.2Thickening of the 
mitral leaflets and subvalvular 
apparatus in a parasternal long-
axis view 
 
 
 
 
 
 
 
 
 
Figure 6.3 Thickening of the mitral leaflets 
in an apical four-chamber view 
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Figure 6.4 Doming of the mitral valve in parasternal long-axis view 
 
 
 
 
 
 
 
 
 
Figure 6.5 Thickening and doming of the mitral valve in parasternal long-axis view 
 
Functional affection 
A significant amount of the individuals (73.4%, n=458) had functional affection of the right 
sided valves. Mitral valve affection was found in 27.7% (n=173) of the individuals and 14.9% 
(n=93) had affection of the mitral and the aortic valve. The aortic valve was affected in 2.4% 
(n=15) of the cases. Affection of the mitral, aortic and tricuspid valve was found in 16% (n=100) 
of the individuals (Figure 6.2) 
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Figure 6.6 Distribution of valve affection 
 
Mitral valve: Mitral regurgitation was found in 64.6% (n=402) of the cases. Trivial regurgitation 
was found in 23.1% (n=144) and mild regurgitation was found in 21.8% (n=136) of the 
individuals. Moderate and severe mitral regurgitation was found in 6.7% (n=42) and 11.9% 
(n=74), respectively (Figure 6.9). 
 
 
 
 
 
 
 
 
 
 
Figure 6.7 Mitral regurgitation in a parasternal long-axis view 
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Figure 6.8 Mitral regurgitation in a apical four-chamber view 
 
Figure 6.9 Severity of mitral regurgitation 
 
  
 
 
 
Figure 6.10 Severe mitral 
regurgitation in a parasternal 
long-axis view 
0 
5 
10 
15 
20 
25 
Trivial Mild Moderate Severe 
MR 
Chapter 6 Clinical characteristics & determinants of RHD in a hospital based study in Egypt 
 
148  
 
 
Rheumatic Heart Disease in Egypt 
 
 
Mitral stenosis was found in 26.4% (n=165) of the cases. Trivial mitral stenosis was found in 
0.3% (n=2) of the cases. Mild and moderate mitral stenosis was found in 5.8% (n=36) and 5.0% 
(n=31) of the cases, respectively. Severe mitral stenosis was found in 14.9% (n=93) of the cases. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.11 Restricted opening of a stenotic mitral valve in a parasternal long-axis view 
 
 
 
 
 
 
 
 
 
 
Figure 6.12 Mitral valve area in a parasternal short-axis view 
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Figure 6.13 Restricted opening of stenotic mitral valve in an apical four-chamber view 
 
Figure 6.14 Restricted flow through stenotic mitral valve (parasternal and apical four-chamber 
view) 
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Figure 6.15 Gradient across a stenotic mitral valve (apical four-chamber view) 
 
 
 
 
Figure 6.16 Severity of mitral stenosis 
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Figure 6.17 Distribution of mitral affection 
 
Isolated mitral regurgitation was found in 22.8% (n=142) of the cases, isolated mitral stenosis 
was found in 2.24% (n=14) of the cases. Part of all mitral regurgitation (35.3%, n=142) and 
8.49% (n=14) of all mitral stenosis cases were isolated. A combination of mitral regurgitation 
and stenosis was found in 3.36% (n=21) of the cases (Figure 6.18). 
 
Figure 6.18 Mitral functional affection (MR= Mitral regurgitation, MS= Mitral Stenosis) 
 
Aortic valve: Aortic regurgitation and stenosis was found in 31.4% (n=196) and 9.8% (n=61) of 
the cases, respectively. 
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Figure 6.19 Thickening of the 
aortic valve in a parasternal 
long-axis view 
 
 
 
 
 
 
 
 
 
Figure 6.20 Aortic 
regurgitation in a 
parasternal long-axis view 
 
 
 
Figure 6.21 
Determination of severity 
by analysis of the 
magnitude of the 
regurgitant jet in aortic 
root in M-mode 
(parasternal long-axis 
view) 
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Figure 6.22 Distribution of aortic affection 
 
Isolated aortic regurgitation was found in 2.56% (n=16) and isolated aortic stenosis was not 
found. A combination of isolated aortic regurgitation and aortic stenosis was found in 0.48% 
(n=3) of the cases. A small fraction (8.16%, n=16) of all aortic regurgitation found was isolated. 
 
 
Figure 6.23 Aortic functional affection (AR= Aortic regurgitation, AS= Aortic Stenosis) 
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Figure 6.24 Measurement of 
aortic valve area in a 
parasternal long-axis view 
 
 
 
 
 
 
Figure 6.25 Detail: Determination of 
aortic valve area in thickened and 
stenotic valve (parasternal long-axis 
view) 
 
 
 
 
 
Figure 6.26 Determination of 
aortic valve area in relation to 
aortic root for determination of 
the severity of stenosis 
(parasternal long-axis view) 
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Figure 6 27 Gradient across a 
stenotic aortic valve (apical 
four-chamber view) 
 
 
Tricuspid valve: Tricuspid regurgitation was found in 32.4% (n=202) and isolated tricuspid 
affection without functional affection of any other valves was found in 3.8% (n=24) of the cases. 
The majority of the cases were trivial (14,3%, n=89) while 9.3% (n=58) and 5.1% (n=32) were 
mild or moderate, respectively. A small number of the tricuspid regurgitation cases (1.8%, n=11) 
were found to be severe. Tricuspid stenosis was found in 1.1% (n=7) of the cases and no isolated 
tricuspid stenosis was found. 
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Figure 6.28 Tricuspid regurgitation in an apical four-chamber view 
 
Figure 6.29 Gradient across regurgitant tricuspid valve in an apical four-chamber view 
 
 
Table 6.2  Distribution of valvular affection 
 
 
Mitral 
% (n) 
Aortic 
% (n) 
Tricuspid 
% (n) 
Isolated 27.7% (n=173) 27.7% (n=173)  
 Regurgitation 
64.6% (402) 
Stenosis 
26.4 (165) 
Regurgitation 
31.4 (196) 
Stenosis 
9.8% (61) 
Regurgitation 
32.4 (202) 
Stenosis 
1.1 (7) 
Trivial 23.1 (144) 0.3 (2) 6.9 (43) 0.2 (1) 14.3 (89)  
Mild 21.8 (136) 5.8 (36) 18.0 (56) 2.7 (17) 9.3 (58)  
Moderate 6.7 (42) 5.0 (31) 4.8 (30) 2.1 (13) 5.1 (32)  
Severe 11.9 (74) 14.9% (93) 10.4 (65) 4.6 (29) 1.8 (11)  
 
 
  
Chapter 6 Clinical characteristics & determinants of RHD in a hospital based study in Egypt 
 
157  
 
 
Rheumatic Heart Disease in Egypt 
 
 
6.2.3.2 Evaluation of newly developed echocardiographic diagnostic criteria  
Prevalence of subclinical RHD following the different diagnostic criteria 
Following our echocardiographic criteria (criteria 4, AHC criteria) which combines functional 
and structural features (as described in chapter 3, pg. 89) for the diagnosis of RHD, 69.2% 
(n=432) of the individuals were diagnosed with RHD (Figure 6.30). 
 
Figure 6.30 Incidence of valvular affection by the AHC criteria 
 
Following criteria 1 (WHO 2004), which is based on the finding of mitral and/or aortic 
regurgitation 46.7% (n=291) would be diagnosed with RHD.  
Following criteria 2 (Carapetis 2008) a total of 54.6% (n=340) would be diagnosed with RHD of 
which 25.9% (n=88) would have been diagnosed by the presence of pathological aortic 
regurgitation, aortic or mitral stenosis. However, 33.2% (n=113) of the individuals diagnosed by 
the criteria had pathological aortic regurgitation, aortic or mitral stenosis in combination with 
structural affection. A small number (0.8%, n=5) of the individuals would be diagnosed with 
borderline RHD in this criteria.  
Following criteria 3 (Marijon 2007) which combined valvular regurgitation with at least 2 
structural signs a total of 40.6% (n=253) individuals would be diagnosed with RHD. A 
combination of at least 2 of the structural findings but no functional affection was found in 
44.6% (n=278) of the individuals (Figure 6.31).  
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Figure 6.31 Diagnosis of RHD following the different criteria 
 
6.2.3.3 Clinical versus echocardiographic diagnosis of subclinical RHD 
The majority (18.1%, n=515) of the individuals screened did not have an audible cardiac murmur 
and only 18.9% (n=120) had a murmur (Figure 6.32). 
 
Figure 6.32 The presence of a cardiac murmur in the screened population 
 
None of the individuals with only structural affection of the heart valves had a murmur. From the 
individuals with functional affection of the heart valves only 17.9% (n=113) had a murmur. The 
majority of the individuals (82.1%, n=519) did not have a murmur and would not have been 
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diagnosed by auscultation only (Figure 6.33). This shows a 4.6-fold increase of detection rate of 
functional lesions by echocardiography when compared to clinical examination. 
 
Figure 6.33 The presence of a cardiac murmur in combination with functional affection of the 
heart valves 
 
From the individuals diagnosed with RHD following our echocardiographic criteria only 17.1% 
(n=108) had a murmur. The majority of the patients diagnosed with RHD (82.9%, n=524) did 
not have a murmur (Figure 6.34). This shows a 4.85-fold increase of detection rate of RHD by 
echocardiography when compared to clinical examination. 
 
 
Figure 6.34 The presence of a cardiac murmur in patients diagnosed with RHD
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6.2.4 Discussion 
In our series only a minority of the individuals with functional affection of the heart valves and 
none of the individuals with isolated structural affection of the heart valves had a murmur.   
From the individuals diagnosed with RHD following our echocardiographic criteria only 17.1% 
had a murmur, showing that 82.9% of the individuals diagnosed with RHD by echocardiography 
would have been missed if assessed by auscultation only. Based on these results we can conclude 
that functional affection of the heart valves and the presence of RHD is diagnosed 4.6 and 4.85 
times more often by echocardiography than clinically, respectively. This is caused by the fact 
that murmurs are missed even by experienced clinicians due to many factors like the associated 
tachycardia, noisy surrounding, low intensity of the murmur (Saxena 2000) and the fact that mild 
valvular regurgitation is subclinical and in the acute phase, even moderate mitral or aortic 
regurgitation may not be clinically audible. Furthermore, Doppler echocardiography is more 
sensitive and more accurate in diagnosing valvular involvement in acute RF (Vijayalakshmi 
2009) as it can detect significant valvar incompetence in the absence of auscultatory findings, 
during both the acute and the quiescent phases of the disease (Veasy 1993, Veasy 1994, Wilson 
1995, Folger 1992). 
Previous reports mention that around 40% of the mitral regurgitation and subclinical RHD cases 
and over 80% of the aortic regurgitation would have been missed when assessed only clinically 
(Vijayalakshmi 2008). Screening based only on auscultation is therefore likely to miss many 
cases of RHD (Carapetis 2008) and comprehensive echocardiographic assessment has been 
shown to identify approximately 10 times as many children with RHD as the traditional strategy 
of clinical screening (Marijon 2007). Our series shows a lower detection benefit with 
echocardiography probably due to the fact that the lesions found in earlier studies were milder, 
leading to a greater discrepancy between the prevalence reported by echocardiography and by 
auscultation (Carapetis 2008). Furthermore, the fact that we assessed a population with history of 
RF and expected to have a higher incidence of more prominent valvular affection might have 
also contributed to the presence of murmurs related to pathology. This suggests that that the 
detection rate by echocardiography will increasingly exceed the auscultatory findings in the 
screening of RHD. 
Chapter 6 Clinical characteristics & determinants of RHD in a hospital based study in Egypt 
 
161  
 
 
Rheumatic Heart Disease in Egypt 
 
 
Our criteria diagnosed 69.2% of the screened population with RHD, while the detection by the 
other criteria ranged only up to 54.6%. This might be due the fact that Criteria 1 and 2 exclude 
trivial regurgitation and miss therefore all trivial and milder functional affection of the valves 
compared to our criteria. Bearing in mind that 31.7% of the individuals screened had isolated 
trivial mitral regurgitation we can conclude that this criteria is not suitable for the diagnosis of 
subclinical RHD, which needs the best identification, as it is the most probable type of affection 
benefitting from treatment and prophylaxis. Although criteria 2 includes structural features for 
the diagnosis of RHD, these features were not required in the presence of regurgitation of mild or 
greater severity. This could lead to over-diagnosis of RHD in an older population where a higher 
incidence of functional valvular affection is expected.  
In criteria 2 the presence of aortic regurgitation, mitral or aortic stenosis were considered to 
indicate RHD while excluding structural features. We believe that aortic regurgitation, mitral or 
aortic stenosis are indeed signs of RHD, but we think that they will be found in combination with 
structural affection and therefore, it is unneeded to create a separate criterion.  
Criteria 1 and 3 do not include stenotic lesions in the diagnostic criteria while it is known that 
mitral and aortic stenosis are mainly caused by RHD, especially in the young population and our 
series shows isolated mitral and aortic stenosis in 5.8% and 2.4% of the cases. This could suggest 
that a great amount of RHD cases expressed by stenotic lesions would be missed in these criteria. 
Furthermore, in criteria 3 a combination of 2 structural features was required for the diagnosis of 
RHD. Our series shows that cardiac affection was mostly related to the finding of only 1 single 
structural feature, suggesting that the requirement of a combination of 2 structural features will 
cause under-diagnosis of especially mild and subclinical cases, which require treatment and 
prophylaxis the most for a possible reversibility of the lesions. Our series confirms that case 
detection may differ importantly according to the diagnostic criteria utilized (Marijon 2009). 
Furthermore, based on these results we believe that all criteria under-diagnose RHD, specially 
mild and subclinical cases, which are mostly expected to resolve with proper treatment and 
prophylaxis.  
 
Echocardiographic definition of RHD based on functional characteristics may depend on the gain 
settings on the ultrasound equipment, therefore, the use of Doppler criteria for
 
abnormalities 
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associated with structural valve changes
 
would be expected to improve the specific diagnosis of 
RHD (Marijon 2007). Also, criteria based on structural changes as defined in the combined 
criteria may be more likely to suggest chronic RHD lesions and is believed to improve the 
detection of children with subclinical RHD but without significant valve regurgitation who 
would not be eligible for secondary RHD prophylaxis under current international guidelines. The 
WHO criteria may be easier to use, however this set of criteria seems to suffer from a 
substantially lower sensitivity. In conclusion, adding structural features to diagnostic criteria has 
significant consequences in terms of case detection rates and the combined criteria seems to be 
better suited for screening of subclinical RHD.  
 
Screening with sensitive and specific echocardiographic criteria for subclinical and valvular 
affection is highly important as it is a relatively common condition in RF (Tubridy-Clark 2007, 
Figueroa 2001) and RHD remains the main origin of heart valve disease in different areas. 
Therefore, significant subclinical valve lesions should be diagnosed and labelled and affected 
individuals should have long-term follow-up and secondary rheumatic fever prophylaxis (WHO 
2004). However, the boundary between physiological valve regurgitation and authentic but 
minimal rheumatic lesions remains difficult to discern as valvular regurgitation is fairly 
common, showing prevalences of 2.4 to 45% for mitral (Shah 1989, Lembo 1988), up to 33% for 
aortic (Shah 1989, Lembo 1988), 6.3 to 95% for tricuspid (Lembo 1988, Kostucki 1986) and 
21.9 to 92% for pulmonary regurgitation (Lembo 1988, Yoshida 1988).  
Furthermore, subvalvular or valvular thickening and any other structural affection of the valve 
may develop before the leaflet retraction and thereby regurgitation, noting that structural changes 
of valves affected by the rheumatic inflammatory process, even before the development of 
pathological regurgitation likely indicate subclinical RHD, which might benefit from 
identification and thence secondary prevention (Marijon 2007). Adding structural features to 
criteria definition has been shown to increase case detection rates by up to 3-fold (Marijon 2009), 
leading to significant consequences in terms of case detection rates, follow-up and use of 
penicillin prophylaxis and  thus  for  eventual  health  and long-term outcomes of RHD. 
Therefore, we confirm the benefit and need for the use of a combined criteria, evaluating  
structural and functional features of the valve, adding to the importance of different features, 
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contributing to improvement and updating the criteria for the diagnosis of RHD to avoid under as 
well as over diagnosis of the condition.  
 
6.2.5 Conclusions 
Screening based only on auscultation is likely to miss many cases of pathological valvular 
lesions due to RHD compared with echocardiographic screening in Egypt. Echocardiography is 
not only more sensitive and more accurate in confirming, diagnosing and quantifying valvular 
involvement in RF as it is essential for establishing the cause of the murmur. Furthermore, it is of 
immense value in ruling out infective endocarditis in patients with RF and RHD.  
Importantly, in Eygpt, around 90% of cases of RHD are clinically silent, occurring in 
asymptomatic individuals without audible murmurs, suggesting that echocardiographic screening 
would be a desirable goal to optimize case identification and targeted secondary prevention 
measures. Detection of lesions is important especially because those with mild and subclinical 
disease stand to benefit most from secondary prophylaxis. Therefore, we confirm that 
echocardiography should be the diagnostic golden standard and screening tool as it is the only 
approach with sufficient sensitivity and specificity for the detection of subclinical carditis and 
RHD in the absence of auscultatory findings and overt evidence of valvular or other cardiac 
involvement, during both the acute and the quiescent phases of the disease. However, there are 
no universally agreed criteria for the echocardiographic diagnosis of RHD and the currently 
criterias in use differ and show different detection rates for the affected individuals.  
We confirm the benefit of a criteria which combines structural and functional characteristics of 
RHD, and we have contributed to the improvement of the criteria which increases the detection 
of rheumatic valvular affection, avoiding under- as well as over-diagnosis of the condition. The 
use of the suggested stringent criteria will have major health care benefits as early recognition 
and diagnosis limits the progression to chronic
 
subclinical valvular disease and improves the 
prognosis of RHD with adherence to secondary penicillin prophylaxis regimens.  
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6.3 Subclinical RHD in individuals with history of RF in EgyptThe aim of this study was to 
analyze the incidence, characteristics and determinants of RHD in a population with hstory of 
RF. 
 
6.3.1 Patients and methods 
Individuals visiting the penicillin or outpatient clinic of the NHI were assessed for the diagnosis 
of RHD and determination of the echocardiographic characteristics as described in chapter 3, pg 
75. 
 
The study group consisted of: 
-Individuals with a positive history of RF visiting the centre for penicillin prophylaxis with 
or without cardiac involvement 
-Individuals visiting the NHI outpatient clinic for suspicion of RF or RHD  
 
Demographic data 
Demographic data from every subject selected were collected in the form of a standardized 
questionnaire (Appendix V). The questionnaire contains questions regarding the patient‘s 
demographics, family environment, risk factors, history of RF, its severity, treatment and 
prophylaxis.  
Issues regarding the onset age of RF, symptoms, severity, presence of recurrences of RF, 
medication and penicillin prophylaxis were questioned on the history of RF and the presence of 
symptoms to confirm the presence of RF and clinical presentation. Penicillin prophylaxis 
schedule was divided into 3 categories, following the most used and prescribed schedules for 
penicillin prophylaxis, every 15 days, 3 weeks or monthly. Compliance rate for the penicillin 
prophylaxis was evaluated by asking the patient about the schedule, how often he ignored or 
postponed the injection date and if he was strict to the schedule. Compliance was then also be 
evaluated in relation to the schedule. A schedule of less than 9 injections a year was considered 
poor. A schedule of 9 to 12 injections a year was considered fair, while an excellent compliance 
rate was more than 12 injections a year. Many individuals were receiving prophylaxis for the 
first time therefore questions on schedule and compliance was not applicable. 
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The disease awareness as classified in 3 categories evaluated on the patients‘ knowledge of the 
RF history, symptoms and penicillin prophylaxis. The disease awareness was also be evaluated 
by the amount and type of questions answered on the knowledge of RF and RF history. The 
disease awareness was evaluated as poor when the patient had no knowledge of the reason for 
penicillin prophylaxis. When the patient was aware of RF or the valvular damage, and knew that 
penicillin is a way of prophylactic prevention but did not know the link between RF and the 
valvular damage the awareness was evaluated as fair. The patient‘s awareness was evaluated as 
good when he was also aware of the correlation between RF and cardiac disease (RHD). The 
same scale was used for the parents‘ awareness. Dental care was evaluated during collection of 
throat swabs by the general condition of the mouth and teeth.  
 
Examination protocol 
The screened individuals underwent a standardized examination protocol consisting of detailed 
medical history recorded by the investigator, physical examination including general analysis of 
the patients‘ health, recognition of Jones criteria and careful cardiac auscultation with the patient 
in the supine and left lateral decubitus positions.  
Disease manifestations and auscultatory findings were evaluated according to internationally 
approved criteria, including the published data from World Health Organization (WHO 1988, 
Figueroa 1992). Detailed transthoracic echocardiography was performed with the use of a hand-
carried, battery operated echocardiographic system (Vivid i, General Electric) with M-mode, 
two-dimensional, and Doppler (pulsed, continuous, and color) imaging. The following were 
obtained: apical two-, four-, and five-chamber views, parasternal long-axis and short-axis views 
at the level of the papillary muscles and the aortic valve and subcostal views. 
Particular attention was paid to valve morphology on cross-sectional, two dimensional imaging 
and the degree and extent of mitral and aortic regurgitation, assessed by color flow Doppler 
imaging. The apical imaging included anterior angulation to evaluate the left ventricular outflow 
tract and the aortic valve. Transvalvular flow was assessed by measuring the peak velocity with 
continuous wave Doppler imaging. Hard copies with detailed location and type of lesions 
(Appendix V, page 3) and electronic records of relevant data were kept for offline re-evaluation.  
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The echocardiographic study was performed by the candidate and two blinded experienced 
cardiologists reviewed the records. The diagnosis of RHD was accepted when there was 
agreement of at least two cardiologists, including the researcher.  
 
Echocardiographic criteria 
Our suggested criteria for the diagnosis of RHD consists of the presence of any Doppler-detected 
valvular affection of the right-sided valves in association with at least one structural rheumatic 
valvular feature as described in chapter 3, pg. 86. Regurgitation should be defined as 
pathological when meeting all four criteria defined by the WHO (Table 1.3). However, including 
trivial affection. Mitral stenosis should diagnosed in case of flow acceleration across the mitral 
valve and a mean pressure gradient greater than 4 mmHg. Similarly, flow acceleration across the 
aortic valve with a peak velocity greater than 2 m/s is necessary for diagnosis of aortic stenosis.  
The structural criteria should be based on the study of (1) quantitative leaflet morphology 
(typical marked thickening of the margins, greater than 4mm), (2) leaflet shortening with 
abnormal motion due to the posterior leaflet tip restriction), and (3) subvalvular apparatus 
morphology (prominent thickening, most often just below the valve, and shortening of chordal 
structures) (Table 3.2). 
 
6.3.2 Results 
A total of 495 individuals were recruited at the NHI penicillin clinic, excluding the individuals 
assessed at the cardiothoracic surgery department and/or with a history of valve replacement.  
6.3.2.1 Demography 
 
Age: The mean age was 20.66 years and the median was 20.66 years (Figure 6.35). 
 
Gender: There was a slight female predominance (52.3%, n=259) with a male to female ratio of 
1:1,1.  
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Figure 6.35 Age at the time of screening 
 
Social factors: The number of siblings ranged up to 12, but most individuals came from families 
with a mean of 3.7 siblings and had good dental care.  
 
Medical history: The majority had no cardiac risk factors and only a small fraction (2.0%, n=10) 
reported other risk factors like diabetes, atrial fibrillation or hypertension.  
 
Family history: The majority of the individuals had a negative family history for cardiac diseases 
and RF. A small fraction of patients (6.0%, n=42) did not know if there was RF in the family.   
Disease awareness: Most individuals had fair disease awareness. A small fraction of the 
individuals (2.7%, n=19) were too young to answer the questions on the disease awareness. A 
total of 182 parents were questioned about their child‘s health condition and the majority had a 
fair awareness of the disease.  
 
Previous interventions: A small amount of the individuals had a history of previous interventions 
(5.3%, n=26), including balloon valvuloplasty, mitral valve repair and valve replacement. The 
intervention date from 3 months to 19 year (5.04 ± 4.95). 
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Table 6.3 Table of demographics 
                   % (nr) Mean ± SD range 
Age   20.66 ± 10.61 3-59 
Sex     
    Male  47.4% (n=236)   
    Female 52.3% (n=259)   
Nr of siblings  3.69 ± 2.04 0-12 
Dental care    
   Poor 4.8% (n=23)   
   Fair 45.1% (n=218)   
   Good  50.1% (n=242)   
Family history for cardiac 
diseases 
   
   Positive 7.9% (n=36)   
   Negative 92.1% (n=417)   
Family history for RF    
   Positive 21.4% (n=97)   
   Negative 78.6% (n=356)   
Other risk factors    
   Yes 2.0% (n=10)   
   No  98.0% (n=483)   
Disease awareness    
   Poor 36.1% (n=168)   
   Fair 38.4% (n=179)   
  Excellent 25.5% (n=119)   
Parents disease awareness    
   Poor 26.4% (n=48)   
   Fair 41.8% (n=76)   
  Excellent 31.9% (n=58)   
 
6.3.2.2 Echocardiographic characteristics 
Structural affection 
Our series showed that 81.6% (n=396) of the individuals assessed had structural affection of the 
heart valves. 36.1% (n=175) had 1 abnormality of the heart valves and 27.0% (n=131) had 2 
different abnormalities of the valves. Thickening of the heart valves and subvalvular thickening 
was found in 74.2% (n=360) and 25.4% (n=123) of the individuals, respectively. Doming was 
found in 33.8% (n=164) of the individuals. The commissures were affected in 4.3% (n=21) of 
the cases. Calcification was found in 0.8% (n=4) and restriction of the heart valves was found in 
14.8% (n=72) of the cases (Figure 6.36). 
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Figure 6.36 Incidence of structural features 
 
Most individuals (66%, n=320) had functional affection of the right sided valves. Affection of 
the mitral valve was found in 33.2% (n=161) of the individuals and affection of the mitral and 
the aortic valve was seen in 12.8% (n=62). The aortic valve was affected in 2.5% (n=12) of the 
cases. Affection of the mitral, aortic and tricuspid valve was found in (5.6%, n=27) of the 
individuals. 
 
Figure 6.37 Distribution of functional affection of the valves 
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Mitral regurgitation was found in 58.7% (n=284) of the cases and mitral stenosis was found in 
13.4% (n=65) of the cases.  
 
Figure 6.38 Incidence of functional affection of the valves 
 
Isolated mitral regurgitation was found in 49.2% (n=238) of the cases, isolated mitral stenosis 
was found in 3.9% (n=19) of the cases. A combination of mitral regurgitation and stenosis was 
found in 9.5% (n=46) of the cases. 
 
Figure 6 39 Distribution of mitral valve affection 
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Figure 6.40 Distribution of the severity of mitral valve affection 
 
Aortic regurgitation and stenosis was found in 20.6% (n=100) and 2.1% (n=10) of the cases, 
respectively. Isolated aortic regurgitation and aortic stenosis was found in 20% (n=97) and 1.4% 
(n=7) of the cases, respectively. A combination of aortic regurgitation and aortic stenosis was 
found in 0.6% (n=3) of the cases. 
 
Figure 6.41 Distribution of aortic valve affection 
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Figure 6.42 Distribution of the severity of aortic valve affection 
 
Tricuspid regurgitation was found in 22.9% (n=111) of the cases. The majority of the cases were 
trivial (14.3%, n=69). Isolated tricuspid regurgitation, without the presence of any other 
functional affection of the heart valves was found in 3.8% (n=24) of the individuals. Tricuspid 
stenosis was not found in this series. 
 
Figure 6.43 Distribution of the severity of tricuspid valve affection 
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6.2.2.3 Incidence of RHD  
The majority of individuals had structural as well as functional affection of the heart valves 
Figure 6.44). Following the suggested echocardiographic diagnostic criteria 60.6% (n=294) of 
the individuals screened would be diagnosed with RHD. 
 
Figure 6.44 Incidence of heart pathology 
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6.4 Echocardiographic characteristics of RHD 
6.4.1 Patients and methods 
Echocardiographic data of individuals recruited at the penicillin clinic and cardiothoracic 
department of the NHI in Cairo as described in chapter 3, pg. 75 and diagnosed with RHD were 
analyzed to define the echocardiographic characteristics of RHD. The echocardiograhic findings 
in the different groups analyzed (chapter 6.2, pg. 122 and 6.3, pg. 136) were compared for the 
evaluation of the echocardiographic characteristics specific for RHD. 
 
6.4.2 Results 
In total, 69.2% (n=432) of the individuals screened at the NHI penicillin clinic, were diagnosed 
with RHD.  
6.4.2.1 Demography 
 
Age: The mean age of the individuals diagnosed with RHD was 25.44 years and the median was 
22.0 years (Figure 6.45). 
 
Figure 6.45 Age at the time of screening 
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Gender: There was a slight male predominance (51.4%, n=222) with a male to female ratio of 
1:1,06.  
 
Social factors: The number of siblings ranged up to 14, but most individuals came from families 
with a mean of 4.26 siblings and had fair dental care.  
 
Medical history: The majority had no cardiac risk factors and only a small fraction (2.3%, n=10) 
reported other risk factors like diabetes, atrial fibrillation or hypertension.  
 
Family history: The majority of the individuals had a negative family history for cardiac diseases 
and RF.  
 
Table 6.4 Profile of patients diagnosed with RHD 
                   % (nr) Mean ± SD range 
Age   25.43 ± 12.74 4-63 
Sex     
    Male  51.4% (n=222)   
    Female 48.6% (n=210)   
Nr of siblings  4.26 ± 2.31 0-14 
Dental care    
   Poor 4.3% (n=18)   
   Fair 51.8% (n=218)   
   Good  43.9% (n=185)   
Family history for cardiac diseases    
   Positive 6.7% (n=26)   
   Negative 93.3% (n=363)   
Family history for RF    
   Positive 18.3% (n=71)   
   Negative 81.7% (n=318)   
Other risk factors    
   Yes 2.3% (n=10)   
   No  97.7% (n=418)   
Disease awareness    
   Poor 47.8% (n=203)   
   Fair 31.3% (n=133)   
  Excellent 20.9% (n=89)   
Parents disease awareness    
   Poor 31.3% (n=48)   
   Fair 35.4% (n=35)   
  Excellent 33.3% (n=33)   
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Disease awareness: Most individuals had poor disease awareness. A total of 116 parents were 
questioned about their child‘s health condition and 31.3% (n=48) showed a poor disease 
awareness of the disease.  
 
Diagnosis: Most individuals was diagnosed by the presence of RF symptoms (63.3%, n=273), while 
36.7% (n=158) were diagnosed by cardiac symptoms or affection. 
 
Recurrences: Most individuals reported recurrences of the RF attacks 55.6%, n=200) with the 
majority of the attacks reported in the last 3 to 4 weeks (98.5%, n=192), while 28.7% (n=56) 
reported recurrence in the last week.  
 
Previous interventions: A small amount of the individuals had a history of previous interventions 
(6.3%, n=27), including balloon valvuloplasty, mitral valve repair and valve replacement. The 
intervention date from 6 weeks to 20 year (6.98 ± 4.97). 
 
Penicillin prophylaxis: The majority of individuals were on penicillin prophylaxis (82.4%, 
n=342). The most common prophylaxis schedule was reported to be every 15-day (66.2%, 
n=215), while a 21-day and monthly prophylaxis routine was reported in 12.3% (n=40) and 
21.5% (n=70), respectively. Good compliance to the penicillin prophylaxis was reported in 
48.2% (n=157) of the cases, while 33.7% (n=110) and 18.1% (n=59) reported a fair or poor 
compliance, respectively. 
 
 
6.4.2.2 Echocardiographic characteristics 
Structural affection 
Thickening of the heart valves and subvalvular thickening was found in 95.4% (n=412) and 
38.5% (n=166) of the individuals, respectively. Doming was found in 56.5% (n=244) of the 
individuals. The commissures were affected in 11.1% (n=48) of the cases. Calcification was 
found in 5.1% (n=22) and restriction of the heart valves was found in 43.3% (n=187) of the 
cases. 
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Figure 6.46 Incidence of structural features 
 
Functional affection 
Isolated mitral valve affection was seen in (35.6%, n=154) and 20.8% (n=90) had affection of 
the mitral and the aortic valve. The aortic valve was affected in 3.0% (n=13) of the cases. A 
combination of mitral, aortic and tricuspid valve affection was seen in 23.1% (n=100) of the 
individuals. 
 
Figure 6.47 Distribution of functional affection of the valves 
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Figure 6.48 Incidence of functional valvular affection 
 
Mitral valve: Mitral regurgitation was found in 86.8% (n=374) of the cases and mitral stenosis 
was found in 38.2% (n=165) of the cases. Most of the cases had trivial (28.8%, n=124) while 
17.2% (n=74) had severe mitral regurgitation. Severe mitral stenosis was seen in 21.6% (n=93) 
of the cases, while 8.4% (n=36) and 7.2% (n=31) had mild and moderate stenosis, respectively.  
 
 
Figure 6.49 Severity of mitral valve affection 
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Aortic valve: Aortic regurgitation and stenosis was found in 44.0% (n=190) and 14.1% (n=61) of 
the cases, respectively. Severe aortic regurgitation was seen in 15% (n=65) of the cases, while 
13.0% (n=56) and 6.9% (n=30) had mild and moderate regurgitation, respectively. Severe aortic 
stenosis was seen in 6.7% (n=29), while mild and moderate stenosis was seen in 3.0% (n=13) 
and 3.9% (n=17) of the cases.  
 
Figure 6.50 Severity of aortic valve affection 
 
Tricuspid valve: Tricuspid regurgitation was found in 40.7% (n=176) of the cases. The majority 
of the cases were trivial (16.5%, n=71).  Mitral stenosis was seen in 1.6% (n=7) of the cases.  
 
Figure 6.51 Severity of tricuspid regurgitation 
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6.4.2.3 Evaluation of echocardiographic findings 
When comparing the echocardiograhic findings in the different groups we notice an increase in 
the incidence of all structural features and mixed lesions in the RHD group as shown in Figure 
6.31 and Figure 6.32.  
Figure 6.52  Distribution of structural affection among the groups  
*Total= total group assessed, Screening= individuals screened at the penicillin prophylaxis, 
RHD= patients diagnosed with RHD 
 
 
Figure 6.53 Distribution of valvular affection among the groups 
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In the group diagnosed with RHD there was an increase in functional affection of all valves 
(Figure 6.54). 
 
 
Figure 6.54 Distribution of valvular functional affection among the groups 
 
The severity of the all functional lesions increased significantly in the group diagnosed with 
RHD, especially when compared with the group diagnosed with RHD at the penicillin clinic 
(Figure 6.55). 
 
 
Figure 6.55 Distribution of severity of mitral regurgitation among the groups 
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The distribution of the severity of the different functional lesions are shown in the figures below.   
 
Figure 6.56 Distribution of severity of mitral stenosis among the groups 
 
Figure 6.57 Distribution of severity of aortic regurgitation among the groups 
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Figure 6.58 Distribution of severity of aortic stenosis among the groups 
 
6.4.3 Discussion 
The vast majority of the individuals screened had structural as well as functional affection of the 
heart valves. An increased thickness of the valvular leaflets was the commonest feature found, 
with a prevalence ranging up to 74.2% in the group screened at the penicillin clinic and 83.8% in 
the total screened population in concordance with earlier reports on cardiac affection as a result 
of RF (Vijayalakshmi 2008). However, in the group diagnosed with RHD it ranged up 95.4%, 
suggesting that valvular thickening
 
seems to be a universal structural feature in RHD, 
highlighting the clinical meaning of this finding during echocardiography. Features like doming 
of the valvular leaflets, calcification and restriction of the valvular apparatus were more common 
in the cohort and in individuals with RHD when compared to the individuals at the penicillin 
clinic. Single and isolated structural features were more prevalent in the group screened at the 
penicillin clinic, however, in the complete cohort and individuals with RHD combinations of 
structural features were more common. Therefore, the presented results suggest that the amount 
and combination of structural features increases with progression of the disease in combination 
with an increase of lesion severity, showing that the cardiac affection is progressive.  
 
In our series, the mean age of the individuals diagnosed with RHD was 25.44 with a median of 
22.0 years, which is in concordance with the expectations as the peak age for RHD has been 
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reported to be 20 to 40 years, with the highest prevalence expected to be in individuals aged 15-
35 years. (White 2010) Furthermore, RHD is the most frequent cause of heart disease among 5 to 
30 year olds, and RF and RHD are responsible for approximately 25-40% of all cardiac hospital 
admissions in some areas, being also the most common causes of death in this age group 
(Markowitz 1981). 
 
Subclinical carditis or valvular affection is known to be relatively common in RF (Tubridy-Clark 
2007, Figueroa 2001) and approximately 90% of cases of RHD are believed to be clinically 
silent. In our series, RHD was diagnosed in 60.6% of the individuals with history of RF visiting 
the NHI penicillin clinic for their penicillin prophylaxis. The mitral valve was predominantly 
affected with regurgitation being the most common lesion showing an incidence of 64.6% in the 
total cohort and 86.8% in the patients diagnosed with RHD. This was in concordance with the 
reported affection of the mitral valve which ranges up to 98% (Woo 1983, Reddy 2004) and 
mitral regurgitation ranging up to 94% (Ransome 1988, Marijon 2007, Ayoub 1995, Park Myung 
1996, Brook 1996, Tandon 2000, Carapetis 2008, Ramakrishnan 2009).  
Mitral stenosis ranged up to 38.2% of RHD patients and 26.4% in the total group which is in 
concordance with some of the earlier studies reporting incidences of 11.0% (Tandon 2000) to 
20% (Longo-Mbenza 1998). However, incidences have been reported to range up to 50% 
(Carapetis 2008, Ramakrishnan 2009). The discrepancy between the reported incidences of 
mitral regurgitation and stenosis might be due to age differences between the groups studied, as 
regurgitant lesions are more common in the young particularly in the early stages of the disease 
while stenosis is seen with progression of the disease. Nevertheless, most of the studies reporting 
the prevalence of the different valvular affection were performed on a population presenting with 
RHD, while a significant amount of the individuals assessed in our series had less severe 
valvular affection and were asymptomatic being diagnosed only by screening for subclinical 
RHD rather than clinical valvular disease.  
Aortic regurgitation was found in around one-third of the individuals in the cohort similarly in 
concordance to earlier reports (Reddy 2004, Sliwa 2010, Woo 1983) while isolated aortic 
regurgitation, without functional affection of any other valves was rare as expected (Reddy 
2004). The absence of isolated aortic stenosis in our series is not surprising, bearing in mind that 
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it is believed to be a rare condition (Ayoub 1995, Park Myung 1996, Brook 1996, Tandon 2000, 
Sliwa 2010). However, there was a significant increase of aortic regurgitation and aortic stenosis 
in the group diagnosed with RHD, showing also an increased severity of the lesions.  
Tricuspid regurgitation was found in one-third of the cases with isolated tricuspid affection 
without functional affection of any other valves in 3.8% of the cases. However, tricuspid 
regurgitation was found in 40.7% of the individuals diagnosed with RHD, which is lower than 
the earlier reported affection ranging up to 56% (Tandon 2000, Reddy 2004). 
 
The second most common finding in the individuals screened was combined affection of the 
mitral and aortic valves. Nevertheless, combined affection of the mitral, aortic and tricuspid was 
the second most common affection in the group diagnosed with RHD. Affection of both mitral 
and aortic valves is seen in around 27% of the RHD cases (Routray 2003, Reddy 2004) 
especially as combined mitral and aortic valve regurgitation while isolated mitral regurgitation or 
stenosis is relatively uncommon (Oli 2004) showing that mixed lesions and affection of several 
valves is more prevalent than isolated lesions in RHD (Reddy 2004). The incidence of the 
combined affections in our series is lower than reported earlier due to the fact that this study 
evolves a significant amount of subclinical and milder conditions, but shows a similar ranking 
(Vasan 1996, Routray 2003, Reddy 2004). An increase of mixed lesions as well as severity of the 
functional affection is found in the group diagnosed with RHD, suggesting that the more 
advanced the disease, the more valves affected with also increase in severity of the lesions. 
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6.5 Prognosis 
The aim of this study was evaluation of the progression and/ or resolution of the valvular lesions 
for the determination of the long term prognosis under the influence of several possible 
prognostic determinants.  
 
6.5.1 Patients and methods 
The patients recruited in the penicillin clinic of the NHI in Cairo (as described in chapter 3, pg. 
75) were reassessed 6 months after the first examination for the evaluation of the lesions, 
progression and/ or resolution of the cardiac condition. 
 
The study group consisted of: 
-Individuals with a positive history of RF visiting the centre for penicillin prophylaxis with 
or without cardiac involvement 
-Individuals visiting the NHI outpatient clinic for suspicion of RF or RHD  
 
6.5.2 Results 
A total of 167 individuals were reassessed after the initial recruitment at the penicillin 
prophylaxis clinic of the National Heart Institute during the follow-up, excluding the individuals 
assessed at the cardiothoracic surgery department and/or with a history of valve replacement.  
 
6.5.2.1 Characterization of the Patients 
Age: The age ranged from 5 to 46 with a mean± SD of 19.26±8.99 years (Figure 6.59). 
 
Gender: There was a slight male predominance, the disease awareness was ranged trough the 3 
categories and the parents‘ awareness was generally fair.  
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Figure 6.59 Age at the time of follow-up 
 
Table 6.5 Patient demographics in the follow up group  
 % (nr) Mean ± SD range 
Age    19.26±8.99  5-46 
Sex     
    Male  53.7% (n=88)   
    Female 46.3% (n=76)   
Disease awareness    
   Poor 31.6% (n=49)   
   Fair 37.4% (n=58)   
  Excellent 31% (n=48)   
Parents disease awareness    
   Poor 25% (n=16)   
   Fair 40.6% (n=26)   
  Excellent 34.4% (n=22)   
    
History for RF    
   Positive 93.3% (n=153)   
   Negative 6.7% (n=11)   
Age at time of RF   9.42±5.23  1-28 
How long ago (mnth)  40.26±74.63  1-432 
Family history for RF    
   Positive 22.9% (n=36)   
   Negative 77.1% (n=121)   
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Figure 6.60 Age at the time of RF onset 
 
Figure 6.61 Date of RF onset 
 
Follow-up time: Follow-up examinations were performed 7 to 12 months after the initial 
examination (median 8 moths). Nine patients were seen 3 times in a period ranging from 17 to 24 
months (mean= 22.33 months ± SD= 2.40).  
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Figure 6.62 Date of start penicillin prophylaxis 
 
Penicillin prophylaxis: The most common penicillin prophylaxis schedule was 15-day, followed 
by the monthly prophylaxis routine. A fraction of the patients (17.7%, n=29) was no longer on 
penicillin prophylaxis. The majority of them had stopped the penicillin prophylaxis in the last 6 
months (59.3%, n=15). Most patients (59.3%, n=80) reported excellent compliance to the 
prophylaxis regimen (Table 6.5). 
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Table 6.6 Follow-up 
 % (nr) Mean ± SD range 
Follow-up time   11.53± 7.23 2-24 
2-6 months 15.2% (n=25)   
7-12 months 51.2% (n=84)   
13-24 months 33.5% (n=55)   
    
Penicillin prophylaxis    
   Yes 82.32% (n=135)   
   No  17.7% (n=29)   
Prophylaxis schedule    
   15-day 69.6% (n=94)   
   21-day/ 3 weeks 9.6% (n=13)   
   1-month 20.7% (n=28)   
    
Start date prophylaxis   27.14±61.33  0-432 
    
Prophylaxis cessation time   1.88±10.34  0-120 
    
Compliance     
   Poor 7.4% (n=10)   
   Fair  33.3% (n=45)   
   Excellent 59.3% (n=80)   
 
 
6.5.2.2 Echocardiographic findings 
The majority of individuals had structural as well as functional affection of the heart valves 
(Figure 6.70), with the most common structural feature being thickness of the valve cusps 
(Figure 6.63) and mitral regurgitation the most common functional feature (Figure 6.65). 
 
Structural affection 
Our series showed that 56.9% (n=95) of the individuals assessed during follow-up had structural 
affection of the heart valves. Most (49.5%, n=47) of the individuals with structural affection had 
1 abnormality of the heart valves while 40.0% (n=38) had 2 different abnormalities of the valves. 
A small number of individuals (2.1%, n=2) had 5 different structural features. 
Thickening of the heart valves and subvalvular thickening was found in 50.9% (n=85) and 10.2% 
(n=17) of the individuals, respectively. Doming was found in 17.4% (n=29) of the individuals. 
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The commissures were affected in 1.2% (n=2) of the cases. Calcification was found in 0.6% 
(n=1) and restriction of the heart valves was found in 15.1% (n=25) of the cases. 
 
Figure 6.63 Incidence of structural features 
 
Functional affection 
Functional affection of the right sided valves was found in 61.1% (n=102) of the individuals. 
From the individuals with functional affection of the valves 63.4% (n=71) had mitral valve 
affection and 12.5% (n=14) had affection of the mitral and the aortic valve. The aortic valve was 
affected in 1.8% (n=2) of the cases. Affection of the mitral, aortic and tricuspid valve was seen in 
2.7% (n=3) of the individuals. Mitral regurgitation was found in 61.1% (n=102) of the cases and 
mitral stenosis was found in 3.6% (n=6) of the cases.  
0% 
10% 
20% 
30% 
40% 
50% 
60% 
Thickening of 
valve cusps 
Doming of 
valve cusps 
Fusion of 
subvalvular 
apparatus 
Fusion of 
commisures 
Calcification Fixed leaflets 
Chapter 6 Clinical characteristics & determinants of RHD in a hospital based study in Egypt 
 
192  
 
 
Rheumatic Heart Disease in Egypt 
 
 
 
Figure 6.64 Distribution of functional affection of the valves 
 
Figure 6.65 Incidence of functional affection of the valves  
 
Isolated mitral regurgitation was found in 42.5% (n=71) of the cases, isolated mitral stenosis was 
found in 0.6% (n=1) of the cases. A combination of mitral regurgitation and stenosis was found 
in 1.2% (n=2) of the cases. 
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Figure 6.66 Distribution of mitral affection 
 
Figure 6.67 Severity of mitral affection 
 
Aortic regurgitation was found in 12% (n=20) of the cases. No aortic stenosis was found in this 
series. Isolated aortic regurgitation was found in 1.2% (n=2) of the cases.  
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Figure 6.68 Severity of aortic regurgitation 
 
Tricuspid regurgitation was found in 15.6% (n=26) of the cases. The majority of the cases were 
trivial (46.2%, n=12). 30.8% (n=8) and 23.1% (n=6) were mild or moderate, respectively. 
Tricuspid stenosis was not found in this series. 
 
Figure 6.69 Severity of tricuspid regurgitation 
 
RHD 
Combination of structural and functional affection leading to the diagnosis of RHD was seen in 
41.9% (n=70) of the individuals. From the individuals diagnosed with RHD 58.6% (n=41) were 
males and 37.7% (n=29) were females. 
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Figure 6.70 Incidence of heart pathology 
 
6.5.2.3 Evaluation of echocardiographic findings  
A part of the individuals (15%, n=25) continued free of structural affection at the time of follow-
up while 25.1% (n=42) of the individuals continued free of functional affection at the time of 
follow-up and 37.1% (n=62) of the individuals continued free of RHD at the time of follow-up.  
 
Development of lesions: A small fraction of the individuals (4.8%, n=8) had developed structural 
affection at the time of follow-up and 10.8% (n=18) of the individuals had developed functional 
affection at the time of follow-up. A small fraction of the individuals (5.4%, n=9) were newly 
diagnosed with RHD at the time of follow-up. 
 
Maintenance of lesions: 52.1% (n=87) of the individuals had sustained the structural affection 
found during the first assessment at the time of the follow-up. Most individuals (50.3%, n=84) 
had sustained the functional affection found during the first assessment at the time of the follow-
up and 36.5% (n=61) of the individuals sustained the diagnosis of RHD found during the first 
assessment at the time of the follow-up. 
 
Reversibility of lesions: In 28.1% (n=47) of the individuals assessed the structural affection had 
resolved. In 13.8% (n=23) of the individuals assessed the functional affection had resolved.  
In 21% (n=35) of the individuals assessed the characteristics leading to the diagnosis of RHD 
had resolved.  
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Figure 6.71 Results of follow-up  
 
6.5.3 Discussion 
Most individuals assessed during follow-up had structural or functional affection of the heart 
valves and the mitral valve was mostly affected, in the form of mitral regurgitation. Combination 
of structural and functional affection leading to the diagnosis of RHD was diagnosed in 41.9% of 
the individuals, with a male predominance in this group.  
The follow-up time was 7 to 12 months, which is believed to be a fair latent period to reassess 
the development or reversibility of the valvular affection and Doppler echocardiographic 
findings over time and the majority of the individuals was still on penicillin prophylaxis, 
reporting a 15-day regimen and an excellent compliance to the prophylaxis program. 
The outcome of subclinical carditis is not well established, however progression of the rheumatic 
valvular lesions to chronic subclinical valvular disease is around 82% (Meira 2005) while 
persistence or deterioration of subclinical carditis has been reported to be up to 44.7% at 3-23 
months after diagnosis (Tubridy-Clark 2007) and around 60% after five years of follow up in 
spite of continuous penicillin prophylaxis and no evidence of recurrent disease (Figeroa 2001). In 
our series, half of the individuals assessed sustained structural and functional affection while 
over one third of the individuals assessed sustained the characteristics leading to the diagnosis of 
RHD. Development of valvular involvement was seen in only a small number of patients. 
Reversibility of the lesions leading to the diagnosis of RHD was seen in 21% of the cases which 
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is lower than the reversibility reported ranging up to 60-80%, with adherence to antibiotic 
prophylaxis (Chin 2010). However, isolated structural or functional affection were more often 
sustained than the combination of both and functional affection was more prone to develop than 
the structural affection. Importantly, structural affection was seen to resolve more often than the 
functional affection. Therefore, individuals were more likely to show reversibility of the 
diagnosis of RHD mainly due to the disappearance of structural affection.  
 
 
6.6 Determinants of RHD  
Variables that seem to correlate with severity of valve disease include the number of previous 
attacks of rheumatic fever, the length of time between the onset of disease and start of therapy, 
and gender. RHD has been reported to be more severe in females than in males (Cole 1976, 
Longo-Mbenza 1998, Mahmudi 2006) and repeated episodes of RF are believed to lead to 
further inflammatory damage and subsequent scarring of cardiac valves (Veasy 1997, Majeed 
1992). Meanwhile, reversibility has been reported with insufficiency from acute rheumatic valve 
disease resolving in 60-80% of patients who adhere to antibiotic prophylaxis (Chin 2010). 
However, other, additional influencing factors have not yet been reported, therefore, this study 
aims at defining the determinants of RHD in Egypt. 
 
6.6.1 Patients and methods 
The population recruited at the penicillin clinic and cardiothoracic department of the NHI in 
Cairo was evaluated as described in chapter 3, pg. 78 to determine the factors influencing RHD. 
 
The study population consisted of: 
 Group I: -Individuals with a positive history of RF visiting the centre for penicillin  
                prophylaxis with or without cardiac involvement 
-Individuals visiting the NHI outpatient clinic for suspicion of RF or RHD  
 Group II: Patients admitted for RHD and scheduled for valve replacement.  
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6.6.2 Results 
In total, we analyzed the data of 639 individuals, excluding individuals with a history of valve 
replacement.  
 
Age: The individuals that had structural (p=0.002) as well as functional (p=0.00) and RHD 
affection (p=0.00) of the cardiac valves tended to be older at the time of screening.  
All individual with functional affection tended to be older at the time of assessment. The 
significance was as follows: mitral regurgitation (p=0.00), mitral stenosis (p=0.00), aortic 
regurgitation (p=0.00), aortic stenosis (p=0.00), tricuspid regurgitation (p=0.00), tricuspid 
stenosis (p=0.002). Furthermore, individuals that developed functional or RHD affection of the 
heart valves tended to be younger at the time of follow-up (p=0.021 and p=0.045, respectively) 
while individuals that sustained characteristics of RHD at the time of follow-up tended to be 
older at the time of screening (p=0.037). 
 
Gender: There was a slight female predominance (50.8%, n=269) in the group diagnosed with 
structural affection (p=0.033) while there was a slight predominance of males (50.5%, n=231) in 
the group diagnosed with functional affection (p=0.011) and RHD (51.3%, n=221) (p=0.004) 
(Figure 6.72). 
 
Figure 6.72 Difference in affection between the gender 
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Affection of the mitral and aortic valve was more common in females, found in 41.9% (n=98) 
and 4.3% (n=10) of the females while a combination of mitral and aortic valve 24.9% (n=60) and 
aortic and tricuspid valve affection (1.7%, n=4) was more common among males (p=0.036) 
(Figure 6.73). 
 
Figure 6.73 Distribution of valvular affection by gender 
 
There was a slight male predominance in the maintenance of the functional affection (59.8%, 
n=52) and characteristics of RHD (44.8%, n=39) during follow-up (p=0.020 and p=0.032, 
respectively).  Nevertheless, there was a female predominance (45.5%, n=35) in the individuals 
that did not have characteristics of RHD during the first assessment and follow-up (p=0.017).  
 
Family history: No correlation was found between structural affection and family history of RF. 
Affection of mitral (51.9%, n=41) as well as a combination of the mitral and aortic valve 
affection (25.3%, n=20) was more common in patients with a positive family history of RF 
(p=0.001). 
In patients with a negative family history of RF the most common affections were of the 
tricuspid valves (5.4%, n=19), a combination of mitral and tricuspid valve (16.9%, n=60) and 
mitral and aortic and tricuspid valve (21.8%, n=77). However, no correlation was found between 
a family history of RF and the presence of functional or RHD affection.   
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Figure 6.74 Distribution of valvular affection by history of RF 
 
History of RF: The majority of the individuals diagnosed with structural affection (86.6%, 
n=459) as well as well functional affection (84.7%, n=387) had a positive history of RF (p=0.041 
and p=0.00, respectively). Furthermore, the majority of the individuals (84.2%, n=363) 
diagnosed with RHD had a positive history of RF (p=0.00) (Figure 6.75). 
Single valve lesions were more common in patients with history of RF, while combinations of 
lesions were more common among patients without history of RF. 
Only 10.7% (n=11) of the individuals that did not undergo tonsillectomy and 28.6% (n=12) of 
the individuals that did undergo tonsillectomy did not have structural affection of the heart 
valves during the first assessment as well as the follow up (p=0.007). The majority of the 
individuals diagnosed with structural affection (80.0%, n=381) did not undergo tonsillectomy 
(p=0.050). Only a small fraction of the individuals diagnosed with RHD had undergone 
tonsillectomy (18.3%, n=72). The majority of the individuals diagnosed with RHD (81.7%, 
n=322) did not undergo tonsillectomy (p=0.006). No correlation was found between functional 
affection and tonsillectomy. 
No correlation was found between functional affection nor the diagnosis of RHD and the 
presence of carditis. However, 16.7% (n=2) of the individuals without history of RF and 3.9% 
(n=6) of the individuals with history of RF had newly developed structural affection of the heart 
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valves during follow-up (p=0.049). A small fraction of the individuals with no history of RF 
(8.3%, n=1) and 38.2% (n=58) of the individuals with history of RF did not have 
echocardiographic characteristics of RHD during the first and follow-up assessment (p=0.038).   
 
Figure 6.75 Valvular affection in the presence of RF history 
 
Age of RF: The individuals that had structural affection of the valves tended to be older at the 
time of the first RF attack (p=0.031). They also reported a longer time since the RF attack 
(p=0.00). Furthermore, individuals that remained having structural affection at the time of 
follow-up also reported RF longer time ago (p=0.032) while individuals that showed regression 
of the structural affection tended to report the RF attack a shorter time ago (p=0.050). 
Importantly, individuals with mitral stenosis were older at the time of the first RF attack 
(p=0.004). The individuals that had functional affection of the valves reported a longer time 
since the RF attack (n=0.00). Furthermore, individuals with mitral regurgitation (p=0.031), 
mitral stenosis (p=0.00), aortic regurgitation (p=0.012), aortic stenosis (p=0.00) and tricuspid 
regurgitation reported RF longer time ago (p=0.004).  
 
Recurrences: Most individuals with functional affection (56.8%, n=218), structural (57%, 
n=260) or RHD characteristics of the heart valves (55.6%, n=200) reported recurrences of RF 
(p=0.042, (p=0.006) and p=0.008, respectively). Most individuals that did not report recurrences 
of the RF symptoms (47.6%, n=30) were diagnosed with RHD during the first as well as the 
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follow up assessment while 28.9% (n=26%) of the individuals that reported recurrences were 
diagnosed with RHD at the time of the first as well the follow-up assessment (p=0.018). 
 
Type of diagnosis: The majority of the individuals diagnosed with structural affection (68.7%, 
n=364) were diagnosed by the RF symptoms while 31.3% (n=166) of the individuals were 
diagnosed by the cardiac symptoms. From the individuals diagnosed with RF symptoms 18.1% 
(n=25) did not have structural affection of the valves during the first assessment and follow-up 
(p=0.018). Most individuals diagnosed with functional affection (65%, n=297) were diagnosed 
by the RF symptoms while 35% (n=160) of the individuals were diagnosed by the cardiac 
symptoms. Nevertheless, the majority of the individuals diagnosed with RHD (63.3%, n=273) 
were diagnosed by the RF symptoms while 36.7% of the individuals were diagnosed by the 
cardiac symptoms. However, a fraction of the individuals reportedly diagnosed by cardiac 
symptoms, had no signs of structural (4.5%, n=4), functional (6.2%, n=10) or RHD affection 
(6.4%, n=12) on echocardiography and 7.7% (n=2) of the individuals diagnosed by cardiac 
symptoms remained of functional or RHD affection during the first assessment as well as follow-
up compared to 26.8% (n=37) and 41.3% (n=57) of the individuals diagnosed by RF symptoms 
(p=0.001, respectively).  
Sustenance of functional affection during follow up was seen in 69.2% (n=18) of the individuals 
diagnosed due to cardiac symptoms and 47.8% (n=66) of the individuals diagnosed by the RF 
(p=0.045). The RHD characteristics found during the first assessment resolved in 38.5% (n=10) 
of the individuals diagnosed by cardiac symptoms and in 18.1% (n=25) of the individuals 
diagnosed by RF characteristics (0.020).  
Chapter 6 Clinical characteristics & determinants of RHD in a hospital based study in Egypt 
 
203  
 
 
Rheumatic Heart Disease in Egypt 
 
 
 
Figure 6.76 Distribution of valvular lesions by diagnosis 
 
Penicillin prophylaxis: The majority of the individuals with structural (83.4%, n=427) as well as 
functional affection of the heart valves (82.5%, n=363) were on penicillin prophylaxis. On the 
other hand, the majority of the individuals on penicillin prophylaxis had structural (84.2%, 
n=427) or functional (71.6%, n=363) affection of the heart valves. Furthermore, the majority of 
the individuals not on penicillin prophylaxis were diagnosed with structural (93.4%, n=85) or 
functional affection (84.6%, n=77) of the heart valves (p=0.021 and p=0.010, respectively) 
(Figure 6.77). 
The majority of the individuals diagnosed with RHD (82.4%, n=342) were on penicillin 
prophylaxis. Most (67.5%, n=342) individuals on penicillin prophylaxis had a diagnosis of RHD 
while 32.5% (n=165) had not. Nevertheless, 80.2% (n=73) of the individuals not on penicillin 
prophylaxis were diagnosed with RHD (p=0.015). However, individuals that showed 
development of RHD at the time of screening tended to have a 21-day or monthly penicillin 
schedule (p=0.028). 
Newly developed functional affection was found in 33.3% (n=4) of the individuals not on 
penicillin prophylaxis and in 9.2% (n=14) of the individuals on penicillin (p=0.010). However, 
there was no correlation between the penicillin schedule and compliance and the presence of 
structural, functional or RHD affection of the heart valves. 
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Individuals with mitral and aortic stenosis tended to be less compliant to the penicillin 
prophylaxis (p=0.00 and 0.002, respectively) while individuals with tricuspid regurgitation and 
those that had developed structural affection at the time of follow-up tended to have a 21-day or 
monthly penicillin schedule (p=0.01 and p=0.020, respectively). 
 
Figure 6.77 Effect of penicillin prophylaxis on valvular affection 
 
Follow-up time: Individuals that sustained structural affection at the time of follow-up tended to 
have a longer follow-up time (p=0.023) while individuals that showed regression of the structural 
affection (p=0.014) or development of functional affection of the heart valves tended to have a 
shorter follow-up time (p=0.011). 
 
6.6.3 Discussion 
Variables that have been reported to correlate with severity of valve disease include the number 
of previous attacks of rheumatic fever, the length of time between the onset of disease and start 
of therapy, and gender. However, in our series, younger patients seemed to be more at risk for 
the development of structural, functional and RHD features while older patients are more at risk 
of sustaining the found RHD features which might have been developed at a younger age. 
Furthermore, it seems that RF attacks at a younger age are a risk factor for the development of 
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RHD. Nevertheless, mitral stenosis was more common in individuals reporting an older age at 
the time of the first RF attack.  
There was a slight female predominance in the group diagnosed with structural affection of the 
heart valves while there was a male predominance in the individuals diagnosed with functional 
lesions and RHD. Single valve lesions of the mitral or aortic valve were seen more often among 
females, while males tended to have combinations of valvular affection. Nevertheless, males 
tended to sustain functional features as well as the diagnosis of RHD suggesting a more severe 
course in males in contradiction with earlier reports of an increased severity in females with 
higher incidence of mitral stenosis and cardiac affection (Cole 1976, Longo-Mbenza 1998, 
Mahmudi 2006). 
Mitral valve or a combination of mitral and aortic valve affection was more common in patients 
with a positive family history of RF, while in patients with a negative family history there was 
more affection of the tricuspid valve, alone or in combination with mitral and/or aortic valve. 
This could indicate that familiar predisposition for RF affects the phenotype of the valvular 
affection.  
The majority of the individuals with structural and RHD affection reported recurrences of RF 
suggesting its role in RHD. However, there was no relationship between the presence of 
recurrences and the development or reversibility of the valvular lesions. This is surprising as 
recurrences have been reported to be a risk factor for the development of mitral stenosis (Thomas 
1971) and the severity of valve regurgitation has been shown to be greater in recurrences of 
carditis, possibly owing to repeated attacks of valvulitis that culminate in greater valvular 
damage and due to the self-perpetuating nature of regurgitant lesions (Vasan 1996) leading to 
worsening of rheumatic valve affection (Jaffe 1988, Vasan 1996, Carapetis JR 2000) and the 
development or deterioration of RHD (Bisno 2005, Carapetis 2005
2
, McDonald 2005, 
Manyemba 2003). However, it has also been suggested that valvular lesions may progress 
despite the lack of symptomatic recurrence (Tompkins 1972). 
Individuals diagnosed by cardiac symptoms were more likely to sustain the found functional 
affection. Importantly, a longer time since the first RF attack seems to be an indicator for 
sustenance of structural and structural affection while a shorter time seems to be a good 
prognostic factor for reversibility of the features. This is logic as lesions present for a longer time 
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tend to be sustained while the lesions that were more prominent to resolve would have done so a 
longer time ago. Furthermore, structural features seem more prone to resolve than functional 
lesions, especially short after the development.  
 
A fraction of the individuals reportedly diagnosed due to cardiac symptoms did not have sign of 
any cardiac affection during the first assessment as well as during follow-up. This might suggest 
that in this group the RHD characteristics had resolved in the time between the cardiac diagnosis 
and our first assessment. However, a diagnosis of RF based on cardiac symptoms is a risk factor 
for sustenance of functional valvular affection which might suggest that clinical functional 
affection is less probable to resolve after established. The fact that the cardiac diagnosis of RF 
seems to correlate with reversibility of the features leading to the diagnosis of RHD might be due 
the disappearance of the structural features, as the functional affection tend to persist. However, 
this might also indicate that diagnosis leads to medical treatment and the use of penicillin 
prophylaxis and contributes therefore to the reversibility of the cardiac lesions.  
Importantly, the majority of the individuals with structural, functional affection or RHD were on 
penicillin prophylaxis and there was no correlation between the penicillin schedule and 
compliance and the presence of valvular affection. However, individuals not on penicillin 
prophylaxis had more often structural and functional affection of the heart valves and the 
diagnosis of RHD.  
Furthermore, a penicillin schedule of 21-days or 1 month was related to development of 
structural features and RHD and non-compliance to prophylaxis was related to development of 
functional affection. This was expected as a 21-day or monthly penicillin schedule was shown to 
be a risk factor for the development of structural and RHD features, which enforces the view that 
a 15-day penicillin prophylaxis should be encouraged. Furthermore, cessation of penicillin 
prophylaxis is a risk factor for the development of functional valvular lesions which is logic as 
secondary penicillin prophylaxis has been shown to prevent development and worsening of RHD 
(Veasy 1997, Majeed 1992). Nevertheless, mitral and aortic stenosis was related to non-
compliance to penicillin prophylaxis. Therefore, we reinforce the opinion that non-compliance to 
penicillin prophylaxis is a risk factor for the development of RHD and highlight the focus on 
adherence to secondary prophylaxis regimens with long-term, regular delivery of penicillin to 
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patients with RHD or a history of RF to prevent recurrences of the attacks and the worsening of 
valve lesions. Importantly, most individuals diagnosed with RHD had poor disease awareness, 
which especially in the form of a missing history of RF was shown to be a risk factor for the 
development of structural features and for sustaining the diagnosis of RHD. This might suggest 
that individuals that are not aware of RF do not receive the needed treatment and prophylaxis and 
are therefore more at risk for the development and progression of RHD. 
 
6.7 Conclusions 
In conclusion, we have shown that in Egypt functional affection tends to develop more often and 
is also more difficult to resolve than structural features. In Egypt, cardiac affection seems more 
severe in males as there is a male predominance in the individuals with functional and RHD 
characteristics, showing also an increase in the amount of mixed lesions. Young age at the time 
of presentation as well as at the time of the first RF attack is related to a tendency of 
development of structural as well as RHD features. Meanwhile, older patients diagnosed with 
RHD tend to sustain the valvular affection. The longer ago the first RF attack, the less probable it 
is that the valvular affection will resolve. Furthermore, clinical functional affection is less likely 
to resolve.  
Patient information is highly desired in Egypt as a lower disease awareness and non-compliance 
to penicillin result in the development of structural as well as functional valvular lesions and 
sustenance of RHD features. Our series confirms the predominance of mitral valve affection, 
with regurgitation being the most common feature. However, in RHD, combination of lesions is 
more predominant. Nevertheless, the amount of mitral stenosis was comparable to earlier studies.   
The presented results also confirm the need to encourage a penicillin regimen of 15-days in 
Egypt, as a longer interval between the injections was shown to be a risk factor for the 
development of structural and RHD features. Long-term follow-up is necessary, nonetheless, to 
determine the outcome in young children with subclinical echocardiographic evidence of valvar 
disease. The serial use of echocardiography in patients with RHD is helpful in finding the 
progression or regression of the disease and will help us determine the development, 
characteristics, progression and reversibility of valvular lesions.  
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7.1 Background  
Different infection parameters are used to confirm the suspicion of RF differentiating between 
general infection parameters and streptococcal specific parameters. The initial routine laboratory 
assessment consists of the major inflammatory parameters and acute phase indicators such as 
ESR and CRP which correlate with the magnitude and severity of inflammation as well as 
disease activity (Lane et al, 2002, Wagner-Weiner 2002). The ESR and CRP are both used in the 
diagnosis of RF in the Jones criteria however, the levels and distribution of these infection 
parameters in different areas, as a response to RF, especially in a quiescent phase of the disease 
is unknown. A major role is suggested for inflammatory cytokines in mediating RF and RHD 
(Guilherme 2009) as they appear  to  play  a  crucial  role  in  triggering immunologic  and  
inflammatory  reactions  in  RF and have been shown in peripheral blood of acute RF and active 
RHD patients (Yegin 1997, Miller 1989, Morris 1993, Narin 1995, Samsonov 1995) as well as 
valvular tissue, suggested to mediate the heart lesions (Guilherme 2009). 
 
Furthermore, cellular infiltration with a predominance of CD4
+
 T-cells (Guilherme 1995) and 
some CD8
+
 T-cells is found in patients that present rheumatic activity (Guilherme 2001). 
However, the immune response and signs of immune activation vary showing different 
characteristics of the cellular as well as the humoral response.  
We hypothesized that there is still an ongoing immunological reaction in apparently quiescent 
phase of the disease and therefore the inflammatory parameters are expected to remain raised in 
RF and RHD. The aim was to analyze the inflammatory parameters and presence of pro- and 
anti-inflammatory cytokines to evaluate the signs of immune activation in RF and RHD in Egypt 
for the recognition of potential inflammatory parameters to monitor RF activity and determine 
the role of inflammatory cells and cytokines in mediating RF and RHD. 
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7.2 Haemal immune response in RF and RHD 
7.2.1 Patients and methods 
Individuals visiting the outpatient clinic or admitted at the Cardio-thoracic department of the 
NHI were recruited as described in chapter 3, pg. 75.  
 
The study population consisted of: 
 Group I: -Individuals with a positive history of RF visiting the centre for penicillin  
                prophylaxis with or without cardiac involvement 
-Individuals visiting the NHI outpatient clinic for suspicion of RF or RHD  
 Group II: Patients admitted for RHD and scheduled for valve replacement.  
 
Blood sample collection and assays 
Blood was collected by venipuncture into 1 siliconised EDTA, 1 non-additive and 1 citrate ESR 
tube as described in chapter 3, pg 88. A complete CBC, ESR analysis, qualitative determination 
and semi-quantitative determination of the ASOT and CRP was done. Serum and plasma was 
obtained and stored. 
 
Analysis of blood samples 
Complete blood count (CBC): Analysis was performed by Sysmex KX-21N (Automated 
Hematology Analyzer, SYSMEX CORPORATION). Parameters in whole blood mode included 
the CBC (WBC, RBC, HGB, HCT, MCV, MCH, MCHC, PLT) and a 3-Part Differential 
leukocyte count (Lymph %, #, Neut %, #, Mixed %,#).  
 
ESR analysis: The ESR analysis was performed following the Wintrobe method.  
A calibrated Wintrobe tube graduated from 0-100mm (0-10cm) and with a capacity of 1 ml of 
blood was placed in a sedimentation rack and filled to the 0 mark with 1 ml of well-mixed 
anticoagulated blood (collected in a ESR citrate tube) using a long-stemmed pipet and left to 
incubate in a vertical position for exactly one hour. At the end of one hour, the distance the 
erythrocytes have fallen from the plasma meniscus (at the zero mark) in the blood samples is 
measured and recorded in millimeters (mm) using the markings on the tube. 
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ASOT- Latex Test: The manual ASOT-Latex Test is an agglutination test for the direct 
qualitative and semi-quantitative detection of clinically significant levels of anti-streptolysin O 
antibodies (ASO) in human serum which are produced by growing strains of Group A 
haemolytic streptococci (and by most strains of groups C and G). The assay is performed by 
testing a suspension of latex particles coated with streptolysin O antigen against unknown serum. 
The presence or absence of a visible agglutination, indicates the presence or absence of ASO in 
the samples tested. The reagent is adjusted in the way that presence of an ASO title of 200 
IU/mL or higher in the serum gives a visible agglutination of the latex particles without previous 
sample dilution.  
 
Qualitative determination 
 One drop of reagent was placed on the field of the slide 
 One drop of undiluted serum was added with a pipette  
 The drops were mixed well with the flat end of the pipette 
 The slide was rocked for 2 minutes 
 Result was read immediately under direct light 
 In case of positive test, a semi-quantitative test was performed 
 
Semi-quantitative determination 
 Dilutions (1:2, 1:4, 1:8, 1:16, 1:32) of the positive samples were prepared with 0.9% of 
sodium chloride solution (saline)  
 One drop of reagent was placed on the field of the slide 
 One drop of diluted serum was added with a pipette  
 The drops were mixed well with the flat end of the pipette 
 The slide was rocked for 2 minutes 
 Result was read immediately under direct light 
 The serum titer was defined as the highest dilution showing a positive result. 
 The ASO concentration was then be estimated from the last dilution with visible 
agglutination. The approximate ASO concentration was obtained by multiplying the titer 
by the limit of sensitivity (200 IU/mL)  
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CRP Latex Test: The CRP Latex test is based on the immunologic reaction between the CRP and 
the corresponding antibody coated on the surface of latex particles. The CRP reagent contains 
polystyrene latex particles coated with human anti CRP antibody. When the reagent is mixed 
with serum containing CRP at a level equal or greater than 6 mg/l, the particles agglutinate 
without previous sample dilution. A smooth homogenous milky suspension indicates a CRP 
concentration of less than 6 IU/ml (as observed with the negative control). Agglutination 
indicates a CRP content more than 6 IU/ml.  
 
Qualitative determination 
 One drop of reagent was placed on the field of the slide 
 One drop of undiluted serum was added with a pipette  
 The drops were mixed well with the flat end of the pipette 
 The slide was rocked for 2 minutes 
 Result was read immediately under direct light 
 In case of positive test, a semi-quantitative test was performed 
 
Semi-quantitative determination 
 Dilutions (1:2, 1:4, 1:8, 1:16, 1:32) of the positive samples were prepared with 0.9% of 
sodium chloride solution (saline)  
 One drop of reagent was placed on the field of the slide 
 One drop of diluted serum was added with a pipette  
 The drops were mixed well with the flat end of the pipette 
 The slide was rocked for 2 minutes 
 Result was read immediately under direct light 
 The serum titer was defined as the highest dilution showing a positive result. 
 The CRP concentration was then be estimated from the last dilution with visible 
agglutination. The approximate CRP concentration may be obtained multiplying the titer 
by the limit of sensitivity (6 mg/L) 
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Cytokine Luminex assay:  
Serum samples: Serum samples require a 4-fold dilution. However, after several trials we have 
decided to use neat serum due to low concentrations of the cytokines. 
 
Standards: The standards were made of standard Cocktails 1 and 2 with Calibrator Diluent RD6-
40 (for serum samples). They were allowed to sit for a minimum of 15 minutes with gentle 
agitation prior to making dilutions. 
 
Assay procedure: The filter-bottomed microplate was pre-wet by filling each well with 100 μL 
of Wash Buffer. The liquid was removed through the filter at the bottom of the plate using a 
vacuum manifold designed to accomodate a microplate. A diluted microparticle mixture was 
resuspend by vortexing andv50 μL of the microparticle mixture was added to each well of the 
microplate. 50 μL of Standard or sample was added per well and incubate for 3 hours at room 
temperature on a horizontal orbital microplate shaker (0.12‖ orbit) set at 500 ± 50 rpm.  Each 
well was filled with Wash Buffer (100 μL) and using a vacuum manifold device designed to 
accommodate a microplate, the liquid was removed. This wash procedure was performed 3 
times. 50 μL of diluted Biotin Antibody Cocktail was added to each well and left to incubate for 
1 hour at room temperature on the shaker set at 500 ± 50 rpm. The wash procedure was repeated 
3 times. 50 μL of diluted Streptavidin-PE was added to each well and incubated for 30 minutes at 
room temperature on the shaker set at 500 ±  50 rpm followed by 3 washings. The microparticles 
were resuspend by adding 100 μL of Wash Buffer to each well and left to incubate for 2 minutes 
on the shaker set at 500± 50 rpm. The results were read within 90 minutes using a Luminex 
analyzer. 
 
Statistical analysis 
The statistical analysis was performed as described in chapter 3, pg 100.  
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7.2.2 Results 
7.2.2.1 Inflammatory parameters in RF and RHD 
A total of 309 blood samples were collected from the individuals recruited. A raised WBC of 
>11 K/uL was found in 10.3% (n=35) and a raised lymphocyte count of >4 was found in 49.5% 
(n=164) of the individuals. 
An RBC <4 M/uL was found in 10.5% (n=35) of the individuals. An HGB <12 g/dL was found 
in 42.5% (n=134) of the individuals, with 18.4% (n=61) showing an MCV <76.0 fL and 51.2% 
(n=162) with an MCH <27.0 pg. 2.56% (n=8) of the individuals had an HGB <9 g/dL. A PLT 
count <140 K/uL was found in 5.4% (n=18), while 2.1% (n=7) had a PLT count >450 (Table 
7.1). 
 
Table 7.1 CBC results 
 Mean ± SD range 
WBC 7.63 ± 3.35 3.20-28.80 
LYM 18.90 ± 18.61 1.20-61.70 
MID 0.55 ± 0.22 0.30- 1.40 
GRAN 4.68 ± 3.48 0.90- 18.0 
RBC 4.65 ± 0.63 2.34- 6.96 
HGB 12.23 ± 1.60 7.0- 16.10 
HCT 37.10 ± 4.79 20.0- 48.40 
MCV 80.08 ± 6.63 51.20-93.50 
MCH 26.43 ± 2.82 16.20- 32.60 
MCHC 33.03 ± 1.61 28.00-43.50 
RDW 15.80 ± 14.21 11.90-262.00 
PLT 255.01 ± 84.78 66.00- 756.00 
MPV 4.42 ± 5.52 7.20-13.30 
   
ESR 29.28 ± 26.22 2.0-132.00 
ASOT 74.91 ± 124.155 0-800 
CRP 7.92 ± 20.48 0-96.00 
 
A positive CRP (≥ 12 IU/ml) was seen in 16.6% (n=51) of the individuals. Most individuals 
(65%, n=199) had a negative CRP (Table 7.2). 
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Table 7.2 CRP results 
CRP  
0 65% (n=199) 
6 18.3% (n=56) 
12 6.5% (n=20) 
24 3.6% (n=24) 
48 2.3% (n=7) 
96 4.2% (n=13) 
 
30.6% (n=95) of the individuals had an ESR ≤10 mm/h, while 20.5% (n=64) had an ESR 
between 11 and 20 mm/h. In total, 51.1% (n=159) of the individuals had an ESR ≤20 mm/h. 
 
7.2.2.2 Relation between inflammatory parameters 
The relation between the ESR rate and CRP and the WBC, LYM count, RBC, HGB and HCT is 
described in Table 7.3. No correlation was found between the ASOT and the WBC, the LYM 
count, RBC count, HGB and HCT.  
 
Table 7.3 Relation between inflammatory parameters 
 Increase  Decrease  
ESR WBC  (p=0.00) LYM   
RBC  
HGB  
HCT  
(p=0.029) 
(p=0.00) 
(p=0.00) 
(p=0.00) 
CRP WBC  
ESR  
(p=0.00) 
(p=0.00) 
LYM  
RBC  
HGB 
HCT  
(p=0.034) 
(p=0.02) 
(p=0.00) 
(p=0.01) 
 
7.2.2.3 Cytokine parameters in RF and RHD 
The serum cytokine levels were as indicated in Table 7.4 and the relation between the cytokines 
is described in table 7.5.  
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Table 7.4 Cytokine levels 
 Mean ± SD 
pg/mL 
Minimum 
pg/mL 
Maximum 
pg/mL 
Normal values 
pg/mL* 
IL-1b  0.22 ± 0.68 0.01 8.17 0.16 ± 0.17 
Il-1ra 803.5 ± 1677.6 0.02 15825.7 829 ± 292 
IL-2 0.25 ± 0.18 0.10 1.97  
IL-4 0.30 ± 0.58 0.01 2.26 3.34 ± 0.84 
IL-6 0.92 ± 2.66 0.01 26.54 0.39 - 12.3 
IL-8 4.99 ± 14.57 0.01 117.8 9.51 
IL-10 0.57 ± 0.43 0.04 2.02 9.2 ± 1.5 
TNF-α 0.67 ± 0.74 0.10 4.41 2.03 - 10.5 
* Reported in earlier studies 
 
Table 7.5 Relation between cytokines 
 Increase  Decrease  
IL-1b IL-2 
IL-6 
TNF-α 
(p=0.00) 
(p=0.00) 
(p=0.035) 
IL-1ra  
IL-10 
(p=0.00) 
(p=0.00) 
IL-1ra IL-4 
IL-8 
IL-10 
TNF-α 
(p=0.00) 
(p=0.00) 
(p=0.00) 
(p=0.00) 
IL-2  
IL-6 
 
(p=0.00) 
(p=0.00) 
 
IL-2 IL-6  (p=0.00) IL-4  
IL-10 
(p=0.00) 
(p=0.00) 
IL-4 IL-8  
IL-10 
TNFa 
(p=0.00) 
(p=0.00) 
(p=0.00) 
IL-6  
 
(p=0.00) 
 
IL-6 TNFa  (p=0.00) IL-10  (p=0.00) 
IL-8 TNFa  
IL-10 
(p=0.00) 
(p=0.00) 
  
 
 
7.2.2.4 Factors influencing the haemal parameters in RF and RHD  
No correlation was found between the level of cytokines found in the serum and the gender, 
family history for RF, the age of the RF attack, the penicillin schedule and compliance was not 
related to the serum cytokine level.  
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Age: Older patients had a higher WBC count (p=0.005), ESR (p=0.00), CRP (p=0.045) as well 
as a higher IL-1b (p=0.027), IL-2 (p=0.002) and IL-6 (p=0.00). However, older patients had a 
lower the platelet count (p=0.001) Furthermore, there was no correlation between the age and the 
ESR, LYM count, RBC count, HGB and HCT. 
 
Gender: Males had higher blood hemoglobin (p=0.000) and hematocriet (p=0.001) than females. 
35.5% (n=54) of the males and 56.2% (n=90) of the females had a hemoglobin ≤12 g/dL. 3.2% 
(n=5) of the males and 1.8% (n=3) of the females had a hemoglobin ≤9 g/dL. Females tended to 
have a higher ESR (p=0.005) and platelet count (p=0.018) than males. No correlation was found 
between the gender and the WBC, lymphocyte count, MCV and ASOT. 
 
History of RF: Individuals with a positive history of RF had a higher lymphocyte count 
(p=0.038) and platelet count (p=0.00). No correlation was found between a history of RF and the 
WBC, hemoglobin, hematocriet, MCV, ESR, ASOT and CRP. A correlation was found for a 
positive history of RF was IL-6 (p=0.010) as patients with a positive history of RF showed lower 
levels of IL-6. 
 
Date of RF: A positive correlation was found between the WBC count and the date of the first 
RF attack (p=0.032). The longer ago the first RF attack was the higher the WBC count. There 
was no correlation between the date of the first RF attack and the ESR, LYM count, RBC count, 
HGB and HCT. There was also no correlation with the CRP. 
A correlation was found between the ASOT and the date of RF onset. The less time since the RF 
attack the higher the ASOT (p=0.004). The longer ago the RF attack had been the higher the IL-
1b (p=0.012), the IL-2 (p=0.008) and the IL-6 (p=0.020). 
 
Familial predisposition: Individuals with a negative family history for RF tended to have a 
higher hemoglobin (p=0.043) and hematocriet (p=0.034). No correlation was found between the 
family history for RF and the WBC, lymphocyte count, MCV, platelet count, ESR, ASOT and 
CRP. 
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Recurrences: Individuals who reported recurrences of RF tended to have a lower WBC 
(p=0.009) than those who did not. No correlation was found between the presence of recurrences 
of RF and the other inflammatory and streptococcal parameters. Individuals that reported 
recurrences showed a lower IL-1b (p=0.027), IL-2 (0.003), IL-6 (p=0.005) and TNFa (p=0.015). 
 
Diagnosis: Individuals who were diagnosed by the RF symptoms tended to have a higher 
lymphocyte (p=0.010) and platelet count (p=0.001) and a lower CRP (p=0.044) than those 
diagnosed by the cardiac symptoms. Individuals that were diagnosed by RF symptoms had lower 
IL-6 levels (p=0.039). There was no correlation between the type of diagnosis and the ESR nor 
the ASOT. 
 
Prophylaxis: Individuals on penicillin prophylaxis tended to have a lower WBC (p=0.037) and 
CRP (p=0.013) and a higher platelet count (p=0.00). No correlation was found between the use 
of penicillin prophylaxis and the other inflammatory and streptococcal parameters. There seemed 
to be a correlation between the compliance to the prophylaxis and the platelet count (p=0.004), 
with individuals with a higher compliance showing higher platelet counts. Patients on penicillin 
prophylaxis had a lower of serum IL-6 (p=0.021). 
 
7.2.3 Discussion 
Inflammatory parameters 
The inflammatory parameters are affected by many factors including the patient‘s age, gender, 
dietary options, medication, etc (Lane 2002). Our series shows a raised WBC in 10.3% and a 
raised lymphocyte count in 49.5% of the individuals screened. The raised WBC, known as 
leukocytosis is a sign of infection and a raised lymphocyte count, lymphocytosis, is usually a 
sign of a viral infection and has also been shown in 84% of the ARF patients (Mahmudi 2006). 
Penicillin is known to lower leukocyte count, which means that in the absence of penicillin 
prophylaxis the lymphocytosis would have been expected to be higher. 
  
Leukocytosis with neutrophilia and mild to moderate anaemia are found in inflammation and 
concurrent anaemia has been reported to be found in up to 62% of the ARF cases (Mahmudi 
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2006) and 8% of the cases of newly diagnosed RHD. (Sliwa 2010) In our series 42.5% of the 
individuals had an HGB <12 g/dL with 18.4% showing an MCV <76.0 fL and 51.2% with an 
MCH <27.0 pg. 
The most common causes of microcytic anemia are iron deficiency due to inadequate dietary 
intake or chronic disease. The MCH value is diminished in hypochromic anemias mainly caused 
by vitamin B6 deficiency from a low iron intake, diminished iron absorption, or excessive iron 
loss. Nevertheless, anemia can also be caused by infections or other diseases and therapeutic 
drugs. The found anemia could however not be caused by the penicillin prophylaxis, which is 
known to cause hemolytic anemia and therefore macrocytic changes of the RBC. Importantly, 
concurrent anaemia has been reported in combination with RHD (Sliwa 2010). In our series, 
anemia was more common among females, as 56.2% had an HGB ≤12 g/dL, however, males 
tended to have more often a more severe anemia with 3.2% showing HGB ≤9 g/dL. A small 
number of individuals (2.56%, n=8) had an HGB ≤9 g/dL which is usually associated with 
severe carditis.     
A normal platelet count in a healthy individual is between 150 and 450 K/uL. In our series a PLT 
count <140 K/uL was found in 5.4%, while 2.1% had a PLT count >450. Low platelet counts 
may be caused by systemic viral or bacterial infection and increases bleeding risks.  
Penicillin is known to impair and inhibit platelet function by inhibiting platelet aggregation 
response and release reaction as it inhibits some essential mechanisms involved in platelet 
activation. However, penicillin is not known to influence the platelet count (Schulz 2010, Rao 
1983). 
 
The normal upper limit of ESR for persons aged 50 years and younger is 15 mm/h in men and 20 
mm/h in women with a mean of normal values around 9.6 mm/h for men and 10.4 mm/h for 
women younger than 20 years (Volanakis 2001). Acute phase reactants are always elevated at 
the onset of acute RF and the erythrocyte  sedimentation  rate  (ESR)  is  elevated  in  the  first  
weeks  of  the  disease. Elevated ESR (>40 mm/hr) has been reported in up to 90% of the ARF 
cases (Mahmudi 2006) with higher levels among patients with cardiac involvement. In our 
series, 48.9% of the individuals screened had a positive ESR with a mean of 29.28 mm/h (Shearn 
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1986), showing that there is a remaining acute phase inflammation as the ESR correlates with 
increased levels of acute phase reactants, in particular, fibrinogen.  
 
The C-reactive protein (CRP) is elevated at the onset of the acute phase and tends to disappear at 
the end of the second or third week; however both ESR and CRP are affected by anti-
inflammatory medications. A positive CRP has been found in up to 85% of the ARF patients and 
in 16.6% of the individuals screened in our series. The mean CRP was 7.92 IU/ml, showing a 
mild magnitude of the inflammation and disease activity. This may be the result of the latent 
period since the RF attack or the treatment and penicillin prophylaxis, as CRP levels change 
quickly in response to inflammation and fall quickly with appropriate treatment bearing in mind 
that 84.4% (n=521) were on prophylaxis. However, 11.3% of the individuals reported the RF 
attack being in the last 2 months, while 48.5%, and 68.5% were in the last 12 and 24 months, and 
most individuals reported recurrences of RF which may explain the found elevated ESR and 
CRP. 
 
Elevated or rising ASO titers provide reliable confirmation and identification of a recent 
preceding GAS infection in patients suspected of RF as these titers rise approximately 1 week 
and peak 3 to 6 weeks after the infection and may persist for several months after even 
uncomplicated GAS infections. However,  approximately  20%  of  patients  with  RF  may  not  
have  this  antibody, although raised ASO titers have been shown to be elevated in 87% of the 
ARF patients (Mahmudi 2006). The fact that only 30.9% of the screened individuals in our series 
had raised ASO titers might be due to the fact that the majority of the RF attacks had been 
months ago and the titers might have resolved and the fact that over 80% of the individuals were 
on penicillin prophylaxis. 
 
Our series shows that a higher LYM and RBC count, HGB and HCT is related to a lower ESR 
and CRP. A higher CRP was related to a higher ESR, which was expected as the ESR as well as 
the CRP are indicators of inflammation and a relationship between the findings is obvious. The 
age of the patient was also related to the inflammatory parameters with older patients showing a 
higher WBC count, ESR and CRP and a lower platelet count. These results are surprising as only 
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the ESR is known to be related to age, being higher in patients older than 50 years. As expected, 
males had higher blood hemoglobin and hematocriet than females. However, females tended to 
have a higher ESR and platelet count than males. The ESR is known to be higher in women than 
in men but there is no gender difference in the platelet count. 
 
Individuals with a positive history of RF had a higher lymphocyte and platelet count. The high 
lymphocyte count is a result of the inflammatory process, but the raised platelet count cannot be 
explained by a history of infection. A longer time since the first RF attack was related to a higher 
WBC count. This is contradictory to our expectations, as the WBC is supposed to lower after the 
acute inflammatory event. Importantly, the shorter the time since the RF attack the higher the 
ASOT, which is logic as the ASOT lowers after the infection while remaining positive for 
several months. 
Penicillin prophylaxis seems to result in a lower WBC and CRP and a higher platelet count and a 
better compliance to the prophylaxis also tends to result in a higher platelet count. Individuals 
who reported recurrences of RF tended to have a lower WBC than those who did not. This is 
strange because the WBC would be expected to be higher as a result of recurrences of the 
inflammatory process.   
Individuals who were diagnosed by the RF symptoms tended to have a higher lymphocyte and 
platelet count and a lower CRP than those diagnosed by the cardiac symptoms.  
Meanwhile, individuals with structural and RHD features tended to have a lower platelet count. 
The finding of structural or cardiac affection seems therefore, to be related to a lower platelet 
count which is dependent on the use and compliance to the penicillin, suggesting that non-
compliance is a risk factor for both. Importantly, individuals with a lower ASOT level tended to 
remain free of structural affection of the valves during follow up.  
 
Furthermore, reversibility of functional affection is related to a lower WBC which is related to 
the age, the time since the RF attack and the use of penicillin, therefore it seems that younger 
age, a shorter time since the RF attack and use and compliance to penicillin are promoters for 
reversibility of functional affection. Strangely, individuals with a higher WBC tended to remain 
free of functional affection at the time of follow-up (p=0.003). 
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In conclusion, a lower platelet count seems to be a risk factor for cardiac affection and the 
presence of structural features and the diagnosis of RHD and a high ASOT seems also to be a 
risk factor for valvular affection. Reversibility can be expected in individuals with a lower WBC, 
which can be achieved by use and better compliance to the penicillin prophylaxis. Meanwhile, 
non-compliance or a lower compliance to the penicillin prophylaxis is a risk factor for the 
presence of structural features.  
 
Haemal cytokine profile 
The levels of IL-1 found in our series is comparable to earlier studies in healthy controls. This is 
strange as IL-1 has been reported to increase during active rheumatic carditis (Morris 1993), 
persisting for up to 48 weeks (Miller 1989) and in ARF and RHD patients (Morris 1993) which 
can be explained by the clinical significance of IL-1 due to its activities as a stimulator of T-cells 
and being in combination with other cytokines an important mediator of inflammatory reactions.  
No data on IL-2 levels in serum of healthy controls has been found, but we believe that plasma 
levels are comparable to serum. Therefore, the significantly lower IL-2 levels compared to 
healthy controls is surprising (Mazzone 1999) especially because IL-2 plays a role in anti-
inflammatory reactions and has been reported to be increased in ARF and RHD patients (Yegin 
1997). 
We have found lower levels of IL-4 compared to healthy controls. Importantly, IL-4 is of clinical 
importance in inflammatory diseases and autoimmune diseases since it inhibits the production of 
inflammatory cytokines such as IL-1, IL-6 and TNF-α by monocytes and of TNF by T-cells. In 
addition, the lack of IL-4 in valvular tissue has been suggested to perpetuate and/or exacerbate 
the production of inflammatory cytokines TNF-α and IFN-γ (Guilherme 20053). However, in our 
series, most of the cytokine levels were lower than reported in control subjects.   
The IL-6 levels found in our series is in the range reported in healthy controls, although a very 
wide range from 0.39 up to12.3 pg/mL has been reported (Morikawa 2003, Yoshida 2002, Straub 
2000, Özbek 2003, Grey 1996, Al-Awadhi 1999, Bas 2004, Steddon et al, 2004). 
The found IL-8 was significantly lower than the average serum levels reported in controls 
(Özbek 2003). This was not expected as significant  elevations  in  the  plasma  levels  of  IL-8 
have been observed  in  active  phase  of  RHD  patients suggesting that IL-8 might have a role in 
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the pathogenesis of RF (Yegin 1997). Furthermore, IL-8 is believed to be a marker for different 
inflammatory processes as it directly affects B-cells through a specific mechanism that is 
different from IFN-γ and IFN-α.  
TNF-α levels were significantly lower in our series (Elkind 2002, Wang 2003, Erdem 2003, 
Mizia-Stec 2003, Halasz 2003, Diez 2002, Yoshida 2002, Mishima 2001, Wang 1999, Özbek 
2003, Grey 1996, Celik 1995, Kalt 2006) which is surprising as TNF-α mediates part of the cell 
mediated immunity against obligate and facultative bacteria and parasites and is required for 
normal immune responses and has been reported to be elevated in patients with ARF (Narin 
1995, Samsonov 1995, Yegin 1997, Miller 1989, Morris 1993, Narin 1995, Yegin 1997) and 
RHD. Furthermore, TNF-α is suggested to play an important role in the initiation of 
multisystemic inflammatory response in RF and in the pathogenesis of RHD (Yegin 1997, Settin 
2006). 
In our series, only IL-6 and IL-10 levels were in the range reported in healthy controls 
(Andersson 2000, De Vita 2000), which might suggest that they are elevated in comparison to 
the other cytokines.  
 
The surprising low levels of cytokines found in our series, especially IL-2, IL-4, IL-8 and TNF-a 
might suggest that decreased levels of these cytokines mediates rheumatic lesions. We expected 
IL-1, IL-6 and TNF-α to be increased as they are believed to be produced to eliminate the 
bacteria (Ramasawmy, unpublished observations) and an increase of TNF-a, IL-1 and IL-2 has 
been described in the peripheral blood of acute RF and active RHD patients (Miller 1989, Morris 
1993, Narin 1995, Samsonov 1995, Yegin 1997). 
Nevertheless, IL-6 and TNF-α are considered well-known inducers of acute phase reactants and 
show significant correlation with the C-reactive protein (CRP) and erythrocyte sedimentation 
rate (ESR) (Yegin 1997). TNFa levels have also been shown to correlate with the IL-6 levels and 
have been suggested to be the major cytokine in RF leading to IL-6 and IL-8 production (Yegin 
1997). However, in a previous study in Egypt, no increase in the production of IL-6 and IL-10 
was found in acute rheumatic carditis (Hafez 2001).  
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7.3 Valvular immune activation in RF and RHD 
7.3.1 Patients and methods 
Individuals admitted at the Cardio-thoracic department of the NHI, Imbaba, Cairo and scheduled 
for valve replacement due to RHD were recruited as described in chapter 3, pg. 75. 
 
Sample collection 
Excised valves from the individuals requiring valve replacement were collected during the 
procedures. The valvular tissue was stored in formalin directly after collection and then 
embedded in paraffin. The samples were transported to the HSC for histology and 
immunohistochemistry analysis. 
The condition of the normal valves is expected to be the same and there was no significant 
difference in the results found. We have therefore reported the combined results for an easier 
overview and comparison of the results. The reason that we have only used 2 control valves is 
due the fact that it is very difficult to collect healthy human valvular tissue.  
 
Immunohistochemistry Analysis 
Immunostaining of the valves for determination of inflammatory cells, ECM proteins and 
cytokine profile was
 
performed on paraffin-embedded tissues using immunoperoxidase. The 
following primary antibodies were used: CD8 (BD Bioscience), CD4 (BD Bioscience), 
Collagens I, III, IV (Novotec), NFKB (Chemicon), CD45 (Vector laboratories), CD68 (DAKO), 
IL-10 and IL-12 (Abcam).   
Prior to immunoperoxidase staining, 5m thick paraffin wax sections of decalcified non 
coronary root of heart valve tissue were dewaxed and rehydrated into water, washed in 
phosphate buffered saline (PBS) for 5 minutes, then the slides were immersed in 0.1M citrate 
buffer (pH 6) and microwaved for 10 minutes before blocking for endogenous peroxidases using 
0.3% hydrogen peroxide in PBS for 15 minutes. Sections were washed twice in PBS and blocked 
with 3% bovine serum albumin (W/V) (BSA) in PBS for 30 minutes. Sections were incubated 
separately for 1hour with primary antibodies. Negative control consisted of 3% BSA in PBS. 
Primary antibodies was then removed by washing the  sections  3 times in PBS followed by  a 
second layer of biotinylated goat anti-mouse immunoglobulins (GAM IgG-Vector laboratories) 
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diluted 1/250 in PBS for 1hour. Sections were then washed 3 times in PBS before 1 hour 
incubation with Avidin-Biotin Complex (ABC-Vector laboratories). Reactivity was detected 
using diaminobenzidine tetrahydrochloride (DAB tablets, Sigma) (25mg/ml) and hydrogen 
peroxide (0.01% W/V). Sections were then counter stained with Mayer‘s haematoxylin and 
viewed on a Ziess Axioskop microscope. Digital micrographs were taken using a Nikon 
DMX1200 camera. The samples were scored semi-quantitatively
 
for the expression of the 
antigens present within the valve
 
tissue.  
 
7.3.2 Results  
Human Rheumatic Valves and Control Valves 
Valve tissues were collected at the time
 
of surgery. We obtained 24 human rheumatic valves 
from patients (n=24, mean age,
 
35.42 years, range, 14 to 63 years, male, 13, female, 11) at
 
the 
time of surgical valve replacement. We compared them to 2 control valve tissue (n=2, gender: 
male, age: 56 and 62 years) obtained by autopsy.  
 
7.3.2.1 Inflammatory parameters in valvular tissue 
CD4
+
 
A total of 19 valves were stained for CD4
+
 which was present in all (n=19) RHD valves, ranging 
from 0 to 15 cells/mm
2
. The total density of CD4
+
 T-cells was 1.18±1.34 cells/mm
2 
in the
 
rheumatic valves and 1.95±0.63 cells/mm
2
 in control valves (p=0.9). The localization of the 
CD4
+
 was studied in 15 valves and CD4
+
 was the most prominent in the spongiosa (Table 7.6). 
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Table 7.6 Localisation of CD4+ 
  %  N 
Ventricularis 33.3%  4 
Spongiosa 100%  19 
Fibrosa 33.3%  5 
   
Localisation   
Ventricularis (only) 0%  0 
Spongiosa (only) 60%  9 
Fibrosa (only) 0%  0 
Ventricularis + spongiosa 6.7%  1 
Ventricularis + fibrosa 0%  0 
Ventricularis + spongiosa + 
fibrosa 
26.7% 4 
Spongiosa + fibrosa 6.7%  1 
 
 
Figure 7.1 CD4
+
 staining in RHD valve (E). * Fibrosa, arrow = CD4
+
 staining in spongiosa 
 
CD8
+
 
A total of 17 valves were stained for CD8
+
 which was present in 88.2% (n=15) of RHD valves, 
ranging from 0-12 cells/mm
2
. The total density of CD8
+ 
T-cells was 0.91 ± 1.30 cells/mm
2
 in the
 
rheumatic valves and 3±1.41 cells/mm
2
 in control valves (p=0.84). CD8
+
 was absent in 1 valve 
(5.9%). The localization of the CD8
+
 was studied in 12 valves, which was found predominantly 
isolated in the spongiosa (33.3%, n=4) (Table 7.7). 
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Figure 7.2 CD8
+
 staining in RHD valve (E). arrow = CD8
+
 staining in spongiosa 
 
Table 7.7 Localisation of CD8+ 
  %  N 
Ventricularis 16.7%  2 
Spongiosa 91.7%  11 
Fibrosa 58.4%  7 
 
Localisation 
  
Ventricularis (only) 0%  0 
Spongiosa (only) 33.3%  4 
Fibrosa (only) 8.3%  1 
Ventricularis + spongiosa 8.3%  1 
Ventricularis + fibrosa 0%  0 
Ventricularis + spongiosa + 
fibrosa 
8.3%  1 
Spongiosa + fibrosa 41.7%  5 
 
CD45
+
 
A total of 11 valves were stained for CD45
+
 which was present in all (n=11) RHD valves, 
ranging from 0 to 49 cells/mm
2
. The total density of CD45
+
 T-cells was 2.29 ± 2.30 cells/mm
2
 in 
the
 
rheumatic valves and 14.0±9.97 cells/mm
2
 in control valves (p=0.7). The localization of the 
CD45
+
 was studied in 8 valves, which was found predominantly isolated in the spongiosa 
(37.5%, n=3) (Table 7.8). 
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 Table 7.8 Localisation of CD45
+
 
  %  N 
Ventricularis 50%  4 
Spongiosa 100%  8 
Fibrosa 37.5%  3 
 
Localisation 
  
Ventricularis (alone) 0%  0 
Spongiosa (alone) 37.5%  3 
Fibrosa (alone) 0%  0 
Ventricularis + spongiosa 25%  2 
Ventricularis + fibrosa 0%  0 
Ventricularis + spongiosa + fibrosa 25%  2 
Spongiosa + fibrosa 12.5%  1 
 
 
 
Figure 7.3 CD45
+
 staining in RHD valve (G). arrow = CD45
+
 staining in spongiosa 
 
CD68
+
 
CD68
+
 was present in 79.2% (n=19) of the 24 valves stained, ranging from 0 to 47 cells/mm
2
. 
The total density of CD68
+
 T-cells was 5.58 ± 4.05 cells/mm
2 
in the
 
rheumatic valves and 
12.1±5.51 cells/mm
2
 in control valves (p=0.4). The localization of the CD68
+
 was studied in 10 
valves, which was found predominantly isolated in the spongiosa (37.5%, n=3) (Table 7.9). 
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Table 7.9 Localisation of CD45
+
 
  % N 
Ventricularis 50%  4 
Spongiosa 100%  8 
Fibrosa 37.5%  3 
 
Localisation 
  
Ventricularis (alone) 0%  0 
Spongiosa (alone) 37.5%  3 
Fibrosa (alone) 0%  0 
Ventricularis + spongiosa 25%  4 
Ventricularis + fibrosa 0%  0 
Ventricularis + spongiosa + fibrosa 25%  2 
Spongiosa + fibrosa 12.5%  1 
 
 
Figure 7.4 CD68
+
 staining in RHD valve (H). arrow = CD68 staining in spongiosa 
 
NFKB 
A total of 7 valves were stained for NFKB. The total density
 
of NFKB-positive cells was 
20.5±9.80 cells/mm
2
 in the
 
rheumatic valves and 19.6±15.6 cells/mm
2
 in control valves (p=0.92), 
as shown in Table 7.10.  
 
Chapter 7 Immune response in RF and RHD 
 
230  
 
 
Rheumatic Heart Disease in Egypt 
 
 
 
Figure 7.5 NFKB staining in RHD valve (I). arrow = NFKB staining 
 
Table 7.10 Summary of the found results 
Valve CD 4 CD 8 CD 45 
 
CD 68 
 
NFKB 
 
RHD 1.18±1.34 0.91±1.30 2.29 ±2.30 5.58 ±4.05 20.5±9.80 
Controls 1.95±0.63 3±1.41 14.0±9.97 12.1±5.51 19.0±15.6 
 (p-value) 0.9 0.84 0.7 0.4 0.92 
* results are presented as number of positive cells/field (MEAN±SD) 
 
IL-1α 
In the 20 valves stained IL-1α was present in 75% (n=15) with a total density of 2.56± 2.67 
cells/mm
2
 in the rheumatic valves valves. IL-1α was most found in the spongiosa (75%, n=15) 
(Table 7.11). 
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Table 7.11 Localization of IL-1α 
  % N 
Ventricularis 35% 7 
Spongiosa 75% 15 
Fibrosa 50% 10 
 
Localisation 
  
Ventricularis (only) 0%  0 
Spongiosa (only) 26.7%  4 
Fibrosa (only) 0%  0 
Ventricularis + spongiosa 6.7%  1 
Ventricularis + fibrosa 0%  0 
Ventricularis + spongiosa + fibrosa 40%  6 
Spongiosa + fibrosa 26.7%  4 
 
IL-1b 
In the 20 valves stained IL-1b was present in 90% (n=18) with a total density of 2.70 ± 2.27 
cells/mm
2
 in the rheumatic valves. IL-1α was the most found in the spongiosa and fibrosa (75%, 
n=15) (Table 7.12). 
 
Table 7.12 Localization of IL-1b 
  % (N) 
Ventricularis 65% (n=13) 
Spongiosa 75% (n=15) 
Fibrosa 75% (n=15) 
 
Localisation 
 
Ventricularis (alone) 11% (n=2) 
Spongiosa (alone) 0% (n=0) 
Fibrosa (alone) 5.5% (n=1) 
Ventricularis + spongiosa 5.5% (n=1) 
Ventricularis + fibrosa 0% (n=0) 
Ventricularis + spongiosa + fibrosa 55.6% (n=10) 
Spongiosa + fibrosa 22.2% (n=4) 
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IL-2 
In the 20 valves stained IL-2 was present in all valves with a total density of 2.93 ± 2.85 
cells/mm
2
 in the rheumatic valves. IL-2 was the most prominent in the spongiosa (95%, n=19) 
(Table 7.13). 
 
Table 7.13 Localisation of IL-2 
  % (N) 
Ventricularis 55% (n=11) 
Spongiosa 95% (n=19) 
Fibrosa 30% (n=6) 
Localisation  
Ventricularis (alone) 0% (n=0) 
Spongiosa (alone) 20% (n=4) 
Fibrosa (alone) 5% (n=1) 
Ventricularis + spongiosa 10% (n=2) 
Ventricularis + fibrosa 0% (n=0) 
Ventricularis + spongiosa + 
fibrosa 
45% (n=9) 
Spongiosa + fibrosa 20% (n=4) 
 
IL-4 
In the 20 valves stained IL-4 was present in 95% (n=19) with a total density of 1.67 ± 1.36 
cells/mm
2
 in the rheumatic valves. IL-4 was the most found in the spongiosa (95%, n=19) (Table 
7.14). 
 
Table 7.14 Localisation of IL-4 
  % (N) 
Ventricularis 50% (n=10) 
Spongiosa 95% (n=19) 
Fibrosa 55% (n=11) 
Localisation  
Ventricularis (alone) 0% (n=0) 
Spongiosa (alone) 36.8% (n=7) 
Fibrosa (alone) 0% (n=0) 
Ventricularis + spongiosa 0% (n=0) 
Ventricularis + fibrosa 0% (n=0) 
Ventricularis + spongiosa + 
fibrosa 
52.6% (n=10) 
Spongiosa + fibrosa 10.5% (n=2) 
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IL-6 
In the 20 valves stained IL-6 was present in all with a total density of 2.21 ± 2.43 cells/mm
2
 in 
the rheumatic valves. IL-6 was the most found in the spongiosa (95%, n=19) (Table 7.15). 
Table 7.15 Localisation of IL-6 
  % (N) 
Ventricularis 40% (n=8) 
Spongiosa 95% (n=19) 
Fibrosa 30% (n=6) 
 
Localisation 
 
Ventricularis (alone) 0% (n=0) 
Spongiosa (alone) 47.4% (n=9) 
Fibrosa (alone) 0% (n=0) 
Ventricularis + spongiosa 21.1% (n=4) 
Ventricularis + fibrosa 0% (n=0) 
Ventricularis + spongiosa + fibrosa 21% (n=4) 
Spongiosa + fibrosa 10.5% (n=2) 
 
 
IL-8 
In the 20 valves stained IL-8 was present in all with a total density of 1.89 ± 1.99 cells/mm
2
 in 
the rheumatic valves. IL-8 was mostly found in the fibrosa (40%, n=8) (Table 7.16). 
 
Table 7.16 Localisation of IL-8 
  % (N) 
Ventricularis 35% (n=7) 
Spongiosa 25% (n=5) 
Fibrosa 40% (n=8) 
 
Localisation 
 
Ventricularis (alone) 0% (n=0) 
Spongiosa (alone) 50% (n=10) 
Fibrosa (alone) 0% (n=0) 
Ventricularis + spongiosa 15% (n=3) 
Ventricularis + fibrosa 0% (n=0) 
Ventricularis + spongiosa + 
fibrosa 
20% (n=4) 
Spongiosa + fibrosa 15% (n=3) 
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Table 7.17 Summary of the found cytokine results 
Valve IL-1α IL-1b IL-2 IL-4 IL-6 IL-8 
RHD 2.56 ±2.67 2.70 ± 2.27 2.93 ±2.85 1.67 ±1.36 2.21± 2.43 1.89± 1.99 
* results are presented as number of positive cells/field (MEAN±SD) 
 
IL-10 
In the 24 valves stained IL-10 was present in 96% (n=23) of the RHD valves with a total density 
of 4.46 ± 3.18 cells/mm
2
 among the valves, ranging from 0 to 76 cells/mm
2
 and 5.25±1.06 
cells/mm
2
 in control valves (p=0.5). In the 19 valves analyzed for localization IL-10 was mostly 
found in the spongiosa of the other valves (94.7%, n=18) (Table 7.18). 
 
Table 7.18 Localisation of IL-10 
  % (N) 
Ventricularis 31.6% (n=6) 
Spongiosa 94.7% (n=18) 
Fibrosa 31.6% (n=6) 
 
Localisation 
 
Ventricularis (alone) 0% (n=0) 
Spongiosa (alone) 61.1% (n=11) 
Fibrosa (alone) 0% (n=0) 
Ventricularis + spongiosa 5.6% (n=1) 
Ventricularis + fibrosa 0% (n=0) 
Ventricularis + spongiosa + 
fibrosa 
27.8% (n=5) 
Spongiosa + fibrosa 5.6% (n=1) 
 
IL-12 
In the 20 valves stained IL-12 was present in 96% (n=23) with a total density of 4.13 ± 3.32 
cells/mm
2
 among the RHD valves, ranging from 0 to 35 cells/mm
2
 and 4.13±2.07 cells/mm
2
 in 
control valves (p=0.42). In the 19 valves analyzed for localization IL-12 was mostly found in the 
spongiosa (85%, n=17) (Table 7.19). 
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Table 7.19 Localisation of IL-12 
  % (N) 
Ventricularis 60% (n=12) 
Spongiosa 85% (n=17) 
Fibrosa 45% (n=9) 
 
Localisation 
 
Ventricularis (alone) 5.3% (n=1) 
Spongiosa (alone) 26.3% (n=5) 
Fibrosa (alone) 0% (n=0) 
Ventricularis + spongiosa 21.1% (n=4) 
Ventricularis + fibrosa 5.3% (n=1) 
Ventricularis + spongiosa + 
fibrosa 
31.6% (n=6) 
Spongiosa + fibrosa 10.5% (n=2) 
 
 
Table 7.20 Summary of the found IL-10 and IL-12 results 
Valve IL-10 
 
IL-12 
RHD 4.46±3.18 4.13±3.32 
Controls 5.25±1.06 4.13±2.07 
 (p-value) 0.5 0.42 
* results are presented as number of positive cells/field (MEAN±SD) 
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7.3.2.2 Relation between inflammatory cells and valvular cytokines 
The relation between the inflammatory cells and the valvular cytokines is shown in table 7.21.  
 
Table 7.21 Relation between inflammatory cells and valvular cytokines 
 Increase  
CD4
+
 CD8+ 
 IL-4 
(p=0.001) 
(p=0.036) 
CD45
+
 IL-10  (p=0.039) 
CD68
+
 IL-6 (p=0.041) 
VWF CD4+ 
CD8+  
CD 45+  
IL-4 
IL-12 
(p=0.011) 
(p=0.006) 
(p=0.00) 
(p=0.025) 
(p=0.020) 
IL-1b IL-6  
IL-12  
(p=0.045) 
(p=0.035) 
IL-2 IL-6  
IL-12  
(p=0.010) 
(p=0.010) 
IL-6 IL-12  (p=0.010) 
IL-8 IL-10 (p=0.018) 
IL-12 IL-1b 
IL-2 
IL-4 
IL-6 
IL-10 
(p=0.035) 
(p=0.010) 
(p=0.021) 
(p=0.037) 
(p=0.00) 
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7.4 Determinants of RF and RHD 
7.4.1 Factors influencing immune activation in valvular tissue  
The longer ago the RF attack, the higher the IL-6 (p=0.020) and a higher ASOT was related to a 
high IL-1α (p=0.010). Males tended to have a higher IL-4 expression in the valvular tissue than 
females (p=0.021) and individuals with a positive family history of RF tended to have higher 
valvular IL-4 levels (p=0.038). A high IL-8 was related to a higher lymphocyte count (p=0.018) 
and hemoglobin (p=0.014).  No correlation was found between a positive history for RF, the use 
of penicillin and valvular CD and IL and ECM levels.  
 
7.4.2 The influence of inflammatory parameters on valvular affection 
A negative correlation was found between the platelet count and the presence of structural 
affection (p=0.010) and diagnosis of RHD (p=0.027) showing that individuals with structural 
and RHD features tended to have a lower platelet count. 
No other correlation was found between the presence of structural, the functional affection 
and/or the diagnosis of RHD and the inflammatory parameters. No correlation was found 
between the inflammatory factors and the maintenance, development or regression of the 
features leading to the diagnosis of RHD during follow up. 
 
There was no correlation between the inflammatory factors and the maintenance, development or 
regression of the structural features during follow up. Individuals with a lower ASOT level 
tended to remain free of structural affection of the valves during follow up (p=0.008). 
The functional affection found during the first assessment tended to resolve in the individuals 
with a lower WBC (p=0.020). Strangely, individuals with a higher WBC tended to remain free of 
functional affection at the time of follow-up (p=0.003). 
 
7.4.3 Serum cytokines 
Individuals with structural valvular findings tended to have a higher level of serum TNF-α 
(0.025) while individuals with functional valvular findings tended to have a higher IL-6 serum 
level (p=0.046) and the higher the TNF-α level (p=0.012).  In addition, idividuals with the 
diagnosis of RHD tended to have a higher TNF-α (p-0.003). 
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Table 7.22 Influence of serum cytokines on valve tissue immune activation 
 Increase  
IL-1b  IL-4 valve (p=0.029) 
IL-8 IL-4 valve  (p=0.010) 
IL-10 IL-12 valve (p=0.011) 
 
 
7.4.4 Valvular cytokines 
An increase in elastin was correlated to an increase in CD4
+
 (p=0.001) and CD8
+
 (p=0.028). 
No correlation was found between the amount of valvular expression (CD, IL and ECM) and 
thickening of the leaflet, calcification, mitral regurgitation and aortic stenosis. Affection of the 
subvalvular apparatus was correlated with higher levels of valvular VWF (p=0.025) 
 
7.5 Discussion 
Our study population had a mean of 35 years and a normal gender distribution, which is fair 
when aiming to avoid valvular mechanisms other than RHD as degenerative, aging or gender 
dependent factors.  
In our series, CD4
+
 and CD45
+
 were found in all RHD valves while CD8
+
 was present in 88.2% 
of the valves. The presence of CD4
+
 and CD8
+
 T-cells in valvular tissue has been demonstrated 
(28,29) and chronic inflammatory cell infiltration with CD4
+ 
T-cells has been observed in both 
calcified and non calcified mitral valves from RHD patients. The highest number of both CD4
+
 
and CD8
+
 T-cells has been reported in patients presenting with rheumatic activity which 
indicates expansions of auto reactive T-cells in the heart during the acute episode and decrease in 
auto reactive T-cells numbers after the acute episode remaining important to maintain the heart 
lesions. (Sampaio 2007) Furthermore, the high frequency and the persistence of T-cell 
oligoclonal expansions in the damaged heart valves seems to be associated with the progression 
of the disease (Guilherme 2001), probably due to the T-cell recognition of several heart tissue 
proteins exposed by local lesions (Figueroa 2002). This indicates that both T-helper/inducer and 
T cytotoxic/ suppressor lymphocytes are involved in the development of lesions in rheumatic 
valvular inflammatory heart disease. Nevertheless, the presence of activated inflammatory cells 
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indicates ongoing inflammatory reaction, with an almost certain interaction with the overlying 
endothelium. Pathologically increased activated lymphocytic infiltrates in association with an 
enhanced expression of adhesion molecules can be regarded as a clear cut indication of a 
persisting chronic inflammatory process. 
The predominance of CD4
+
 T-cells and macrophages at the site of heart lesions in RHD (Raizada 
1985, Kemeny 1989) is apparently caused by the fact that adhesion molecules  such  as  VCAM-
1  facilitate  the  extravasation  of CD4
+
  and CD8
+
 T-cells  into  the  valves,  after  being up-
regulated on the vascular endothelium of the valve of ARF patients (Guilherme 1995), 
suggesting a direct role for these cells in the pathogenesis of RHD (Raizada 1985, Kemeny 
1989). Therefore, it is believed that CD4
+
 T-lymphocytes are the major effectors of heart lesions 
and display a degenerate pattern of antigen recognition (Guilherme 2004
2
). Predominance of 
macrophages has also been demonstrated in immunohistochemical studies (Raizada 1985, 
Kemeny 1989) and CD8
+
 and CD68
+
, glycoproteins expressed on monocytes/macrophages, were 
found in 88.2% and 79.2% of the RHD valves analyzed in our series, respectively. 
It is known that Th1 cytokines play an important role in certain organ-specific autoimmune 
diseases (Libiau 1995, Falcone 1999) and seem also to be predominant in heart lesions, 
especially valvular lesions (Guilherme 2004
2
) In our series IL-2, IL-6 and IL-8 was found in all 
RHD valves while IL-1α was found in 75% of the RHD valves.  IL-1b, IL-4, IL-10 and IL-12 
were found in over 90-95% of the RHD valves confirming a major role of inflammatory 
cytokines in rheumatic valvular lesions.  
An increased expression of IL-1b has been demonstrated in stenotic aortic valves in association 
with an infiltrate of leukocytes. In contrast, control valves have been reported to show only 
scattered leukocytes and no staining for IL-1b. IL-1 is  expressed  mainly  by  leukocytes,  but 
can also be seen in local myofibroblasts, fibroblasts (Fini 1994, Siwik 2000), and smooth muscle 
cells (Galis 1994, Galis 1995) and belongs  to  a  family  of  cytokines  that  play  an  important 
role in the regulation of acute inflammation. The expression of IL-1b in leukocytes and 
myofibroblasts in stenotic valves suggests an activation of these cells. Thus, activated leukocytes 
may, by secretion of IL-1, promote an inflammatory microenvironment in stenotic aortic valves 
that, in turn, leads to activation of local interstitial cells. Therefore, IL-1 is believed to be a 
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prototypical pro-inflammatory cytokine (Dinarello 1984, Dinarello 1996, Bazan 1996) and might 
be associated with RHD.  
Furthermore, the production of IL-1, TNFa and IL-2 has been correlated with progression of the 
Aschoff nodules in heart lesions during the acute phase of RHD, localized mainly in the 
endocardium, subendocardium or perivascular regions of the myocardial interstitium (Fraser 
1997). Moreover, an increased expression of the interleukin-2 receptor has been shown on 
leukocytes in stenotic aortic valves (Olsson 1994). 
In our series IL-4 was found in 95% of the fragments analyzed. This is surprising as earlier 
reports of sparse production of the regulatory cytokine IL-4 by valve-infiltrating intralesional 
mononuclear cells (under 10% IL-4-positive cells) in the majority of valve fragments of both 
acute RF and chronic RHD patients, in combination with large numbers of IL-4-positive  cells  
(over  50%)  in the myocardium fragments analyzed suggest that low numbers of IL-4-producing 
cells in the  valvular  tissue  might  contribute  to  the progression of valvular RHD lesions 
(Guilherme 2004
2
, Guilherme 2005
3
). However, in our series IL-4 showed the lowest amount of 
positive cells among the tested cytokines. Importantly, it is believed that RHD lesions are 
mediated by inflammatory cytokines with low numbers of IL-4 producing cells in the valvular 
tissue contributing to the development and progression of valvular tissue damage in RHD, and 
perpetuating or exacerbating the production of inflammatory cytokines (TNF-α and IFN-γ) 
leading to permanent damage in the valves (Guilherme 2005
3
, Guilherme 2004
2
, Guilherme 
2004). 
IL-10 and IL-12 positive cells were the most prominent in our series in concordance to earlier 
reports that show that IL-10 positive cells, a predominantly Th-2 regulatory cytokine, are 
consistently predominant in both myocardium and valvular tissue (Guilherme 2005-3, Guilherme 
2004-2, Guilherme 2004) suggesting that despite the presence of Th2 cells, they are probably not 
sufficient to down-regulate the deleterious effect of Th-1 cytokines, predominant mainly in the 
valves (Guilherme 2004
2
). 
Normally, no infiltration is expected in normal valve tissue. However, in our series the control 
valves showed infiltration of all cells analyzed. This might be due to the fact that both valves 
were from individuals with 56 and 62 years of age, and that these valves could have been in a 
degenerative process, which might be caused by identical mechanisms as valvular damage due to 
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accelerated damage in RHD. It is very difficult to collect healthy human valvular tissue for 
analysis, as most of the collected tissue might be affected by other mechanisms which might be 
similar to the end result of RHD. 
When compared to normal valves, the RHD valves showed a lower expression of all cells except 
NFKB and an equal expression of IL-12, although with a bigger SD, showing that the amount of 
IL-12 positive cells varies in the different valves. The biggest difference was found in the 
amount of CD8
+
, CD45
+
 and CD68
+
, although, there was no significant correlation between the 
control and the RHD valves. 
 
Mediators of valvular affection 
A lower ASOT level at the time of assessment is related to absence of structural lesions which 
might suggest that high ASOT levels might be indicators or risk factors for the development of 
structural affection. Diagnosis of RHD was related to a lower platelet count, while high IL-6 
levels were related to functional lesions. Importantly, structural, functional and RHD features 
were related to high TNF-α levels while a lower WBC was an indicator for reversibility of the 
functional affection. 
All cytokines were present in the majority of the valves, however, the presence and grade of 
staining was increased for IL-10 and IL-12. IL-4 was found in the majority of the valves, 
however, it showed the lowest grade of staining. The presented results suggest that an increase in 
IL-10 and IL-12 are the major regulatory cytokines in mediating valvular damage, while an 
increase of IL-2, IL-6 and IL-8 might also contribute to the pathogenesis. Importantly, till date 
IL-6 and IL-12 had not been reported to be elevated in RF and RHD.  IL-1α was found only in 
75% of the valves, however, it showed an increase grade in staining, suggesting its contribution 
to valvular lesions. Importantly, IL-4 was present in the majority of the valves, however, in a 
lower amount compared to the other cytokines, suggesting that a decrease in IL-4 contributed to 
the valvular affection. An increase in serum IL-10 and a decrease in IL-1b and IL-8 seem to be 
indicators for the development of valvular lesions, as they seem to be related to an increase of 
valvular IL-12 and decrease of IL-4. Moreover, high lymphocyte counts and ASOT indicate an 
increase of IL-8 and IL-1α, respectively. 
Chapter 7 Immune response in RF and RHD 
 
242  
 
 
Rheumatic Heart Disease in Egypt 
 
 
Variables that seem to correlate with valvular lesions include older age at the time of the RF 
attack and female gender which seem be related to an increase in valvular IL-6 and decrease of 
IL-4. However, younger age at the time of screening, which is related to a younger age at the 
time of the first RF attack was related to a decrease of haemal IL-1b, leading to decrease of 
valvular IL-4, which might be a negative prognostic indicator. 
 
7.6 Conclusions  
In Egypt, lower ASOT and WBC levels seem to suggest a lower level of infection while high 
TNF-α and IL-6 levels seem to be an indicator of disease. Furthermore, an increase in serum IL-
10 and decrease in IL-1b and IL-8 seem to be indicators for the development of valvular lesions.  
In our series, CD4+, CD8+ and CD45+ were found in the majority of valves, which seems to be 
associated with the progression of the disease (Guilherme 2001, Figueroa 2002) with IL-10 and 
IL-12 being the major regulatory cytokines in mediating valvular damage, while IL-2, IL-6 and 
IL-8 might also contribute to the pathogenesis. Therefore, it is believed that T lymphocytes are 
the major effectors of heart lesions and display a degenerate pattern of antigen recognition 
(Guilherme 2004
2
). Nevertheless, the presence of activated inflammatory cells indicates ongoing 
inflammatory reaction suggesting that an ongoing immunological reaction is still present in the 
apparently quiescent phase of the disease, which might mediate the valvular affection seen in 
RHD. 
CD4
+
 T-cells are suggested the major effectors of the heart tissue, leading to RHD lesions in 
Egypt as Streptococcal and host antigen cross-reactive antibodies facilitate heart tissue 
infiltration by T-lymphocytes. Therefore, inflammatory cytokines such as, TNF-α and others 
seem to be mediators of valve lesions and the decrease of IL-4, a regulatory cytokine, seems to 
be related to the pathogenesis valve lesions in RHD patients.  
The presented results illustrate earlier observations describing how the predominant Th1-type 
cytokine produced mainly by CD4
+
 T-cells infiltrating valve tissue could mediate the severe 
RHD valve lesions, with the pattern of cytokine production in the heart lesions favouring a Th1-
mediated disease.  
The raised WBC and lymphocyte count found in our study, nevertheless the use of penicillin 
prophylaxis, are signs of ongoing infection, common seen in ARF. Furthermore, elevated ESR 
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and CRP levels suggest maintenance of acute phase inflammation. However, the elevated 
inflammatory parameters may be related to the short interval since the RF attack or the presence 
of recurrences. In Egypt, a low platelet count and high ASOT seem to be risk factors for cardiac 
affection while reversibility of functional lesions is related to a lower WBC. Importantly, 
penicillin prophylaxis results in a lower WBC and CRP and a higher platelet count, showing the 
importance of use and compliance to the regimen.  
Based on the presented results that show immune activation there is evidence of the presence of 
an ongoing immunological reaction in an apparently quiescent phase of the disease in Egypt. The 
presence of several proinflammatory cytokines in peripheral blood as well as valvular tissue of 
RF and RHD patients enforces the hypothesis of a major role of inflammatory cytokines in 
mediating heart lesions earlier suggested. Importantly, disease seems more severe in females and 
in those who acquire RF at an older age and is related to non-compliance to the penicillin 
prophylaxis. 
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8.1 Background 
RHD valves have shown altered architecture and histology (Sampaio 2007), which seem to lead 
to distortion of valve function and mechanics. We hypothesized that the inflammation process 
seen in RHD changes the valvular histology and architecture, affecting the location, features and 
characteristics of the different areas of the valve. The aim was to analyze the structural 
characteristiscs of RHD valves from Egypt to determine the changes caused by the disease and 
the related determinants of RHD. 
 
8.2 Patients and methods 
Individuals admitted at the Cardio-thoracic department of the NHI, Imbaba, Cairo and scheduled 
for valve replacement due to RHD were recruited as described in chapter 3, pg. 75. 
 
Sample collection 
Excised valves from the individuals recruited were collected during the procedures. The valvular 
tissue was stored in formalin directly after collection and then embedded in paraffin as described 
in chapter 3, pg. 89. The samples were transported to the HSC for histology and 
immunohistochemistry analysis. 
The condition of the normal valves is expected to be the same and there was no significant 
difference in the results found. We have therefore reported the combined results for an easier 
overview and comparison of the results. The reason that we have only used 2 control valves is 
due the fact that it is very difficult to collect healthy human valvular tissue.  
Histology Analysis 
Staining was graded as mild, moderate and intense depending on intensity of the staining. 
 
Grading: 
Mild (1+) - Weak staining. 
Moderate (2+) – Moderate expression and staining of the fragment 
Intense (3+) – Intense staining of the fragment 
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Van Gieson staining: Sections were dewaxed in xylene and immersed in 100% alcohol and 
stained with Miller‘s Elastin (VWR) for 2 hours. This was followed by differentiation in 90% 
methanol and washing in tap water and distilled water. The sections were incubated with Van 
Gieson for 5 minutes and then rehydrated rapidly and mounted with DPX. 
 
Alcian Blue/ Sirius red staining: Sections were dewaxed and rehydrated in water and then the 
nuclei were stained with Weigests Haematoxylin A + B for 10 minutes. This was followed by 
differentiation in Acid Alcohol, washing in distilled water, staining with Alcian Blue 0.5% for 
15-20 minutes then washing with distilled water. The sections were then stained with 
phosphomolybdic acid 1% acid for 20 minutes, washed with distilled water, then stained with 
Sirius Red for 1 hour. The sections were dehydrated with alcohol and mounted with DPX. 
 
Statistical analysis 
The statistical analysis was performed as described in chapter 3, pg 100. 
 
8.3 Results 
Human Rheumatic Valves and Control Valves 
Valve tissues were collected at the time
 
of surgery. We obtained 24 human rheumatic valves 
from patients (n=24, mean age,
 
35.42 years, range, 14 to 63 years, male, 13, female, 11) at
 
the 
time of surgical valve replacement. We compared them to 2 control valve tissue (n=2, gender: 
male, age:, 56 and 62 years) obtained by autopsy.  
 
Calcification 
Macroscopic inspection of the valve fragments after collection revealed calcification in 80.2% 
(n=19) of the valves. 
 
Neovascularisation 
Haematoxylin stained sections showed neovascularisation in 71.4% (n=17) of the RHD valves as 
VWF stains endothelial cells in the blood vessels showing vascularisation in valves.  
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Histology staining of the Valves for ECM proteins   
Elastin fibres and sulphated GAG distribution 
A total of 19 valves were stained for ECM proteins. The Elastin Van Gieson staining showed 
that there was an increase of elastic fibres in the RHD valves. Furthermore, elastic fibres 
appeared to be fragmented and were distributed throughout the leaflet (84.2%, n=16).  In the 
normal leaflet elastin fibres was localized mostly in the ventricularis (Figure 8.1).  In the RHD 
valves, elastin fibres was also mostly found in the ventricularis in 14 of the 19 valves studied, 
however was present in all areas (ventricularis, spongiosa and fibrosa) in one of the valves.  
 
Figure 8.1 Elastin van Gieson staining in control valve (A) and RHD valve (B), respectively. 
(dark purple= elastin fibres, pink= collagen) The elastin fibres seem to be fragmented and 
distributed throughout the whole leaflet in the RHD valve while it is localized mostly in 
ventricularis in the control valve. * Ventricularis, arrow = fragmented elastin 
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Figure 8.2 Magnification of elastin staining in RHD valve (B1) 
 
 
Table 8.1 Strength and distribution of Elastin Van Gieson staining 
 
 
 
 
 
 
 
 
 
 
 
Table 8.2 Localisation of elastin fibres 
 
 
  %  N 
Score for staining strength   
Weak 5.3%  1 
Intermediate  15.8% 3 
Intense 78.9% 15 
   
Distribution   
Ventricularis 73.7%  14 
Spongiosa 63.2%  12 
Fibrosa 10.5%  2 
   
Fragmented 84.2%  16 
Localisation  N 
Ventricularis (only) 31.6%  6 
Spongiosa (only) 26.3%  5 
Fibrosa (only) 0%  6 
Ventricularis + spongiosa 31.6%  1 
Ventricularis + fibrosa 5.3%  1 
Ventricularis + spongiosa + 
fibrosa 
5.3%  1 
Spongiosa + fibrosa 0%  0 
Chapter 8 Structural and Biochemical characteristics of RHD 
 
249  
 
 
Rheumatic Heart Disease in Egypt 
 
 
   
Figure 8.3 Alcian Blue staining in control (C) and RHD valve (D), respectively.  
 
GAGs 
Alcian blue staining in a total of 19 valves demonstrated that in the RHD valves leaflets 
sulphated GAG distribution and the amount was comparable to normal valves. GAGs were the 
most prominent the spongiosa (84.2%, n=16), followed by the fibrosa of 10.5% (n=2) valves and 
the least in the ventricularis (5.3%, n=1).  
 
Table 8.3 Strength and distribution of GAGs 
  %  N 
Score for staining strength   
Weak 26.3%  5 
Intermediate  26.3%  5 
Intense 
 
47.4%  9 
Distribution   
Ventricularis 5.3%  1 
Spongiosa 84.2%  16 
Fibrosa 10.5%  2 
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VWF 
A total of 7 valves were stained for VWF which was present in all (n=7) RHD valves with a total 
density of 3.01±3.77 cells/mm
2
 among the valves. VWF was the most prominent in the 
spongiosa (100%, n=7) (Table 8.4). 
 
Table 8.4 Strength and distribution of VWF 
  %  N 
Ventricularis 85.7%  6 
Spongiosa 100%  7 
Fibrosa 42.9% 3 
 
Localisation 
  
Ventricularis (only) 0%  0 
Spongiosa (only) 0%  0 
Fibrosa (only) 0%  0 
Ventricularis + spongiosa 57.1%  4 
Ventricularis + fibrosa 0%  0 
Ventricularis + spongiosa + 
fibrosa 
28.6%  2 
Spongiosa + fibrosa 14.3%  1 
 
 
Staining of the Valves for Collagen 
Collagen types I, III  
Immunohistochemistry studies on Collagen types I and III show that collagen I was increased in 
the coapting edge and predominantly found in the spongiosa. Collagen III was mostly found in 
the spongiosa and ventricularis of the RHD valves.   
 
Collagen I  
Collagen I was present in the spongiosa of all valves stained (n=20), and in the ventricularis of 
63.2% (n=12) and the fibrosa of 57.9% (n=11) of the valves. Most of the collagen I was 
fragmented (94.7%, n=18) and shifted from its natural location (89.5%, n=17). Furthermore, the 
total amount of collagen I was decreased in 84.2% (n=16) of the valves compared to normal 
valves. 
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Table 8.5 Strength and distribution of collagen I 
  % (N) 
Score of staining strength  
weak 47.4% (n=9) 
Intermediate  26.3% (n=5) 
Distribution  
Ventricularis 63.2% (n=12) 
Spongiosa 100% (n=19) 
Fibrosa 57.9% (n=11) 
  
Fragmented 94.7% (n=18) 
Distribution  
Normal  10.5% (n=2) 
Shifted 89.5% (n=17) 
Amount  
Normal 15.8% (n=3) 
Increased 0% (n=0) 
Decreased 84.2% (n=16) 
 
Table 8.6 Localization of collagen I 
Localization  
Ventricularis (alone) 0% (n=0) 
Spongiosa (alone) 26.3% (n=5) 
Fibrosa (alone) 0% (n=0) 
Ventricularis + spongiosa 15.8% (n=3) 
Ventricularis + fibrosa 0% (n=0) 
Ventricularis + spongiosa + 
fibrosa 
47.4% (n=9) 
Spongiosa + fibrosa 10.5% (n=2) 
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 Figure 8.4 Collagen I staining in control valve (J) and RHD valve (K), respectively. * Ventricularis, 
arrow = collagen I 
 
Collagen III 
Collagen III was present in the spongiosa and ventricularis of all valves stained (n=20), and the 
fibrosa of almost all valves (94.7%, n=18). Collagen III was present in the ventricularis, 
spongiosa and fibrosa in 94.7% (n=18) of the valves. All collagen III present in the valves was 
fragmented (100%, n=19) and most was shifted from its natural location (84.2%, n=16). The 
amount of collagen III was normal in most valves (63.2%, n=12) compared to normal valves. 
 
 
Figure 8.5 Collagen III staining in control valve (L) with collagen mainly in the fibrosa and RHD 
valve (M) where the staining seems to be shifted to the middle, respectively. * fibrosa 
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Table 8.7 Strength and distribution of collagen III 
  % (N) 
Score  
weak 0% (n=0) 
Intermediate  15.8 (n=3) 
intense 84.2% (n=16) 
Distribution  
Ventricularis 100% (n=19) 
Spongiosa 100% (n=19) 
Fibrosa 94.7% (n=18) 
 
Fragmented 
100% (n=19) 
Distribution  
Normal  15.8% (n=3) 
Shifted 84.2% (n=16) 
Amount  
Normal 63.2% (n=12) 
Increased 31.6% (n=6) 
Decreased 5.3% (n=1) 
 
Table 8.8 Localization of collagen III 
Localization  
Ventricularis (alone) 0% (n=0) 
Spongiosa (alone) 0% (n=0) 
Fibrosa (alone) 0% (n=0) 
Ventricularis + spongiosa 5.3% (n=1) 
Ventricularis + fibrosa 0% (n=0) 
Ventricularis + spongiosa + 
fibrosa 
94.7% (n=18) 
Spongiosa + fibrosa 0% (n=0) 
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8.4 Discussion 
In our series the stained sections of the diseased valves showed distortion of normal architecture. 
However, this was not surprising as RHD valves have shown altered architecture and histology, 
including fibrosis, calcification and neovascularization (Sampaio 2007) as well as changes in the 
collagen, elastin and GAGs distribution and localization, which seem to lead to distortion of 
valve function and mechanics. 
 
The amount of elastic fibres found was increased and predominantly fragmented, and could be 
found throughout the whole leaflet while in normal valves it was found in the ventricularis (Scott 
1995). However, elastic fibers have been reported to be increased with age (Gallegos 2005, 
Bashey 1967) and in pathological valves (Imayama 1989). Therefore, the found results might 
suggest that the pathology RHD affects the elastic fibres in the valve, accelerating the 
mechanism of aging in the valve. VWF was found in all RHD valves, but predominantly in the 
spongiosa and not lining the ventricularis as expected.  
 
Only the GAG distribution and amount was comparable to normal valves, which together with 
water form the main components of the spongiosa (Scott 1995). This is not as we had expected 
as the composition and amount of GAGs is known to vary based on the type of mechanical 
loading (Grande-Allen 2004) as seen in valve affection, and the fact that altered GAG 
composition has been shown to play an important role in several heart valve diseases. However, 
our findings might be due the fact that GAG composition and amount might not be affected by 
inflammatory mechanisms associated with RHD. 
Collagen I was found mainly fragmented and shifted to the spongiosa, although present in all 
areas of the leaflets and Collagen III was present in normal amounts but was fragmented and 
shifted predominantly to the spongiosa of the RHD valves. This is surprising as collagen with 
only a small amount of elastin is primarily found in fibrosa (Clark 1974). Importantly, the 
collagen in the fibrosa is more organized than in the ventricularis. However, damage to the 
elastin  network  alters  the mechanics and accelerates mechanical degeneration, enforced by the 
Chapter 8 Structural and Biochemical characteristics of RHD 
 
255  
 
 
Rheumatic Heart Disease in Egypt 
 
 
additional effects of fragmentation of elastin and reconformation and slippage of collagen fibers 
(Viidik 1982) which might explain the distorted location of the collagen fibers.  
The presented results showing changes in elastin and collagen amount, localization and 
distribution suggest that changes in valve mechanics in RHD might be due to the changes in the 
elastin and elastic fibres in combination with changes in valvular collagen as the valve function 
and mechanics rely on an interaction between elastin and collagen conditions and changes of 
which the folded shape of the valve is dependent. Importantly, the function of elastin is highly 
dependent on its configuration and relative content in the valve and specially its organization 
relative to collagen.  Furthermore, valvular elastin seems to act as a ‗housekeeper‘ that restores 
the collagen fibre geometry back to its original  conformation  between  successive  loading 
cycles, and is therefore critical to proper valve function (Vesely 1998) which shows how changes 
in elastin can affect the collagen fibres and therefore the valvular function, leading to damage of 
the valve. 
 
Collagen I has been found to be decreased in aortic stenosis compared to normal aortic valves, 
despite a two- to three-fold increase in type I procollagen synthesis indicating an increased 
turnover of type I collagen in aortic stenosis, with degradation exceeding the synthesis. 
Importantly, this finding seemed to be more predominant around calcified nodules. However, the 
amount of collagen III did not show changes and the proportions of type I and type III collagens 
remained preserved. These results could implicate that RHD influences the decrease in collagen I 
as found in our series leading to the calcification and the resulting valvular damage (Eriksen 
2006). 
 
Features like fibrosis and neovascularization have been observed in most of RHD valves, 
indicating that the valve has gone through previous episodes of rheumatic activity and it is 
believed that the degree of fibrosis is also proportional to the number of acute episodes (Sampaio 
2007). In our series, neovascularization was seen in 71.4% of the RHD valves, confirming the 
earlier suspicions. Calcification is a feature that suggests chronic valvular involvement (Sampaio 
2007). Furthermore, calcification in diseased/distorted valves in RHD as recent studies indicate 
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that calcification is not merely an inactive, "dystrophic" process but involves a regulated 
inflammatory process associated with expression of osteoblast markers and neoangiogenesis 
(Chopra 2007). 
The composition of the mitral and aortic valves is very similar, being composed mostly of 
collagen and GAGs with elastin constituting a much smaller fraction of valve substance (Gross 
1931, McMillan 1964, Sell 1965). However, alterations in valve tissue composition start to differ 
between the mitral and aortic valves as the valves age. The proportion of constituent GAGs and 
elastin increases significantly in the mitral valve between the third and sixth decades of life, 
while there is a concomitant decrease in the proportion of collagen. Surprisingly, the GAG 
content in aortic valves does not change significantly with advancing patient age. 
Collagen fibers appear thicker and more disoriented with time in the mitral valve while in the 
aortic valve aging shows that modest decrease in relative collagen content is accompanied by a 
dramatic increase in elastin (McDonald 2002). The similarity between the mitral and aortic 
valves suggests that the mechanisms affecting the valves in RHD might be equal, leading to 
similar pathology. 
 
8.5 Conclusion 
Distortion of normal architecture was found in the majority of the studied valves as expected in 
RHD which is characterized by altered architecture and histology as well as composition. 
Features like fibrosis and neovascularization have been suggested to be the result of 
inflammatory process and rheumatic activity. The increase of elastic fibres suggests that the 
pathology RHD affects the elastic fibres in the valve, accelerating the mechanism of aging in the 
valve. Nevertheless, changes in the collagen, elastin and GAGs distribution and localization, 
seem to lead to distortion of valve function and mechanics as these features rely on an interaction 
between elastin and collagen conditions. Moreover, the function of elastin is highly dependent on 
its configuration and relative content in the valve and specially its organization relative to 
collagen. Therefore, fragmentation and dislocation of the majority of valvular components alters 
the valve mechanics and accelerates mechanical degeneration. The presented results also show 
that the mechanisms related to RHD differ from degenerative lesions, being more dependent of 
collagen conditions and minerals rather than cholesterol.   
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9.1 Background 
Penicillin remains the drug of choice for treatment of streptococcal infections, and ever since 
penicillin was first introduced all strains have remained exquisitely sensitive to this antibiotic. 
(Betriu 1989, Brook 1984, Kim 1985) However, in recent years, increasing rates of macrolide 
resistance have been described in various regions of the world (Michos 2009, Bingen 2004, 
Green 2006, Perez-Trallero 2007) and it is believed that changes in the prescription pattern of 
antibiotics or macrolide consumption could theoretically have an impact on the macrolide 
resistance rates (Bergman 2004, Fujita 1994).  
The resistance for Erythromycin, which is currently recommended as an alternative antibiotic for 
treatment of GAS infections in patients allergic to B-lactams or in cases of penicillin failure 
(Lowbury 1959, Bisno 1996, Maruyama 1979, Zackrisson 1988, Trallero 1989, Linares 1992, 
Hsueh 1995, Wu 1997, Cornaglia 1998) has been reported to reach up to 100% (Liu 2009). 
Furthermore, resistance to clarithromycin, azithromycin, and clindamycin has been detected with 
resistance rates ranging up to 44.8%, 19.2% and 23.2%, respectively (Kim 1985). Therefore, the 
increase in macrolide resistance among streptococci is a concern, as they are the common 
regimen for the treatment of streptococcal infections.  
The aim of this study was to determine the antimicrobial susceptibilities of B-hemolytic strains 
cultured from throat swabs of individuals with history of RF or RHD and evaluate the 
effectiveness of penicillin prophylaxis in these cases. It is also important to identify the current 
antibiotic sensitivity and resistance rate in our region for the best treatment regimen for 
streptococcal infections. 
 
9.2 Patients and methods 
Individuals visiting the outpatient clinic or admitted at the Cardio-thoracic department of the 
NHI were recruited as described in chapter 3, pg. 75.  
 
The study population consisted of: 
 Group I: -Individuals with a positive history of RF visiting the centre for penicillin  
                prophylaxis with or without cardiac involvement 
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-Individuals visiting the NHI outpatient clinic for suspicion of RF or RHD  
 Group II: Patients admitted for RHD and scheduled for valve replacement.  
 
Sample collection 
A throat swab was taken and streaked immediately across a blood agar plate for culturing of the 
organism as described in chapter 3, pg. 90. The B-hemolytic strains cultured from the throat 
swabs were analyzed for the antibiotic sensitivity. 
 
Culturing 
 The swab was streaked immediately after collection across a blood agar plate 
 The blood agar plate was allowed to incubate at (35°–37°C) for 24–48 hours to allow the 
growth of bacteria 
 After incubation the colonies on the agar plates were analyzed 
 Hemolytic colonies were identified  
 
Sensitivity testing: Susceptibility testing is used to determine which antimicrobial inhibits the 
growth of the bacteria causing the infection. If the bacteria are susceptible to a particular 
antibiotic, an area of clearing surrounds the wafer where bacteria are not capable of 
growing (called a zone of inhibition). The size of the zone and the rate of antibiotic 
diffusion are used to estimate the bacteria‘s sensitivity to that particular antibiotic. The 
results from this test helps determine which antibiotic is the most effective in treating the 
infection. 
 
 Antibiotics tested:  
 Levofloxacin 5 mcg (BioAnalyse) 
 Erythromycin 15 mcg (BioAnalyse) 
 Vancomycin 30 mcg (BioAnalyse) 
 Ciprofloxacin 5 mcg (BioAnalyse) 
 Gentamycin 10 mcg (BioAnalyse) 
 Doxycicline 30 mcg (BioAnalyse) 
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 Penicillin 10U (BioAnalyse) 
 Bacitracin 10U (BioAnalyse) 
 Taxo- differentiation discs (Benex Limited) 
 
Detailed steps: 
 Samples of the identified colonies were re-streaked on antibiotic agar plates  
 Antibiotic discs were placed on the agar plate 
 After incubation the colonies on the agar plates were analyzed for the growth pattern 
 The antibiotic sensitivity was analyzed  
 
Statistical analysis 
The statistical analysis was performed as described in chapter 3, pg 95.  
9.3 Results 
From the total of 309 throat swabs collected, 16.18% (n=50) showed growth of B-hemolytic 
organisms. All cultures were sensitive to Ciprofloxacin and Levofloxacin. Three (6%) cultures 
were intermediately sensitive while 11 (22%) were resistant to Vancomycin. One (2%) culture 
was intermediately sensitive while 2 (4%) were resistant to Penicillin. Five (10%) cultures were 
intermediately sensitive while 14 (28%) were resistant to Gentamycin. Two (4%) cultures were 
intermediately sensitive while 4 (8%) were resistant to Erythromycin. One (2%) culture was 
intermediately sensitive while 1 (2%) were resistant to Doxycycline.   
One (2%) culture was intermediately sensitive for Erythromycin and resistant to Gentamycin, 
while 1 (2%) culture was additionally resistant to Vancomycin. Two (4%) cultures were resistant 
to Vancomycin and Gentamycin. Resistance to Gentamycin and Erythromycin was seen in 1 
(2%) culture, while another culture was intermediately sensitive to Vancomycin. One (2%) 
culture was resistant to Vancomycin, Penicillin and Gentamycin.  
 
 
 
Determinants of antibiotic sensitivity 
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Females tended to show higher resistance rates to Vancomycin, Gentamycin and Doxycycline, 
while males showed higher resistance to erythromycin (Table 9.1). Younger patients tended to 
show more often resistance to erythromycin (p=0.045), and although not significantly correlated, 
older patients tended to show higher rates of resistance to Vancomycin (p=0.080).  
History of RF and the presence of recurrences was related to higher resistance rates for all 
antibiotics and individuals on penicillin prophylaxis showed more often resistance to the tested 
antibiotics (Figure 9.2). A shorter time since the first RF attack was related to an increase in 
resistance to Gentamycin. No relation was found between the penicillin schedule and compliance 
and the resistance profile for the tested antibiotics. However, no significant correlation was 
found between the gender, history RF, recurrence, penicillin prophylaxis and the resistance to 
antibiotic.  
 
Table 9.1 (1) Distribution of antibiotic resistance 
 
 
Vancomycin Penicillin Gentamycin 
Intermediate Resistant Intermediate Resistant Intermediate Resistant 
Male 2% (n=1)  8% (n=4) 0% (n=0) 2% (n=1)  4% (n=2) 14% (n=7) 
Female 2% (n=1)  14% (n=7) 2% (n=1)  2% (n=1) 4% (n=2) 14% (n=7) 
       
History of RF 4% (n=2) 20% (n=10)  2% (n=1) 2% (n=1) 6% (n=3) 24%(n=12) 
No history RF 0% (n=0) 2% (n=1) 0% (n=0) 2% (n=1) 2% (n=1) 4% (n=2) 
       
Recurrences 4.9% (n=2)  14.6% (n=6) 2.4% (n=1) 2.4% (n=1) 7.3% (n=3) 26.8% (n=11) 
No 
recurrences    
recurrences 
0% (n=0) 9.8% (n=4) 0% (n=0) 0% (n=0) 0% (n=0) 2.4% (n=1) 
       
Penicillin 4.0% (n=2) 20% (n=10) 2% (n=1) 4.0% (n=2) 8.0% (n=4) 24.0% (n=12) 
No penicillin 0% (n=0) 2% (n=1) 0% (n=0) 0% (n=0) 0% (n=0) 4.0% (n=2) 
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Table 9.1 (2) Distribution of antibiotic resistance 
 Erythromycin Doxycycline 
 Intermediate Resistant Intermediate Resistant 
Male 0% (n=0) 6% (n=3) 0% (n=0) 0% (n=0) 
Female 4% (n=2) 2% (n=1) 2% (n=1) 2% (n=1) 
     
History of RF 4% (n=2) 8% (n=4) 2% (n=1) 2% (n=1) 
No history RF 0% (n=0) 0% (n=0) 0% (n=0) 0% (n=0) 
     
Recurrences 4.9% (n=2) 7.3% (n=3) 2.4% (n=1) 2.4% (n=1) 
No 
recurrences    
recurrences 
0% (n=0) 2.4% (n=1) 0% (n=0) 0% (n=0) 
     
Penicillin 4.0% (n=2) 8.0% (n=4) 2% (n=1) 2% (n=1) 
No penicillin 0% (n=0) 0% (n=0) 0% (n=0) 0% (n=0) 
 
 
 
 
Figure 9.1 Distribution of antibiotic resistance by gender 
 
0% 
2% 
4% 
6% 
8% 
10% 
12% 
14% 
I R I R I R I R I R 
Vancomicin Penicillin Gentamicin Erythromicin Doxycycline 
Male 
Female 
Chapter 9 Streptococcal sensitivity to antibiotics 
 
263  
 
 
Rheumatic Heart Disease in Egypt 
 
 
 
Figure 9.2 Distribution of antibiotic resistance by history of RF, recurrences and penicillin use 
 
9.4 Discussion 
The resistance for penicillin found in our series was surprising as all streptococcal strains have 
been reported to remain exquisitely sensitive and susceptible to Vancomycin (Ciftci 2003, Betriu 
1993) and penicillin till date (Horn 1998, Betriu 1993), which is interesting, although the reason 
for this unique lack of development of resistance to penicillin is still unknown (Horn 1998). 
However, penicillin failure has also been reported in up to 10- 25% for streptococcal disease, 
(Stillerman 1986, Holm 1995) especially due to penicillin tolerance (Grahn 1987, Kim 1985
2
). 
Importantly, the presented results show for the first time resistance to Vancomycin in 22% of the 
cases, with intermediate sensitivity in 6% of the cases.  
Resistance to erythromycin has been reported in 5% to 44.8% of the strains (Ciftci 2003, Koh 
2010, Kim 1985) with a significant prevalence of Erythromycin resistant streptococci around the 
world (Maruyama 1979, Zackrisson 1988, Trallero 1989, Linares 1992, Hsueh 1995, Wu 1997, 
Cornaglia 1998). However, in our series the resistance for Erythromycin was 8%, with 
intermediate sensitivity in 4%. These results do not support the theory of the substantial increase 
in erythromycin resistance which has been associated with the increase in the consumption of 
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macrolide antibiotics (Ciftci 2003), however, these findings might be dependent on 
epidemiological and geographic factors.  
Our series shows cross resistance of several strains for different combinations of antibiotics, 
especially Gentamycin, Erythromicin and Vancomycin and indicate a concern regarding 
tolerance and increased resistance rates for Vancomycin and Gentamycin, with also a slight 
tolerance or resistance to Penicillin. This is of high importance when selecting the best treatment 
regimen for streptococcal disease and indicates new public health concerns. The resistance rates 
and profiles found, which have been related to increase or excessive use of macrolide antibiotics 
show the importance to determine the geographic prevalence of resistant strains and resistance 
profiles to facilitate and improve clinical care.  
The gender differences in resistance rates could not be explained in our study. However, 
resistance to erythromycin seems related to the male gender and younger age, while older 
patients tend to show resistance to Vancomycin.  
The fact that history of RF and the presence of recurrences were related to higher resistance rates 
for all antibiotics might be due the fact that this resistance results in development and 
recurrences of RF due to antibiotic failure. Interestingly, individuals on Penicillin prophylaxis 
showed more often resistance to the tested antibiotics, which might be related to excessive and 
prolonged consumption of antibiotics. These results should be considered when prescribing 
antibiotic treatment and prophilaxis regimens and might have huge impact on clinical care. 
 
9.5 Conclusions 
Our series shows significant resistance for Penicillin and Vancomycin in Egypt, while the 
resistance to erythromycin was not shown to be as common as expected. Importantly, cross 
resistance for different combinations of antibiotics was found, indicating new public health 
concerns when treating streptococcocal infection. The presented results suggest that the 
resistance to antibiotic regimens might be the cause of development and recurrences of RF, being 
therefore a determinant factor for the development of RHD in Egypt. This study underlines the 
importance to determine the geographic prevalence of resistant strains and resistance rates and 
profiles for an improvement in clinical care. It also points to the importance of limiting antibiotic 
consumption to prevent decreased sensitivity and cross resistance to antibiotics.  
  
 
 
 
 
 
CHAPTER 10 
 
 
ANTIGENIC TARGETS FOR EVALUATION AND 
DIAGNOSIS OF STREPTOCOCCAL INFECTION 
  
Chapter 10 Antigenic targets for evaluation and diagnosis of streptococcal infection 
 
266  
 
 
Rheumatic Heart Disease in Egypt 
 
 
10.1 Streptococcal strain responsible for RF in Egypt 
RF is believed to be caused by repeated infections with group A (GAS), and recently group C 
and G streptococci have been identified as possible causative pathogens. Furthermore, the variety 
in M-types of GAS caused by variations in emm gene sequences leads to different characteristics 
and rheumatogenic potential of the strains adding to the complexity of the pathogenesis of RF.  
The variety in causative strains, their rheumatogenicity and geographic variety have led to 
difficulties in the understanding of the epidemiology of streptococcal disease, while RF and 
RHD remain major health care concerns. Importantly, the geographical variety in types of 
streptococcal strains and their rheumatogenicity has not been clarified till date. This study was 
designed to identify the particular strain of Streptococci responsible for RF/RHD in Egypt and its 
rheumatogenicity through serotyping for the particular type of M protein as well as DNA studies 
of the genes which encode these virulence factors (emm). 
 
10.1.1 Patients and Methods 
Individuals visiting the outpatient clinic or admitted at the Cardio-thoracic department of the 
NHI were recruited as described in chapter 3, pg. 75.  
 
The study population consisted of: 
 Group I: -Individuals with a positive history of RF visiting the centre for penicillin  
                prophylaxis with or without cardiac involvement 
-Individuals visiting the NHI outpatient clinic for suspicion of RF or RHD  
 Group II: Patients admitted for RHD and scheduled for valve replacement.  
 
Sample collection 
A throat swab was taken and streaked immediately across a blood agar plate for culturing of the 
organism as described in chapter 3, pg. 90. 
 
Culturing 
 The swab was streaked immediately after collection across a blood agar plate 
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 The blood agar plate was allowed to incubate at (35°–37°C) for 24–48 hours to allow the 
growth of bacteria 
 After incubation the colonies on the agar plates were analyzed 
 Hemolytic colonies were identified  
 
The cultured organisms were stored in THB as follows: 
 Samples of the identified colonies were collected with a sterile loop 
 Sterile loop were stabbed in THB agar tubes 
 The tubes was allowed to incubate at (35°–37°C) for 24–48 hours  
 The agar tubes were stored at 4°C for a maximum of 3 weeks 
 The tubes were transported to the Helmholtz Centre at room temperature 
 
10.1.2 Results and discussion 
The cultured organisms were stored in THB prior to their transport to the Helmholtz Centre for 
analysis. Unfortunately, upon arrival, none of the organisms was retrieved.  
To rule out technical failure, the protocol for culturing and storage of the organisms was revised 
and a pilot of 25 new samples was collected from the same patient group and in the same 
conditions. However, this has not led to retrieval of organisms for serotyping for the particular 
type of M protein as well as DNA studies of the genes for profiling of the emm gene sequences 
and determining the geographical variety of the strains and their rheumatogenic potential.  
We have therefore, been unable to identify the particular strain of Streptococci responsible for 
RF/RHD in Egypt and its rheumatogenicity. 
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10.2 The potential of PARF as a diagnostic marker 
It has been shown that rheumatogenic streptococcal strains are able to bind and aggregate human 
collagen and that the development of RF and RHD is related to the formation of a streptococcal 
autoantigenic complex with human collagen
 
IV with binding and aggregation to collagen through 
an octapeptide in M proteins of rheumatogenic strains, PARF (peptide associated with rheumatic 
fever). Furthermore, a collagen
 
autoimmune response accompanied by specific reactivity against
 
the collagen-binding proteins has been shown in sera of RF patients, linking the observed effect 
to
 
clinical cases. PARF is therefore believed to play a crucial role in the pathogenesis of RF 
through its action on collagen, making it a promising candidate for diagnosis of rheumatogenic 
streptococcal strains. This study aims at shedding more
 
light on regional characteristics of RF 
pathogenesis trough identification of the causative bacteria and the value of PARF as a 
diagnostic marker for the early detection of rheumatogenic strains (Dinkla 2007). This included 
Collagen-binding assays were performed for the evaluation and analysis of the binding between 
the octapeptide PARF and collagen IV and the potential of PARF as a diagnostic marker for
 
the 
early detection of rheumatogenic strains and the diagnosis of RHD. 
 
10.2.1 Patients and Methods 
Individuals visiting the outpatient clinic or admitted at the Cardio-thoracic department of the 
NHI were recruited as described in chapter 3, pg. 75.  
 
The study population consisted of: 
 Group I: -Individuals with a positive history of RF visiting the centre for penicillin  
                prophylaxis with or without cardiac involvement 
-Individuals visiting the NHI outpatient clinic for suspicion of RF or RHD  
 Group II: Patients admitted for RHD and scheduled for valve replacement.  
 
Sample collection  
Blood was collected by venipuncture into 1 non-additive tube as described in chapter 3, pg. 88. 
The serum samples were analyzed by collagen-binding assays for the evaluation and analysis of 
the collagen IV binding and the potential of PARF as a diagnostic marker.  
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Detection of collagen-reactive antibodies in patient sera 
To determine anti-collagen antibody  titers,  plates  (Greiner,  Frickenhausen,  Germany) were 
coated overnight at 4°C with anti–human CIV rabbit serum (Progen Biotechnik GmbH) diluted 
1:100 in coating buffer, blocked with 2% BSA in PBS, and incubated with CIV (2 µg/ml in PBS) 
for 1 hour at room temperature.  
Patient sera (diluted 1:50 to 1:50,000 in serial dilutions in PBS) were added to wells and 
incubated for 1 hour at 4°C. After washing, a 1:5,000 dilution of HRP-conjugated rabbit anti-
human IgG (Sigma-Aldrich) was added and incubated for 1 hour at 37°C.  
Antibody binding was detected using 2,2-azino-di-[3-ethylbenzthiazoline sulfonate] 
diammonium salt (ABTS) tablets (Boehringer Ingelheim GmbH, Mannheim, Germany) as 
substrate. The absorbance was determined at 405 nm in triplicates. 
The cutoff titer for CIV was defined as 165 calculated from sera from healthy controls. Serum 
titers were obtained in independent assays and normalized against a rheumatic fever serum 
included in all tests for standardization. 
 
10.2.2 Results and discussion 
Testing of the protocol for detection of collagen-reactive antibodies in test sera (Rheumatic 
Fever serum) prior to the analysis of the collected patient samples resulted in insufficient levels 
of collagen and failed to show collagen reaction. This has led to revision and evaluation of the 
protocol. 
The protocol was revised and adapted as follows: 
  
-The dilution of CIV was decreased to 1:20 and 1:2 
-The 1 hour incubation with CIV was was replaced by overnight incubaction. 
-The dilution of the sera was decreased up to 1:1 and a finaly, undiluted serum was used. 
-The 1 hour incubation of the sera was replaced by overnight incubaction.  
-The dilution of HRP-conjugated rabbit anti-human IgG was decreased from 1:5,000 to 1:3,000 
and 1:2,000 
-The 1 hour incubation of the HRP-conjugated rabbit anti-human IgG was replaced by overnight 
incubaction. 
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Finally, newly acquired and prepared CIV, CIV rabbit serum, BSA, HRP-conjugated rabbit anti-
human IgG and ABTS were tested. However, the anti-collagen antibody titers remained bellow 
significance threshold to allow analysis and comparison and the tests were therefore labeled 
negative for the collagen reaction.  
 
As we were unable to show any collagen reaction in the test sera, which was positive for 
Rheumatic Fever we have therefore been also unable to test the collagen reaction in our collected 
samples, analyze the aggregation between rheumatogenic streptococcal strains and human 
collagen and evaluate the formation of a streptococcal autoantigenic complex with human 
collagen
 
IV through PARF. This has also led to the fact that we were also unable to test the role 
of PARF in the pathogenesis of RF and its potential of PARF as a diagnostic marker for
 
the early 
detection of rheumatogenic strains and the diagnosis of RHD. 
 
10.3 Conclusions 
We have failed in the aims of this study and in shedding more
 
light on regional characteristics of 
RF pathogenesis trough identification of the causative bacteria and the value of PARF as a 
diagnostic marker for the early detection of rheumatogenic strains.  
Unfortunately, the methods used today are still insufficient and need revision and evolution in 
order to satisfy the aims of this chapter. This shows the need and importance of more research 
focused on the antigenic features of the disease to define the mechanisms related to the 
pathogenesis of RF and evaluate the proposed formation of a streptococcal autoantigenic 
complex with human collagen
 
IV through PARF and its potential as a diagnostic marker for RF 
and RHD. 
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11.1 Conclusions 
Our project describes a series of studies on the epidemiology, clinical and laboratory profile of 
RF and RHD, a major health challenge and one of the leading neglected diseases worldwide.  
This condition affects several million people throughout the world, especially children and 
young adults. However, the true disease burden has been underestimated with many gaps in our 
knowledge of its pathogenesis and mechanisms, owing to the almost total lack of 
echocardiographic screening for this condition and little attention from the scientific community 
in the last decades leading to few important initiatives and little research. 
Echocardiography is a successful screening tool to diagnose subclinical cardiac affection which 
benefits from identification and thence secondary prevention. However, there has been debate 
concerning the echocardiographic signs of early RHD and the diagnostic criteria to be used. 
Our study has attempted at using modern tools and innovative approaches to investigate RF and 
RHD, and integrates large-scale epidemiological studies with clinical research and laboratory 
investigations aiming at unveiling the pathogenesis of the disease. Our main results concern 
epidemiology, diagnosis and pathogenesis of RF and RHD and have raised new interrogations 
regarding the mechanisms involved. 
 
EPIDEMIOLOGY 
Echocardiographic screening has shown that RHD is common in Egypt, affecting up to 69.2% of 
the individuals with history of RF and around 23 in 1,000 school children in Aswan. This leads 
to the calculated estimates that around 16% of the Egyptian population might have signs of the 
disease.  
 
CLINICAL MANIFESTATION 
RF 
In Egypt, RF presents predominantly in children and young adults, however, it can affect adults 
as well. There are considerable variations in the prevalence of the symptoms and clinical 
manifestation of RF in different areas and age groups showing the need for a validation of the 
clinical diagnostic criteria. Recurrences are very common, and may contribute to the rapid 
progression to advanced valvular RHD. The disease awareness affects the use and compliance to 
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the penicillin prophylaxis and the success with secondary prophylaxis is critically dependent on 
patient education.  
 
RHD 
Our series confirms the predominance of mitral valve affection, with regurgitation being the 
most common feature in individuals with history of RF in Egypt. However, in overt RHD, 
combination of lesions is more predominant. Nevertheless, the amount of mitral stenosis was 
comparable to earlier studies.   
Over 90% of the RHD cases found in school children in Aswan were subclinical, presenting 
predominantly by mitral regurgitation. Aortic or combined valvular lesions are less common and 
no stenosis was found in this young population.   
 
Diagnosis 
Clinical diagnosis has shown insufficient, resulting in under-diagnosis of cardiac affection in RF 
and RHD in Egypt. Echocardiography enables detection of cardiac affection in early phases of 
the disease in individuals who might benefit from secondary prevention with penicillin 
prophylaxis, resulting in major potential public health benefits.  
Since echocardiography uncovers the presence of asymptomatic disease we conclude that it is 
the most powerful tool for screening of subclinical RHD, however, there are no universally 
agreed criteria for the echocardiographic diagnosis of RHD. As the most characteristic 
echocardiographic features of RHD are composed of a combination of structural and functional 
affection, we propose the use of diagnostic criteria which combines the functional and structural 
characteristics of the disease.  
 
Determinants 
Variables that correlate with severity of valve disease in Egypt include age, gender, age at the 
time of the first RF attack, family history for RF, recurrences of RF attacks, poor disease 
awareness and non-compliance to penicillin prophylaxis.  
Younger patients are more at risk for the development of structural, functional and RHD features 
while older patients are more at risk of sustaining the found RHD features, with RF attacks at a 
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younger age being a risk factor for the development of RHD. However, mitral stenosis is more 
common in individuals reporting an older age at the time of the first RF attack. Cardiac affection 
seems more severe in males with a higher incidence and sustainability of functional lesions and 
RHD as well as increase in the amount of mixed lesions. Diagnosis by cardiac symptoms, 
recurrences and a longer time since the first RF attack are indicators for the presence and 
sustenance of structural and structural lesions.  
A lower disease awareness and non-compliance to penicillin prophylaxis or a regimen with an 
interval longer than 15-days result in the development of structural as well as functional valvular 
lesions and sustenance of RHD features. Furthermore, a penicillin regimen with an interval 
longer than 15-days between the injections is a risk factor for the development of structural and 
RHD features. Furthermore, resistance to the antibiotic regimens seems to lead to development 
and recurrences of RF, being therefore a risk factor for the development and severity of RHD.  
 
Antibiotic regimens 
There is a significant resistance for Penicillin and Vancomicin in Egypt, with cross resistance for 
different combinations of antibiotics indicating new obstacles in the treatment of RF and 
prevention of RHD.  
 
Prognosis 
The outcome of RF is not well established, however, development, sustainance as well as 
deterioration of rheumatic valvular lesions are common in RHD while reversibility is related to 
adherence to antibiotic prophylaxis. However, in Egypt, structural or functional affection alone 
are more often sustained than the combination of both and functional affection are more prone to 
develop and less prone to resolve than the structural affection.  
Echocardiographic follow-up should be encouraged to assess the progression and long term 
outcome of the valvular affection as well as the response to medical treatment and prophylaxis. 
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MECHANISMS OF THE DISEASE 
Cellular features in RF and RHD 
The presented results suggest the presence of immune activation and an ongoing immunological 
reaction in an apparently quiescent phase of the disease with a major role attributed to several 
proinflammatory cytokines in peripheral blood as well as valvular tissue in mediating heart 
lesions in RF and RHD patients. The presented results illustrate how the predominant Th1-type 
cytokines produced mainly by CD4+ T cells infiltrating valve tissue could mediate the severe 
RHD valve lesions as streptococcal and host antigen cross-reactive antibodies facilitate heart 
tissue infiltration by T lymphocytes. Importantly, valvular lesions seem more severe in females 
and in those who acquire RF at an older age and is related to non-compliance to the penicillin 
prophylaxis. 
 
Structural features in RF and RHD 
Our series shows distortion of normal architecture, histology and composition in RHD valves. 
Fibrosis, calcification and neovascularization as well as changes in the collagen, elastin and 
GAGs distribution and localization are common features in RHD, are the result of inflammatory 
process and rheumatic activity and lead to distortion of valve function and mechanics. 
The pathology of RHD affects the elastic fibres in the valve leading to acceleration of the 
mechanism of aging in the valve. The changes in the collagen, elastin and GAGs distribution, 
localization and configuration, lead to distortion of valve function and mechanics as these 
features are dependent on an interaction between elastin and collagen conditions, which is highly 
dependent on its configuration and relative content in the valve and specially its organization 
relative to collagen.  
 
Antigenic targets for evaluation and diagnosis of streptococcal infection 
Unfortunately, the mechanisms known today are still not sufficient to explain the pathogenesis 
and mechanisms of RF or determine the antigenic targets for the evaluation and diagnosis of 
streptococcal infection. More epidemiological and laboratory work is needed to analyze and 
evaluate the role of PARF in the formation of the autoantigenic complex that seems to be the key 
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mechanism for the development of RF and RHD and analyze and evaluate the potential of PARF 
as a diagnostic marker for RF and RHD.  
 
11.2 Future directions 
This study shows high rates of RHD in Aswan, however, the prevalence in other parts of Egypt 
remains unknown.Current accurate data from Egypt remains lacking, while a high prevalence of 
RHD is expected around the country, showing the urgent need for more systematic 
echocardiography screenings to identify individuals at risk and determine the true disease 
burden. RF is a notifiable condition in Egypt, however, no measure has been taken till date to 
ensure that cases are enrolled in registers and are offered secondary prophylaxis with regular 
penicillin injections, leading therefore to insufficient compliance to the penicillin regimen. 
Registration of RF and RHD cases in high burden countries is crucial, as a measure to ensure 
control of the disease through the implementation of registry based secondary prophylaxis 
programs to improve the compliance to the penicillin prophylaxis. 
The epidemiological research has established cohorts of individuals who are well phenotyped by 
echocardiographic examination, and whose follow up will give new insights into the mechanisms 
and determinants of this condition as well as the long term prognosis. Future research should 
include prospective case-control studies to identify the mechanisms of the disease, and define the 
determinants involved in the pathogenesis. The cohort of school children established in this study 
will be followed up regurlarly, with collection of samples for determination of the cellular and 
humoral mechanisms of the disease for the determinants of the disease and the long term 
prognosis.  
 
We have confirmed that echocardiographic diagnosis of subclinical RHD is superior and more 
specific than clinical diagnosis and detection of a murmur. Therefore, there is the need to define 
a new classification of characteristics of valvular affection and lesions in RHD for evaluation and 
validation of the echocardiographic diagnostic criteria to be used in screening purposes as well as 
clinical diagnosis and management of patients. For this purpose, development of universally 
agreed criteria for the echocardiographic diagnosis of RHD is essential, as well as the most 
appropriate screening approach to be used, as early detection of subclinical RHD and application 
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of and adherence to secondary prevention lead to major public health benefits by decrease of the 
morbidity and mortality. However, this will require broader epidemiological research, with larger 
cohort and evaluation of the criteria used.  Importantly, standardization of the echocardiographic 
criteria will allow comparison of prevalence in different areas and improve case detection.   
 
Apart from its importance for indication of the true disease burden and detect those in danger of 
developing or progressing into valvular disease and application of secondary prevention, 
screening programs in different parts of the world where the disease is common, are essential for 
understanding the pathogenesis of the disease, developing new specific diagnostic methods and 
importantly helping the development of effective vaccines.  
Long-term follow-up is necessary, nonetheless, to define the clinical significance of subclinical 
rheumatic valve lesions and determine the outcome of subclinical echocardiographic evidence of 
valvar disease and the effect of secondary prophylaxis. The serial use of echocardiography in 
patients with RHD is helpful in finding the progression or regression of the disease and will help 
determine the development, characteristics, progression and reversibility of valvular lesions. On  
the  other  hand  research  should  concentrate  on the prognostic  value  of  the different 
structural and functional features found by echocardiography. 
 
Although we have succeeded in providing new insighs in different aspects of RF and RHD in 
Egypt, the presented results are irrefutable proof of the need for more laboratory, 
epidemiological, and clinical research. 
Routine laboratory assessment of the major inflammatory parameters and acute phase indicators 
such as ESR and CRP correlates with the magnitude and severity of inflammation as well as 
disease activity (Lane et al 2002, Wagner-Weiner 2002), however, the levels and distribution of 
these infection parameters in different areas, as a response to RF, especially in a quiescent phase 
of the disease is unknown. Additional research is needed to evaluate the value of inflammatory 
parameters in the diagnosis of RF and their role as prognostics indicators of disease.  
 
A major role is suggested for inflammatory cytokines in mediating RF and RHD (Guilherme 
2009) as they appear  to  play  a  crucial  role  in  triggering immunologic  and  inflammatory  
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reactions  in  RF. Their presence in peripheral blood of acute RF and active RHD patients (Yegin 
1997, Miller 1989, Morris 1993, Narin 1995, Samsonov 1995) as well as valvular tissue, leads to 
the suggestion of their contribution to the mediation of heart lesions (Guilherme 2009). 
Furthermore, cellular infiltration with a predominance of CD4
+
 T-cells (Guilherme 1995) and 
some CD8
+
 T-cells is found in patients that present rheumatic activity (Guilherme 2001). 
However, the immune response and signs of immune activation vary regarding the 
characteristics of the cellular as well as the humoral response.  
The low cytokine levels found in our studies are surprising as their role in the pathogenesis of RF 
and RHD has been suggested to be determinant. Several cytokines have been reported to increase 
in RF and RHD due to their activity as stimulators of T-cells and for being in combination with 
other cytokines important mediators of inflammatory reactions (Miller 1989) (Morris 1993) and 
playing a role in anti-inflammatory reactions (Yegin 1997). Furthermore, IL4 is of clinical 
importance in inflammatory diseases and autoimmune diseases as it inhibits the production of 
inflammatory cytokines such as IL1, IL6 and TNF-alpha (Guilherme 2005
3
). TNF-a mediates 
part of the cell mediated immunity against obligate and facultative bacteria and parasites and is 
required for normal immune responses (Narin 1995, Samsonov 1995, Yegin 1997, Miller 1989, 
Morris 1993, Narin 1995, Yegin 1997) and is suggested to play an important role in the initiation 
of multisystemic inflammatory response in RF and in the pathogenesis of RHD (Yegin 1997, 
Settin 2006). The presented results confirm the presence of an ongoing immunological reaction 
in apparently quiescent phase of the disease with sustenance of raised inflammatory parameters 
in RF and RHD. Nevertheless, further studies are needed to validate the analysis of the 
inflammatory parameters and pro- and anti-inflammatory cytokines for the evaluation of the 
signs of immune activation in RF and RHD for the recognition of potential inflammatory 
parameters to monitor RF activity and determine the role of inflammatory cells and cytokines in 
mediating RF and RHD. Furthermore, the  definition  of  the  biological  profile  of  RF and RHD  
is  of  paramount importance, particularly the clarification of the role of the immunological 
reaction and immune activation as well as inflammatory parameters and cytokines in mediating 
RF and RHD. 
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The altered architecture and histology shown in RHD valves (Sampaio 2007), which seems to 
lead to distortion of valve function and mechanics should be investigated in greater depth. The 
inflammation process related to RHD seems to lead to changes in the valvular histology and 
architecture, affecting the location, features and characteristics of the different areas of the valve, 
however, the precise mechanisms remain unclear. 
 
Research  focusing on all these issues should be performed using valvular tissue and blood  
obtained  from  participants  in  prospective  studies,  since  it  could  be  of  value  for unveiling  
the  sequence  of  events  that  lead  to  cardiac lesions.  On the other hand, better understanding 
of the development and progression of the lesions and identification of specific markers of injury 
is mandatory.   
Another area of future research will be the genetics aiming at clarification of the role of  heredity  
in  determining  familial  predisposition  and  the immunogenetic  susceptibility found  in  earlier  
studies.  This could be done through  genetic  epidemiological  studies  in  endemic  and  non-
endemic  areas,  looking  for  candidate  genes  known  to  have  a  role  in RF and RHD,  as  
well  as  searching  for  genetic  polymorphisms  to  biological  markers  with relevance to the 
mechanisms of the immune activation and immunological reaction related to the disease.  
 
We aimed to analyze and evaluate the role of PARF in the formation of the autoantigenic 
complex that seems to be the key mechanism for the development of RF and RHD. It is crucial 
to evaluate the potential of PARF as a diagnostic marker for RF and RHD in Egypt for early 
detection of rheumatogenic strains and recognition of patients at risk of developing RF and RHD 
and in need for clinical management and prophylaxis. Unfortunately, the mechanisms known 
today are still not sufficient to fully explain the pathogenesis of RF and re-evaluations of data 
and epidemiological
 
studies are needed to shed more
 
light on regional characteristics of RF 
pathogenesis and evaluate the potential of PARF as a diagnostic marker for RF and RHD. This 
demonstrates the importance of continuous monitoring of the molecular epidemiology of GAS 
strains and comparison of these strains on a large scale for the appropriate selection of treatment 
agents and efforts for infection control.   
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We have planned a new trial, with collection of new samples and revision of the protocols and 
methods to satisfy these aims and to contribute to elucidation of the mechanisms and the 
antigenic targets of the disease, as well as the development of new diagnostic markers for RF and 
RHD. 
 
Our study shows worrying resistance to different antibiotics, which might lead to an increase in 
development and recurrences of RF and subsequently an increase in incidence and severity of 
RHD. This shows the need to determine the geographic prevalence of resistant strains and 
resistance rates and evaluate the regimens used in the treatment of streptococcal disease. 
Furthermore, there is an urgent need for limiting antibiotic consumption to prevent decreased 
sensitivity and cross resistance to antibiotics.  
 
Geographic variation in prevalence and characteristics of RF and RHD has been recognized 
within countries. We aknowledge that the results presented in this thesis reflect the situation in 
one specific region with high prevalence of RF and RHD. However, replication of similar 
programs of translational research in endemic countries will allow indepth analysis of the 
epidemiological and clinical characteristics of RF and RHD, the mechanisms involved in its 
pathogenesis and determining factors as well as the validation  of  the echocardiographic  criteria  
proposed  by  us  for  diagnosis  of  early  disease. Standardized national registries should be 
implemented for the encouragement of penicillin prophylaxis and follow up of the cardiac 
involvement in order to prevent the development and deterioration of the cardiac affection and 
the determination of the long term outcome.  
We believe that this thesis addresses critical  issues  regarding  the  epidemiological and clinical 
characteristics including improved diagnostic criteria as well as the cellular and structural 
features of RF and RHD, contributing  to  better understanding of the disease in Egypt,  and will 
hopefully stimulate  further  research looking at elucidation of the pathogenesis and new 
therapeutic targets for the disease. 
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Appendix I 
Population: 83,082,869 (July 2009 est.) 
Age structure: 0-14 years: 31.4%  
(male 13,345,500/female 12,743,878) 
15-64 years: 63.8%  
(male 26,823,127/female 26,169,421) 
65 years and over: 4.8%  
(male 1,701,068/female 2,299,875) (2009 est.) 
Median age: total: 24.8 years 
male: 24.4 years 
female: 25.2 years (2008 est.) 
Population growth rate: 
Population density 
1.642% (2009 est.) 
84 persons per sq km (2009 est.) 
Birth rate: 22.12 births/1,000 population (2008 est.) 
Death rate: 5.09 deaths/1,000 population (2008 est.) 
Sex ratio: at birth: 1.05 male(s)/female 
under 15 years: 1.05 male(s)/female 
15-64 years: 1.02 male(s)/female 
65 years and over: 0.74 male(s)/female 
total population: 1.02 male(s)/female (2009 est.) 
Life expectancy at birth: 
 
Urbanization 
Urban 
Rural 
total population: 72.12 years 
male: 69.56 years 
female: 74.81 years (2009 est.) 
42% (2005 est.) 
58% (2005 est.) 
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Appendix III 
Area Age group N 
children 
in area 
Representation 
of area 
N needed 
to screen in 
area 
Representation 
of age groups 
N needed to 
screen in 
age group 
1 
5 y 18     0.21% 1 
6 y \ 12 y 6334 
  
74.60% 370 
13 y \ 15 y 2136     25.17% 125 
Total  8488 16.50% 495     
2 
5 y 12     0.55% 12 
6 y \ 12 y 1495 
  
68.70% 87 
13 y \ 15 y 670     30.77% 39 
Total  2177 4.20% 127     
3 
5 y 626     4.35% 37 
6 y \ 12 y 8603 
  
60.00% 502 
13 y \ 15 y 5145     35.80% 300 
Total  14374 27.90% 839     
4 
5 y 47     2.10% 3 
6 y \ 12 y 1448 
  
67.50% 85 
13 y \ 15 y 648     30.20% 38 
Total  2143 4.10% 125     
5 
5 y 230     1.54% 14 
6 y \ 12 y 10991 
  
73.80% 641 
13 y \ 15 y 3674     24.70% 214 
Total  14895 28.98% 869     
6 
5 y 316     4.00% 18 
6 y \ 12 y 5598 
  
69.00% 327 
13 y \ 15 y 2184     27.00% 128 
Total  8098 15.75% 473     
7 
5 y 0     0.00% 0 
6 y \ 12 y 740 
  
39.70% 30 
13 y \ 15 y 487     60.30% 43 
Total  1227 2.38% 72 2.38%   
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Appendix IV 
 
 Number 
of 
children  
screened 
Amount of 
children  
Age group Name of school Area 
370  523 6 y \ 12 y Mostafa Kamel 1 
125 308 13 y \ 15 y Shawky Abed  
12 
87 
12 
123 
5 y 
6 y \ 12 y 
AlKoba AlGedieda 2 
39 91 13 y \ 15 y Ahmed Saber  
37 155 5 y Ali Nasser 3 
502 962 6 y \ 12 y   
300 825 13 y \ 15 y AlMo2assa2  
3 47 5 y Mogame3 
ElMahmoudeya 
4 
85 769 6 y \ 12 y   
38 648 13 y \ 15 y Abdel Sabour 
AlGuilawy 
 
14 22 5 y   5 
641 1181 6 y \ 12 y AlArwa Alwasska  
214 639 13 y \ 15 y   
18 71 5 y El Gomhoreya 6 
327 499 6 y \ 12 y    
128 526 13 y \ 15 y   
30 234 6 y \ 12 y Mahmoud Ibrahim  7 
43 487 13 y \ 15 y Abdelkhalek Allam  
* In area 1 and 7 there are no schools in the cathegory of 5 years of age  
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Appendix VI 
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